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Available online 4 December 2015Background: A recent meeting of international imaging experts sponsored by the International Spinal Research
Trust (ISRT) and the Wings for Life Foundation identiﬁed 5 state-of-the-art MRI techniques with potential to
transform the ﬁeld of spinal cord imaging by elucidating elements of the microstructure and function: diffusion
tensor imaging (DTI), magnetization transfer (MT), myelin water fraction (MWF), MR spectroscopy (MRS), and
functional MRI (fMRI). However, the progress toward clinical translation of these techniques has not been
established.
Methods: A systematic review of the English literature was conducted using MEDLINE, MEDLINE-in-
Progress, Embase, and Cochrane databases to identify all human studies that investigated utility, in terms
of diagnosis, correlation with disability, and prediction of outcomes, of these promising techniques in pa-
thologies affecting the spinal cord. Data regarding study design, subject characteristics, MRI methods, clin-
ical measures of impairment, and analysis techniques were extracted and tabulated to identify trends and
commonalities. The studies were assessed for risk of bias, and the overall quality of evidence was assessed
for each speciﬁc ﬁnding using the Grading of Recommendations Assessment, Development and Evaluation
(GRADE) framework.
Results: A total of 6597 unique citations were identiﬁed in the database search, and after full-text review of
274 articles, a total of 104 relevant studies were identiﬁed for ﬁnal inclusion (97% from the initial database
search). Among these, 69 studies utilized DTI and 25 used MT, with both techniques showing an increased
number of publications in recent years. The review also identiﬁed 1 MWF study, 11 MRS studies, and 8 fMRI
studies. Most of the studies were exploratory in nature, lacking a priori hypotheses and showing a high
(72%) or moderately high (20%) risk of bias, due to issues with study design, acquisition techniques, and
analysis methods. The acquisitions for each technique varied widely across studies, rendering direct com-
parisons of metrics invalid. The DTI metric fractional anisotropy (FA) had the strongest evidence of utility,
with moderate quality evidence for its use as a biomarker showing correlation with disability in several
clinical pathologies, and a low level of evidence that it identiﬁes tissue injury (in terms of group differences)
compared with healthy controls. However, insufﬁcient evidence exists to determine its utility as a sensitive
and speciﬁc diagnostic test or as a tool to predict clinical outcomes. Very low quality evidence suggests that
other metrics also show group differences compared with controls, including DTI metrics mean diffusivity
(MD) and radial diffusivity (RD), the diffusional kurtosis imaging (DKI) metric mean kurtosis (MK), MT
metrics MT ratio (MTR) and MT cerebrospinal ﬂuid ratio (MTCSF), and the MRS metric of N-
acetylaspartate (NAA) concentration, although these results were somewhat inconsistent.
Conclusions: State-of-the-art spinal cord MRI techniques are emerging with great potential to improve the
diagnosis andmanagement of various spinal pathologies, but the current body of evidence has only showed
limited clinical utility to date. Among these imaging tools DTI is the most mature, but further work is nec-
essary to standardize and validate its use before it will be adopted in the clinical realm. Large, well-designed
studies with a priori hypotheses, standardized acquisition methods, detailed clinical data collection, andKeywords:
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193A.R. Martin et al. / NeuroImage: Clinical 10 (2016) 192–238robust automated analysis techniques are needed to fully demonstrate the potential of these rapidly evolv-
ing techniques.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Contents1. Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
2. Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
2.1. Electronic literature search . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
2.2. Data extraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
2.3. Data analysis and synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
2.4. Risk of bias for individual studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
2.5. Overall quality of the body of literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
3.1. Study selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
3.2. Methodology and risk of bias of individual studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
3.3. Acquisition techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 198
3.4. Analysis methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 198
3.5. Evidence regarding diagnostic utility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
3.6. Evidence regarding biomarker utility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
3.7. Evidence regarding predictive utility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
3.8. Evidence summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
4. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
4.1. Interpreting the evidence in the context of risk of bias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
4.2. The design of imaging studies for clinical translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
4.3. State-of-the-art spinal cord MRI acquisition techniques: a work in progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
4.4. State-of-the-art imaging deserves state-of-the-art analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
4.5. Statistical analysis: a big data problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
4.6. Limitations of this study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
4.7. Future directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
5. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
Appendix A. Electronic literature search terms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
A.1. Medline in-process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
A.2. Embase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
A.3. CCTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
A.4. CDSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
Appendix B. Ratings of risk of bias for individual studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
Additional References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
5
7
9
31
36
371. Background
The advent of magnetic resonance imaging (MRI) in the mid-1980s
transformed the ﬁeld of spinal cord imaging and provided clinicians
with high-resolution anatomical images, directly leading to improved
clinical decision-making. Conventional MRI techniques (spin echo,
gradient echo, and inversion recovery sequences, with T1-, T2-, or
proton density-weighting) have continued to mature over 3 decades
of use, establishing MRI as the imaging modality of choice for most spi-
nal disorders. However, conventional MRI provides little information
regarding the health and integrity of the spinal cord tissue itself, due
to the fact that signal intensity changes are non-speciﬁc and do not
correspond directly with aberrant physiological processes (Wada
et al., 1995). This is reﬂected in the poor correlation of conventional
MRI data with neurological and functional impairment in various spinal
cord pathologies (Tetreault et al., 2013;Wilson et al., 2012), and failure
to provide reliable prognostic information. In the degenerative condi-
tion cervical spondylotic myelopathy (CSM), weak correlates with
clinical status have been identiﬁed using T2-weighted hyper-intensity
(T2w-HI), T1-weighted (T1w) hypo-intensity, and measures of cord
compression (Matsuda et al., 1999; Tetreault et al., 2013; Wada et al.,
1995). In multiple sclerosis (MS), numerous studies have found that
spinal cord lesion load is less important than atrophy, measured as the
cross-sectional area (CSA) of the cord (Stevenson et al., 1998). As a result,conventional MRI techniques are of limited value in developing imaging
biomarkers or predicting clinical outcomes because they are not sensitive
and speciﬁc measures of the degenerative and regenerative changes that
occur within the spinal cord at the microstructural and functional levels.
A 2013 international meeting of spinal cord imaging experts, spon-
sored by the International Spinal Research Trust (ISRT) and the Wings
for Life (WfL) Spinal Cord Research Foundation, outlined 5 emerging
MRI techniques that have the potential to revolutionize the ﬁeld, by
elucidating details of the microstructure and functional organization
within the spinal cord (Stroman et al., 2014; Wheeler-Kingshott et al.,
2014). This group highlighted the following techniques due to their
ability to characterize microstructural features of the spinal cord:
diffusion tensor imaging (DTI), magnetization transfer (MT), myelin
water-fraction (MWF), and magnetic resonance spectroscopy (MRS).
DTI measures the directional diffusivity of water, and several of the
metrics that it produces correlate with axonal integrity, and to a lesser
degree, myelination (Wheeler-Kingshot et al., 2002). MT involves an
off-resonance saturating pre-pulse that takes advantage of the chemical
and magnetization exchange between protons bound to lipid macro-
molecules and nearby water protons, and provides a surrogate measure
of myelin quantity (Graham and Henkelman, 1997). This is most often
expressed in a ratio between scans with and without the pre-pulse
(MTR) or between the spinal cord and cerebrospinal ﬂuid (MTCSF).
MWF estimates the fraction of tissuewater bound to themyelin sheath,
194 A.R. Martin et al. / NeuroImage: Clinical 10 (2016) 192–238by ﬁtting the T2 relaxation curve to a multi-exponential model and
identifying the fraction of the signal with a T2 parameter between 15
and 40ms (Wu et al., 2006). MRS quantiﬁes either the absolute or rela-
tive concentrations of speciﬁcmolecules of interestwithin a single large
voxel, including N-acetylaspartate (NAA), myo-inositol (Ins), choline
(Cho), creatine (Cre), and lactate (Lac) (Gomez-Anson et al., 2000).
The expert panel also highlighted functional MRI (fMRI) of the spinal
cord, due to its potential to characterize changes in neurological
function, using either blood oxygen-level dependent (BOLD), which re-
lies upon the concept of neuro-vascular coupling in which changes in
neurological function produce corresponding changes in local blood
ﬂow, or signal enhancement by extravascular protons (SEEP), which is
thought to detect neural activity indirectly through changes in the intra-
cellular/extracellular volume ratio (Stroman et al., 2001). fMRI studies
can involve a variety of designs, includingmotor tasks or sensory stimuli
in block or event-related designs, and can visualize and provide indirect
measures reﬂecting neuronal activity and connectivity occurringwithin
the spinal cord (Stroman et al., 2014).
All 5 of these emerging MRI techniques are highly amenable to
quantitative analysis, offering the opportunity to develop quantitative
MRI biomarkers that correlate with disability and/or predict outcomes.
The development of these techniques may also provide more sensitive
and speciﬁc diagnostic tests. For example, in the earliest stages of
CSM, symptoms may include vague complaints of numbness and neck
pain, but the cause may be unclear between early myelopathy vs. mus-
culoskeletal pain and peripheral nerve compression. Objective evidence
of damage to the cord tissue could provide important information to
prompt earlier surgery. Furthermore, quantitative biomarkers could
act as surrogate outcomemeasures in clinical trials, such as therapeutic
remyelination agents in MS or spinal cord injury (SCI), providing short-
term end-points and reducing the time and costs associated with novel
drug development (Cadotte and Fehlings, 2013). In acute SCI, these
techniques could potentially discriminate reversible and irreversible
components of damage (demyelination, axonal loss, gray matter loss)
early after injury, and thus provide a more accurate prognosis to help
guide therapeutic strategies and focus rehabilitation resources.
Unfortunately, the application of these advanced MRI techniques to
image the spinal cord is far from trivial. These techniques were initially
developed and validated in brain imaging, but the spinal cord is a far
more challenging structure to obtain accurate data. In fact, the spine is
among themost hostile environments in the body for MRI, due tomag-
neticﬁeld inhomogeneity at the interfaces between bone, intervertebral
disk, and cerebrospinal ﬂuid (CSF), and also because of the small size of
the cord and its white matter tracts, and the relatively large motion of
the cord during cardiac and respiratory cycles (Stroman et al., 2014).
High-quality spinal cord imaging using thesemethods has only recently
been achieved, requiring specialized acquisition sequences, complexTable 1
Study inclusion and exclusion criteria.
Inclusion
Patient • Studies involving adult or pediatric human population (no age restric
• Studies that include patients with a known or suspected pathological
(SCI, CSM, MS, ALS, infarction, tumor, etc.)
Prognostic
factors
• Metrics derived from spinal cord DTI: FA, MD, AD, RD
• Metrics derived from spinal cord DTI tractography: ﬁber length, ﬁber
• Metrics derived from spinal cord MT imaging: MTR or MTCSF
• Metrics derived from spinal cord MWF imaging
• Metrics derived from spinal cord MRS: absolute or relative (expresse
• Metrics derived fMRI signal conduction loss
Outcome • Diagnosis by disease speciﬁc criteria (e.g. McDonald criteria for MS)
• Clinical severity by validated clinical tools/measures (e.g. ASIA for SC
• Outcomes by disease-speciﬁc measures or quality of life measures (e
Study Design • Restrospective or prospective cohort studies designed to assess the a
○Make a diagnosis
○ Correlate with neurological/functional impairment
○ Predict neurological/functional outcome after at least 3 months
• Minimum 24 total subjects, with at least 12 having spinal pathologicashimming, custom receive coils, long acquisition times, and substantial
post-processing to correct for motion, aliasing, and other artifacts.
This systematic review aims to summarize the progress of clinical
translation of these imaging techniques to date, and identify the most
common technical methods employed. The review will also highlight
the major barriers that are currently preventing the adoption of these
techniques into clinical use. The search was designed to identify all
studies that applied one or more of these MRI techniques to assess for
clinical utility in one or more of the following 3 key questions:
1. Diagnostic utility: Does the MRI technique provide metrics that
demonstrate group differences or improved diagnostic accuracy
(sensitivity/speciﬁcity) in the diagnosis of spinal pathologies?
2. Biomarker utility: Does the advancedMRI technique generatemetrics
that quantify the amount of injury and thus correlate with neurolog-
ical/functional impairment and/or show longitudinal changes over
time that correlate with changes in disability in spinal pathologies?
3. Predictive utility: Does the advanced MRI technique generate metrics
that predict neurological, functional, or quality of life outcomes in
spinal pathologies?
2. Methods
2.1. Electronic literature search
A systematic search of MEDLINE, MEDLINE-in-Progress, Embase, and
Cochrane databases was conducted, with the results formatted in accor-
dance with the PRISMA statement for systematic reviews and meta-
analyses (Liberati et al., 2009). The search included literature published
from January 1, 1985 to June 1, 2015 and sought all studies that describe
the use of one or more of the state-of-the-art spinal cord MRI techniques
(DTI, MT, MWF, MRS, and fMRI) on subjects with any clinical pathology
(complete search terms listed in Appendix A, inclusion/exclusion criteria
in Table 1). Studies that employed diffusion kurtosis imaging (DKI), an ex-
tensionofDTI usingmultiple b-values,were included as these studies typ-
ically also report DTI metrics in addition to measures of kurtosis. Studies
that employed advancedMRI techniques to image only thebrainwere ex-
cluded (e.g. brain MRS in CSM). We also excluded studies utilizing
diffusion-weighted imaging (DWI) that only calculated an apparent diffu-
sion coefﬁcient, but did not calculate tensors (which require the use of
diffusion-sensitizing gradients in at least 6 directions) or tensor-derived
metrics such as fractional anisotropy (FA), axial diffusivity (AD), and radi-
al diffusivity (RD). The searchwas limited to human studies, but limits on
study design were not placed. Abstracts identiﬁed in the initial search
were reviewedby3of the authors (A.R.M., I.A., N.S.) to determine relevant
manuscripts for full-text review. The inclusion criteria required that stud-
ieswere original research that appeared to answer one ormore of the keyExclusion
tion)
diagnosis affecting the spinal cord
• Animal subjects
• Studies in only healthy subjects
density
d as a ratio) metabolite concentrations
• Studies involving brain imaging
techniques
I, JOA/mJOA score for CSM, EDSS for MS, etc.)
.g. SF-36)
• Subjective or unvalidated
outcome
measures
bility of an imaging factor to:
l condition of interest
• Review articles
• Opinions
• Technical reports
• Studies in healthy controls
• Animal or biomechanical studies
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least 12of these subjectswith a speciﬁc spinal pathology. Thus,we includ-
ed studies with at least 24 pathological subjects (with no control sub-
jects), and studies with at least 12 pathological subjects and a total of at
least 24 subjects (including controls). Studies that included 3 ormore dif-
ferent groups for comparison (e.g. NMOvs.MS vs. healthy)were required
to have at least 12 subjects with the primary pathology of interest. Case
reports or smaller series, meeting abstracts, white papers, editorials, re-
view papers, technical reports, or studies of only healthy subjects were
excluded. The full text of each article was then analyzed by 2 of the au-
thors (A.R.M., I.A.) in the context of each key question to determine suit-
ability for ﬁnal inclusion, with discrepancies resolved by discussion. If
multiple articles were identiﬁed with redundant results based on the
same group of subjects, only the most relevant article (larger sample
size or more recent publication) was kept in the review. References of
each full-text article and each review paper that were identiﬁed were
also systematically checked to identify additional eligible articles (Fig. 1).
For key question 1 (diagnostic utility) we sought all articles that com-
pared the presence or absence of a speciﬁc MRI feature or the value of a
quantitative metric between patients and controls, relating to diagnosis.
For question 2 (biomarker utility), we identiﬁed articles that identiﬁed
relationships between MRI metrics and measures of clinical disability,
including the calculation of correlation coefﬁcients (Pearson, Spearman,
or multivariate) or identiﬁcation of differences between severity groups.
To be relevant to key question 3 (predictive utility), studies needed to as-
sess the relationship between baselineMRImetrics and follow-up clinical
data at a speciﬁed time at least 3 months after the initial imaging.
2.2. Data extraction
For each of the articles that met all inclusion/exclusion criteria after
full-text review, the following data were extracted redundantly by 2 of
the authors (A.R.M., Z.T.): study design, subject characteristics (age,Fig. 1. Flowchart showing resgender, diagnosis, treatment(s) administered), follow-up duration,
MRI sequences,MRI acquisition parameters, MRI data analysismethods,
clinical data recorded, and results pertaining to diagnosis, correlation
with disability, and correlation with outcomes. Differences in extracted
data were resolved by discussion.
2.3. Data analysis and synthesis
Regardingdiagnosis,we analyzedgroupdifferences and their statistical
signiﬁcance (P-value), and also the number of subjects with each speciﬁc
MRI feature, present or absent (or a quantity above/below a threshold),
that was reported for pathological and healthy subjects, to assess sensitiv-
ity (SE), speciﬁcity (SP), positive predictive value (PPV), and negative pre-
dictive value (NPV). For correlations with disability and prediction of
clinical outcomes, we collected results that were reported as odds ratios,
univariate or multivariate correlation coefﬁcients, and P-values.
Although many of the studies identiﬁed in this systematic review
reported results using the same quantitative metrics, a formal meta-
analysis was not performed due to the wide variation in acquisition and
data analysis techniques. Such a meta-analysis would only be relevant for
a group of studies that showed substantial homogeneity in subject popula-
tions, MRI techniques, regions of interest (ROIs), and clinical measures.
However, trends in thedatawere tabulatedand summarized independent-
ly by 2 authors (A.R.M., I.A.) anddiscrepancieswere resolved bydiscussion.
2.4. Risk of bias for individual studies
Risk of bias was assessed for each article independently by 2
reviewers (A.R.M., I.A.). The risk of bias criteria were deﬁned by the au-
thors by consensus, combining criteria from the Center for Evidence-
Based Medicine (CEBM) Diagnostic Study Appraisal Worksheet (CEBM
Website) and The Journal of Bone & Joint Surgery for prognostic studies
(Wright et al., 2003), in addition to the modiﬁcations described inults of literature search.
Table 2
Risk of bias for diagnostic, correlation, and prognostic advanced MRI studies.
Risk of bias Study design Criteria for diagnostic studies Criteria for correlation (biomarker) studies Criteria for prognostic studies
Low risk:
Study adheres to commonly held tenets of
high quality design, execution and
avoidance of bias
Good quality cohort* • Prospective cohort design
• Demographic and other potentially
confounding information (age, gender, duration
of disease) reported and matched/analyzed
• Cohort includes patients with a homogeneous
diagnosis
• Patients have a range of severity of disease
including mild/early (non-obvious) cases
• Patients are randomly selected or recruited
consecutively (on admission or in clinic)
• Acquisition techniques likely to produce
reliable results (acceptable SNR and distortions)
• Quantitative MRI metrics derived using
automated or blinded techniques
• Objective criteria used for diagnosis based on
presence/absence of distinct features or
measurements
• Appropriate reporting of SE, SP, PPV, NPV
and/or ROC curves
• Prospective cohort design
• Demographic and other potentially
confounding information (age, gender, duration
of disease) reported and matched/analyzed
• Cohort includes patients with a homogeneous
diagnosis
• Patients have a range of severity of disease
including mild/early (non-obvious) cases
• Patients are randomly selected or recruited
consecutively (on admission or in clinic)
• Acquisition techniques likely to produce
reliable results (acceptable SNR and distortions)
• Quantitative MRI metrics derived using
automated or blinded techniques
• Calculation of univariate correlation
coefﬁcients (Spearman or Pearson) or
multivariate regression analysis on quantitative
imaging features, related to clinical measures
• Prospective longitudinal cohort design
• Demographic and other potentially
confounding information (age, gender, duration
of disease) reported and matched/analyzed
• Patients are randomly selected or recruited
consecutively (on admission or in clinic)
• Cohort includes patients with a homogeneous
diagnosis
• Patients at reasonably similar point in the
course of their disease or treatment (**differs
from diagnostic and correlation studies)
• F/U rate of greater than 80%
• Patients followed long enough for outcomes to
occur
• Accounts for other known prognostic factors
• Acquisition techniques likely to produce
reliable results (acceptable SNR and distortions)
• Quantitative MRI metrics derived using
automated or blinded techniques
Moderately low risk:
Study has potential for some bias; does not
meet all criteria for class I but deﬁciencies
not likely to invalidate results or introduce
signiﬁcant bias
Moderate quality cohort • A cohort study that violates one of the criteria
for low risk of bias
• A cohort study that violates one of the criteria
for low risk of bias
• Prospective design, with violation of one of the
other criteria for good quality cohort study
• Retrospective design, meeting all the rest of
the criteria for low risk of bias
Moderately high risk:
Study has ﬂaws in design and/or execution
that increase potential for bias that may
invalidate study results
Poor quality cohort, good quality
case–control or cross-sectional
(prognostic only)
• A cohort study that violates two of the criteria
for low risk of bias
• A case–control study that violates one of the
other criteria for low risk of bias
• A cohort study that violates two of the criteria
for low risk of bias
• A case–control study that violates one of the
other criteria for low risk of bias
• Prospective design with violation of 2 or more
criteria for good quality cohort
• Retrospective design with violation of 1 or
more criteria for good quality cohort
• A good case–control study
• A good cross-sectional study
High risk:
Study has signiﬁcant potential for bias;
does not include design features geared
toward minimizing bias and/or does not
have a comparison group
Very poor quality cohort, poor
quality case–control or
cross-sectional (prognostic only),
case series
• A cohort study that violates three or more of
the criteria for low risk of bias
• A case–control study that violates two of the
other criteria for low risk of bias
• Any case series design
• A cohort study that violates three or more of
the criteria for low risk of bias
• A case–control study that violates two of the
other criteria for low risk of bias
• Any case series design
• Other than a good case–control study
• Other than a good cross-sectional study
• Any case series design
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197A.R. Martin et al. / NeuroImage: Clinical 10 (2016) 192–238Skelly et al. (2013). The criteria were further modiﬁed to also consider
potential sources of bias related to technical factors. The criteria are
summarized in Table 2. Factors that were considered to be potential
sources of bias include retrospective, case series, or case–control study
designs; failure to match or analyze differences in demographics (age,
gender) or control for other confounders; heterogeneity in the diagnosis
of the study population; non-random enrollment methods (e.g. conve-
nience sampling or postersmay have increased selection bias compared
with consecutive enrollment); unreliable acquisition and analysis
methods; and a narrow range of severity of illness.More speciﬁcally, ac-
quisition techniqueswere considered to have a higher risk of bias if they
produced wide conﬁdence intervals for metrics (N20%), showed distor-
tions/artifacts that frequently required the exclusion of slices/subjects
(N5%), or were subject to potential systematic bias, such as acquisitions
that have substantial partial volume effects due to in-plane resolution
N1.5 × 1.5 mm2, or thickness N5 mm. Analytical techniques were
considered to confer a higher risk of bias if they involved manual
processes (e.g. ROI selection) without blinding, or liberal statistical
assumptions (e.g. uncorrected p b 0.05 for activations in fMRI). For
diagnostic studies, failure to calculate and report diagnostic accuracy
was considered a potential source of reporting bias, as it conceals
how many pathological subjects have an “abnormal” result on a
given metric. Similarly, correlation studies that did not publish
univariate or multivariate correlation coefﬁcients do not disclose
the strength of the correlation. Prognostic studies were also judged
to have potential bias if the patients were not at a similar point in
the course of disease (lacking internal validity), if the study did not
achieve N80% clinical follow-up, if follow-up was not long enough
for a majority of patients to show a clinical change, or if other
known prognostic factors were not reported and analyzed. If an
article failed to report important information for any of the
aforementioned potential sources of bias, or technical details that
are necessary to reproduce the image acquisition, it was considered
to have an increased risk of bias. Following rating of each article for
risk of bias by the 2 reviewers, discrepancies were resolved by
discussion.2.5. Overall quality of the body of literature
After individual article evaluation, the overall body of evidence
with respect to each key question and speciﬁc ﬁnding was determined
based upon precepts outlined by the Grading of Recommendation
Assessment, Development and Evaluation (GRADE) Working Group
(Schünemann et al., 2008). The possible ratings for overall quality
of evidence are high, moderate, low, very low, and insufﬁcient. The
initial quality of the overall body of evidence was considered high
if the majority of the studies had low or moderately low risk of
bias, and low if the majority of the studies had high or moderately
high risk of bias. The body of evidence was then upgraded 1 or 2
levels (only if no downgrading occurred) on the basis of the follow-
ing criteria: (1) large magnitude of effect or (2) dose–response
gradient, or downgraded 1 or 2 levels on the basis of the following
criteria: (1) inconsistency of results, (2) indirectness of evidence,
(3) imprecision of the effect estimates (e.g., wide conﬁdence inter-
vals [CIs] N50% of the estimate), or (4) non-a priori statement of
subgroup analyses. The ﬁnal overall quality of evidence expresses
our conﬁdence in the estimate of effect and the impact that further
research may have on the results (Schünemann et al., 2008). The
overall quality reﬂects the authors' conﬁdence that the evidence
reﬂects the true effect and the likelihood that further research will
not change this estimate of effect. For example, a high level of evi-
dence suggests that the evidence reﬂects the true effect, and further
research is very unlikely to change our conﬁdence in the estimate. A
grade of “insufﬁcient” means that evidence either is unavailable or
does not permit a conclusion.3. Results
3.1. Study selection
The literature search was designed to be highly inclusive and gener-
ated a total of 6597 unique citations (Fig. 1). Following review of the
title and abstract, 256 articles were retained for full-text review and
47 reviewpaperswere identiﬁed. The full-text review of the 256 articles
excluded another 156, leaving 101 articles that met all inclusion/
exclusion criteria and were relevant to one or more of the 3 key ques-
tions. The reference lists of these 101 articles and the 47 review papers
identiﬁed another 18 articles for full-text review, and 1 additional study
that was electronically published following the literature search was
identiﬁed by the authors. Among these 19 articles, 3 were retained
for a ﬁnal total of 104 studies. Many of the articles excluded at the
full-text stage employed advanced MRI techniques in the brain but
not the spinal cord, or the number of subjects fell below the threshold.
Several articles were also excluded that used MT as a method to
enhance contrast between the spinal cord and surrounding tissues,
but did not perform quantitative analyses such as computing MTR
or MTCSF. Of the ﬁnal 104 articles, 101 (97%) were identiﬁed by the
electronic database search.
The systematic review identiﬁed 69 DTI studies, including 62 that
performed ROI-based quantitative analysis and 16 that performed
ﬁber tractography (FT), 25 MT studies, 1 MWF study, 11 MRS studies,
and 8 fMRI studies. Ten of the studies employed multi-modal acquisi-
tion techniques, including DTI and MT (6 studies), DTI and fMRI (3
studies), or DTI and MRS (1 study). Eight studies that used DTI FT also
performed ROI-based quantitative analysis. The chronological trends
of each of these imaging techniques are displayed in Fig. 2. The number
of DTI studies that used ROI-based analysis sharply increased in recent
years, whereas FT analysis decreased slightly. MT studies decreased
after 2003, but saw a resurgence in recent years. MRS, MWF, and fMRI
have been used in only a small number of studies, and recent use of
these techniques has been limited. Tables 3–8 summarize the details
of each study included in the review, separated by the imagingmodality
that was employed (with DTI divided by analysis technique).3.2. Methodology and risk of bias of individual studies
Among the 104 studies, the risk of bias assessment foundmoderate-
ly low risk (with regards to at least 1 of the key questions) in only 6
studies, with the remainder of studies showing moderately high (24)
or high (74) risk. Among the 69 DTI studies, the risk of bias was felt to
be high in 52, moderately high in 14, and moderately low in only 3
studies. For MT studies this risk was high in 12, moderately high in 8,
and moderately low in 5 studies. MRS studies showed high risk of bias
in 7 studies and moderately high risk in 4. All of the fMRI studies and
the single MWF study were all assessed to have high risk of bias. Most
of the studies reviewed were exploratory in nature (i.e. early transla-
tional studies) and not clearly based on a priori hypotheses, frequently
making many statistical comparisons without appropriate correction.
Most were prospective cohort studies (101), and the remaining 3
were retrospective cohort studies. Furthermore, 43 of the 104 studies
failed to account for confounding factors such as age and/or gender,
either by ensuring age/gender-matched groups or by performing appro-
priate multivariate analyses. The vast majority of studies focused on a
population with a homogenous diagnosis (98/104), avoiding possible
issues with internal validity. However, only 15 of the 104 studies clearly
reported the use of consecutive or random enrolment procedures to
avoid possible selection bias, whereas the remaining 89 studies either
used convenience sampling or failed to report enrolment methods in
detail. Most of the studies (82/104) included patients with a range of
severity of impairment, including mild/early cases that are more
difﬁcult to diagnose.
Fig. 2. Chronological trends in clinical/translational studies utilizing state-of-the-art spinal cord MRI techniques.
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Among the reviewed studies, a large fraction utilized technical
methods that could introduce signiﬁcant bias in terms of quantita-
tive results. The group of DTI studies used a wide range of pulse
sequences, with the majority (41/69) employing a relatively
straightforward single-shot EPI (ssEPI) sequence, whereas 3 studies
used multi-shot EPI (msEPI), 9 studies used more complex reduced
ﬁeld of view (rFOV) techniques, 1 study used line scan DTI, 1 study
utilized a fast spin echo (FSE) sequence, one study used a spectral
adiabatic inversion recovery (SPAIR) sequence, and the remaining
13 studies did not provide sequence details. Acquisition parameters
were also highly variable, including b-values, FOV, matrix, number
of excitations (NEX), saturation bands, shimming, and the use of
cardiac gating, which was employed in 16/69 (23%) studies. Two of
the studies utilizedmultiple b-values and calculated measures of dif-
fusion kurtosis, such as mean kurtosis (MK) and root mean square
displacement (RMSD) (Hori et al., 2012; Raz et al., 2013). 27 of 69
studies acquired images with very large voxels (greater than
1.5 × 1.5 × 5 mm in at least 1 dimension) or failed to report resolu-
tion, potentially biasing the results due to increased partial volume
effects. Several studies also performed analyses that could introduce
a systematic bias against the pathological group, such as obtaining FA
from an ROI in thinned spinal cord tissue at the level of syringomye-
lia or a hemorrhagic SCI lesion, which is more likely to include voxels
with partial volume effects that artiﬁcially lower FA (Cheran et al.,
2011; Hatem et al., 2009, 2010; Koskinen et al., 2013; Yan et al.,
2015). The group of MT studies tended to use more consistent acqui-
sition methods with less variation, with 24/25 studies employing
some form of gradient echo (GE) sequence, all studies using a sinc
or Gaussian shaped saturating pre-pulse, and none of the studies
utilizing cardiac gating. Only 2 studies computed MTCSF followinga single MT acquisition. The remaining 23 studies acquired images
with and without a saturation pre-pulse, coregistered the images,
and calculated MTR. The study investigating MWF used a 32-echo
sequence with inversion recovery (without cardiac gating) to mea-
sure the short T2 component using a multi-exponential model, but
this technique only acquired a single axial slice with an acquisition
time of 30 min. All of the MRS studies uniformly employed similar
acquisition sequences, making use of point-resolved spectroscopy
(PRESS) with chemical shift selective (CHESS) water suppression,
while cardiac gating was employed in 5/11 (45%). Unfortunately,
these studies all produced metrics with wide conﬁdence intervals
within subject groups. All of the spinal fMRI studies were based on
a fast spin echo (FSE) acquisition, and none used cardiac gating.
The fMRI studies appeared to suffer from challenges with reliable
acquisitions, although reporting was not detailed enough to deter-
mine conﬁdence intervals or measures of reliability, as the results
typically involved processed data in terms of group activations and
connectivity analyses.
3.4. Analysis methods
Whole-cord ROIs were used in the vast majority of DTI, MT, and
MWF studies. Among the 62 ROI-based DTI studies, 18 reported
tract-speciﬁc metrics, 3 extracted metrics from WM, and 2 reported
data from GM, with the remaining 39 reporting whole-cord metrics
or non-speciﬁc ROIs (e.g. mixed GM and WM from a mid-sagittal
slice). Among DTI FT studies, only 2 reported tract-speciﬁc metrics,
with the remainder averaging results across all WM identiﬁed. 5/25
MT studies reported tract-speciﬁc metrics, 1 averaged results across
all WM, and 2 offered GM-speciﬁc metrics. All MRS results were
whole-cord, and fMRI results were typically broken into cord quad-
rants (combining GM and WM). Only 5 of the ROI-based DTI studies
Table 3
Summary of ROI-based quantitative DTI studies.
Authors (year);
design
Subjects B0; vendor; coil;
gradients
Anatomical
region/position
DTI acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
DTI metrics ROI Clinical measures Key results Risk of bias; key
barriers to
translation
Demir et al
(2003);
prospective,
cross-sectional
CSM (36 total, 21
with myelopathy)
vs. HCs (8)
1.5 T; Philips;
surface coil; 23
mT/m
• C1–C7
• 3 sagittal slices,
1 mm gap
• SE multishot EPI, 13
echoes
• 6 directions
• b = 300,600 s/mm2
240 mm2; 256 × 195;
0.9 × 1.2 × 5 mm3;
3 beats/36; yes;
13 min
FA, MD Manual, whole
cord at MCL and
NASC
• Presence of
myelopathy
• SSEPs
• To detect clinical/SSEP myelopathy, MD
had SE = 92%, SP = 50%, PPV = 80%,
NPV = 75%, and FA had SE = 90%,
SP = 50%, PPV = 76%, NPV = 75%
•MD, FA had higher SE but lower SP than
T2w changes
High; minimal
clinical data, several
subjects excluded
due to low SNR
Agosta et al.
(2005);
prospective,
cross-sectional
PPMS (24) vs. HCs
(13)
1.5 T; Siemens;
phased-array
spine coil
• C1–C7
• 5 sagittal slices,
contiguous
• ssEPI, SENSE = 2
• 3 sat bands
• Repeated 4×
• 14 directions
• b = 900 s/mm2
240 × 90 mm2; 128 ×
48; 1.9 × 1.9 ×
4 mm3; 7000/100;
no; AT NR
FA, MD
(corrected with
CSA)
Manual ROI,
mid-sagittal
slice, excluding
edge voxels
• EDSS • Reduced mean FA: 0.38 vs. 0.42,
P = 0.007
• Increased MD: 1.20 vs. 1.28 (P = 0.024)
• No correlations of DTI metrics found
with EDSS
High; coarse clinical
data, large voxels
increase partial
volume effect
Facon et al.
(2005);
prospective,
cross-sectional
CM (15 total, 6
CSM, 5 abscess, 4
tumor) vs. HCs
(11)
1.5 T; NR; NR;
NR
• Cervical, thoracic
• 12 sagittal slices,
contiguous
• ssEPI, GRAPPA = 2
• 6 directions
• b = 500 s/mm2
179 mm2; 128 × 128;
1.4 × 1.4 × 3 mm3;
4600/73; no; 7 min
(3 acquisitions)
FA, MD Manual, at MCL
(CM) or
averaged over
all levels (HCs)
• Presence of pain,
motor or sensory
impairment
• No effect of rostrocaudal level seen on
FA, MD
• FA lower at compressed levels (0.67)
than normal appearing cord (0.74,
P = 0.01) and controls (0.75, P = 0.01)
• FA had better SE (73%) and SP (100%)
than T2w-HI or ADC
High;
heterogeneous
population, metrics
at MCL potentially
biased
Mamata et al.
(2005);
prospective,
cross-sectional
CSM (79) vs. HCs
(11)
1.5 T; GE; spine
PAC; 22 mT/m
or 40 mT/m
• C1–C7
• 1 sagittal slice
• Sagittal line scan
• b = 5 s/mm2 taken
in 2 directions
• 6 directions
• b = 1000 s/mm2
220 × 110 mm2;
128 × 128; 1.7 × 1.7 ×
4 mm3; 2733/86; no;
31 s per slice
FA, MD Manual, 2 ROIs
drawn at C2–3
and at MCL (or
C4–C7 in HCs)
• None • 54% of spondylosis subjects have low
FA, high MD
• Age correlates with FA (r =−0.24) and
MD (r = 0.24)
• FA is decreased, MD increased within T2
hyper-intensity (P b 0.05)
High; no clinical
data, single
mid-sagittal slice
misses key WM
tracts
Valsasina et al.
(2005);
prospective,
cross-sectional
MS (44 total, 21
RRMS, 23 SPMS)
vs. HCs (17)
Same as Agosta et al. (2005) Manual, drawn
on mid-sagittal
slice
• EDSS • Reduced mean FA: 0.36 vs. 0.43,
P = 0.008
• FA not different in SPMS vs. RRMS
• FA correlates with EDSS: r =−0.48,
P = 0.001
• MD correlates with EDSS: r = 0.37,
P = 0.02
High; coarse clinical
data, single
mid-sagittal slice
misses key WM
tracts
Hesseltine et al.
(2006);
prospective,
cross-sectional
RRMS (24) vs. HCs
(24)
1.5 T; NR; NR;
NR
• C2–C3
• 10 axial slices,
contiguous
• SE EPI
• 6 directions
• b = 1000 s/mm2
140 mm2; 128 × 128;
1.1 × 1.1 × 4 mm3;
2000/74; no; 2 min
20 s
FA, MD Manual, 7 ROIs
at C2–3:
bilateral STTs,
LCSTs, DCs, and
central cord
• None • FA decreased in LCSTs (P b 0.0001) and
DCs (P = 0.001)
• Model using spatial FA data has
SE = 87%, SP = 92%
High; no clinical
data
Renoux et al.
(2006);
prospective,
cross-sectional
Myelitis (15 total,
9 MS, 6 other) vs.
HCs (11)
1.5 T; Philips;
NR; 23 mT/m
• C2–C5, T1–T6,
T7–T12
• 3 sagittal slices,
1 mm gap
• Multi-shot EPI
• 25 directions
• b = 300, 600 s/mm2
240 mm2; 256 × 195;
0.9 × 1.2 × 5 mm3;
3 beats/80; yes; NR
FA, MD
(calculated as
z-statistics)
Manual,
whole-cord
(avoiding edge
voxels)
• None • All T2 hyperintense lesions had
signiﬁcantly decreased FA
• 9 subjects showed signiﬁcant FA
decrease in normal-appearing SC, and 5
had areas of increased FA
High; no clinical
data, no correction
for multiple
comparisons
Agosta et al.
(2007a);
prospective,
longitudinal
MS (42 total, 13
RRMS, 14 SPMS, 15
PPMS) vs. HCs (9)
Same as Agosta et al. (2005) • EDSS
• FU at 1.5–3 years
(mean 2.4)
• At FU, FA decreased: 0.36 vs. 0.37,
P = 0.01
• At FU, MD increased: 1.26 vs. 1.37,
P b 0.001
• Cord FA correlates with EDSS:
r =−0.51, P = 0.001
• Cord FA decrease was greatest in PPMS:
P = 0.05
• Baseline FA predicts EDSS at FU:
r =−0.40, P = 0.03
High; coarse clinical
data
Ohgiya et al.
(2007);
prospective,
cross-sectional
MS (21 total, 16
RRMS, 4 SPMS, 1
PPMS) vs. HCs
(21)
1.5 T; GE;
8-channel
neuro-vascular
PAC
• C2–C5
• Axial slices,
number NR,
contiguous
• ssEPI
• 25 directions
• b = 900 s/mm2
170 mm2; 128 × 128;
1.3 × 1.3 × 4 mm3;
12,000/107; no; 6
min
FA, MD Manual, ROIs
drawn on
plaques and
NAWM (DCs
and R/L LCs),
matched in HCs
• None • FA decreased in all ROIs vs. HCs (all
P b 0.001)
• MD increased in 6/9 ROIs (P b 0.05)
• FA decreased in plaques vs. NAWM vs.
HCs (0.44 vs. 0.54 vs. 0.74, P b 0.01)
High; no clinical
data
(continued on next page)
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Table 3 (continued)
Authors (year);
design
Subjects B0; vendor; coil;
gradients
Anatomical
region/position
DTI acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
DTI metrics ROI Clinical measures Key results Risk of bias; key
barriers to
translation
Valsasina et al.
(2007);
prospective,
cross-sectional
ALS (28) vs. HCs
(20)
1.5 T; Siemens;
spine PAC; 33
mT/m, 125
mT/m/ms
• C1–C7
• 5 sagittal slices,
1.2 mm gap
• ssEPI
• 12 directions
• 3 sat bands
• Repeated 2×
• b = 900 s/mm2
240 × 90 mm2; 128 ×
48; 1.9 × 1.9 × 4
mm3; 2900/84; no;
NR
FA, MD (with
and without
correction for
CSA)
Semi--
automated
segmentation,
manual ROI of
cord excluding
edge voxels
• ALSFRS
• FU at 6–12
months (mean 9)
• Decreased mean FA: 0.48 vs. 0.52,
P = 0.002
• MD not different than controls: 0.88 vs.
0.85, NS
• Mean FA correlates with ALSFRS,
r = 0.74, P b 0.001
High (diagnostic),
moderately high
(correlation); gaps
in sagittal
acquisition exclude
some WM
Agosta et al.
(2008b);
prospective,
cross-sectional
RRMS (25) vs. HCs
(12)
1.5 T; Siemens;
spine PAC; 33
mT/m, 125
mT/m/ms
• C1–C7
• 5 sagittal slices,
contiguous
• ssEPI
• 12 directions
• 3 sat bands
• Repeated 4×
• b = 900 s/mm2
240 × 180 mm2; 192
× 144; 1.3 × 1.3 × 4
mm3; 2700/71; no;
NR
FA, MD (with
and without
correction for
CSA)
Semi--
automated
segmentation,
manual ROI of
cord excluding
edge voxels
• EDSS • Decreased mean FA: 0.48 vs. 0.58,
P b 0.001
High; FA higher than
in previous similar
studies, correlation
with EDSS NR
Manconi et al.
(2008);
prospective,
cross-sectional
MS (82 total, 30
with restless leg
syndrome), no HCs
Same as Agosta et al. (2005) Semi--
automated
segmentation,
manual ROI in
mid-sagittal
slice from
C1–C5
• EDSS
• Qualitative RLS
and sleep data
• Mean FA decreased in RLS subjects vs.
non-RLS (P = 0.02)
• FA histogram peak higher in RLS
(P = 0.004)
• No correlations between spinal cord DTI
metrics and brain DTI or number of cord
lesions (on STIR)
High; coarse clinical
data, single
mid-sagittal slice
misses key WM
tracts
Shanmuganathan
et al. (2008);
retrospective,
cross-sectional
aSCI (20 total, 16
with neurological
injury) vs. HCs (8)
1.5 T; Siemens;
12-channel
head/neck PAC
• Medulla-T1
• 67 axial slices,
contiguous
• ssEPI
• Partial Fourier
• 6 direcctions
• b = 1000 s/mm2
200 mm2; 128 × 128;
1.6 × 1.6 × 3 mm3;
8000/76; no; 3 min
40 s
FA, MD, RA, VR,
λ1, λ2, λ3
Manual, 3 ROIs
drawn to
include GM and
WM,
medulla-C2,
C3–C5, and
C6–T1
• None • Decreased MD vs. HCs in all 3 ROIs:
P ≤ 0.01
• Decreased λ1 vs. HCs in all 3 ROIs:
P ≤ 0.002
High; retrospective,
4/20 subjects
excluded due to
image quality, no
clinical data
Agosta et al.
(2009a);
prospective,
longitudinal
ALS (17) vs. HCs
(20)
Same as Valsasina et al. (2007) • ALSFRS
• FU at 6–12
months (mean 9)
• At FU, FA decreased: 0.45 vs. 0.48,
P = 0.01
• At FU, MD increased: 0.95 vs. 0.89,
P = 0.01
• FA, MD changes did not correlate with
ALSFRS changes
High; only 61% had
FU MRI, prediction
of FU EDSS NR
Agosta et al.
(2009b);
prospective,
cross-sectional
PPMS (23) vs. HCs
(18)
Same as Agosta et al. (2008b) • EDSS • Decreased FA: 0.45 vs. 0.57, P b 0.001
• Increased MD: 0.99 vs. 0.85, P b 0.001
• FA correlates with mean cord fMRI
signal change: r =−0.58
High; coarse clinical
data, correlation
with EDSS NR
Cruz et al.
(2009);
retrospective,
cross-sectional
RRMS (41) vs. HCs
(37)
1.5 T; Siemens;
8 channel head
coil; NR
• C2–C3
• Axial slices: 30%
gap; sagittal
slices: contiguous,
number NR
• DTI sequence NR
• 12 directions
• b value NR
Axial: 225 mm2;
128 × 128; 1.8 × 1.8 ×
3 mm3; 3200/80; no;
AT NR; sagittal: 280
mm2 192 × 192; 1.5 ×
1.5 × 3 mm3,
2800/90; no; NR
FA Manual, on
plaque,
peri-plaque,
NASC, vs.
whole-cord
(HCs)
• None • FA in plaques (0.44) is lower than
periplaque (0.57), NASC (0.63), or HCs
(0.74): P b 0.001
• FA lower in NASC vs. controls: P b 0.05
High; retrospective,
no clinical data
van Hecke et al.
(2009);
prospective,
cross-sectional
MS (21) vs. HCs
(21)
1.5 T; Siemens;
spine, neck
coils; 40 mT/m
• C1–C5
• 30 axial slices,
contiguous
• ssEPI
• Parallel (factor NR)
• 60 directions
• b = 700 s/mm2
256 mm2; 128 × 128;
1.4 × 1.4 × 3 mm3;
10,400/100; no; 12
min 18 s
FA, MD, AD, RD,
ψ (from FT)
Manual, whole
cord
• None • Decreased FA, ψ in MS with lesions
(P b 0.01) and without (P b 0.02)
High; no clinical
data, diagnostic
accuracy NR
Benedetti et al.
(2010);
prospective,
cross-sectional
MS (68 total, 40
BMS, 28 SPMS) vs.
HCs (18)
Same as Agosta et al. (2005) • EDSS • Total MS: increased MD (P = 0.001),
decreased FA: (P b 0.001)
• SPMS: lower mean cord FA than BMS:
0.33 vs. 0.37, P = 0.01
• Mean FA correlates with EDSS:
r =−0.37, P = 0.002
• Multivariate model (brain, cord)
correlates with EDSS: r = 0.58
High (diagnostic),
moderately high
(correlation); coarse
clinical data
Freund et al.
(2010);
prospective,
longitudinal
MS with acute
lesion (14) vs. HCs
(13)
1.5 T; GE; NR;
33 mT/m
• C1–C5
• 30 axial slices,
contiguous
• CO-ZOOM-EPI rFOV
• 60 directions
• b = 1000 s/mm2
70 × 47 mm2; 48 ×
32; 1.5 × 1.5 ×
5 mm3; 15 beats/96;
yes; NR
FA, MD, AD, RD,
FU MRI at 1
min, 3 min, 6
Manual, 4 ROIs
in ACs, DCs, L/R
LCs
• EDSS
• 9 hole peg
• 25-foot TWT
• MSWS-12
• FA decreased and RD increased vs. HCs
in all ROIs (P b 0.05)
• Baseline RD predicted EDSS, 9 hole peg,
and TWT at 6 min (P b 0.05)
Moderately high;
several datasets
excluded due to
artifact
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min • FU at 1 min, 3
min, 6 min
• Baseline FA of the LCs predicted EDSS
recovery at 6 min (P = 0.02)
Nair et al.
(2010);
prospective,
cross-sectional
ALS (14) vs. HCs
(15)
3 T; Siemens;
12-channel
head and
2-channel neck
PACs
• C1–C6
• 19 coronal slices,
contiguous
• ssEPI
• NEX = 2
• 2 acquisitions
• 30 directions
• b = 1000 s/mm2
160 mm2; 128 × 128;
1.3 × 1.3 × 2.5 mm3;
3200/105; no; 7 min
(for 2 acquisitions)
FA, MD, AD, RD Semi-automatic,
FA skeleton
used to deﬁne
WM
• ALSFRS-R
• FVC
• Finger/foot
tapping speed
• FA decreased (P = 0.003), RD increased
(P = 0.03)
• Multiple correlations: FA with tapping:
r = 0.61, P = 0.02; RD with ALSFRS-R
(r =−0.55, P = 0.04), FVC (r =−0.69,
P = 0.01), and tapping (r =−0.59,
P = 0.03); MD with ALSFRS-R
(r =−0.56, P = 0.04) and FVC
(r =−0.54, P = 0.01)
High (diagnostic),
moderately high
(correlation);
complex analysis
likely requires
expert
Xiangshui et al.
(2010);
prospective,
cross-sectional
CSM (84) vs. HCs
(21)
3 T; GE; neck
PAC; 40 mT/m
• C1–C7
• 28 axial slices,
contiguous
• SENSE EPI
• 15 directions
• b = 1000 s/mm2
270 mm2; 96 × 96;
2.8 × 2.8 × 4 mm3;
6000/83; no; 5 min
FA, MD, λ1, λ2,
λ3
Manual,
whole-cord
• None • CSM divided into groups A–D by T2w
changes
• All metrics altered vs. HCs in groups
B–D (P b 0.01)
• Only λ2, λ3 differed between group A
and HCs (P b 0.05)
High, no clinical
data, large voxels
Cheran et al.
(2011);
prospective,
longitudinal
aSCI (25 total, 13
HC, 12 NHC) vs.
HCs (11)
1.5 T; Siemens;
12-channel
head/neck PAC
• Caudal medulla
and C1–T1
• 67 axial slices,
contiguous
• ssEPI, partial Fourier,
GRAPPA = 2
• 6 directions
• b = 1000 s/mm2
200 mm2; 128 × 128;
1.6 × 1.6 × 3 mm3;
8000/76; no; 3 min
40 s
FA, MD, AD, RD Manual,
mid-sagittal
slice: C1–C2,
C3–C5, C6–T1,
avoiding
hemorrhage
ASIA motor score
FU data in 12
subjects (at 1–29
months)
FA reduced at C3–C5, C6–T1 (NHC:
P b 0.001, HC: P b 0.05) and at injury site
(P b 0.001)
MD, AD reduced in all regions (P b 0.001)
All metrics correlated with motor score
in NHC (R = 0.78–0.92)
High (diagnostic),
moderately high
(correlation); 7
subjects excluded,
ROI misses key WM,
prediction of
outcomes NR
Cohen-Adad
et al. (2011);
prospective,
cross-sectional
cSCI (14) vs. HCs
(14)
3 T; Siemens;
head/neck/-
spine PACs; NR
• C2–T2
• 8 axial slices,
mid-VB (gap
adjusted to ﬁt)
• ssEPI, GRAPPA = 2
• 2 sat bands
• Repeated 4×
• Manual shim
• 64 directions
• b = 1000 s/mm2
128 mm2; 128 × 128;
1 × 1 × 5 mm3; 1
heartbeat/76; yes
(delay NR); NR
FA, MD, AD, RD,
GFA
Manual, 4 ROIs:
ACs, DCs, L/R
LCSTs; lesion
levels skipped
• ASIA motor and
sensory scores
• Decreased FA,GFA (P b 0.0001) and AD,
RD (P = 0.01)
• FA, GFA, RD correlate with total ASIA
(abs r = 0.66–0.74, P b 0.01)
• Tract-speciﬁc metrics: weak speciﬁcity
with motor vs. sensory scores
High (diagnostic),
moderately high
(correlation);
manual ROI
Kamble et al.
(2011);
prospective,
cross-sectional
cSCI (18) vs. HCs
(11)
1.5 T; GE; spine
coil; NR
• Cervical or
lumbar
• Axial slices,
contiguous,
number NR
• EPI
• 25 directions
• b = 1000 s/mm2
260 mm2; 128 × 128;
2 × 2 × 5 mm3;
8500/98; no; NR
FA Manual, 3 ROIs
placed
randomly
• None • FA in areas above/below lesion
decreased vs. HCs: 0.37 vs. 0.55,
P = 0.001
High; no clinical
data, random ROI
placement could
miss key WM
Lee et al. (2011);
prospective,
longitudinal
CM (20) vs. HCs
(20)
3 T; Philips;
head/neck PAC;
40 mT/m
• C1–T1
• Sagittal slices,
number, gap NR
• ssEPI, SENSE = 2
• NEX = 4
• 15 directions
• b = 600 s/mm2
250 × 224 mm2;
128 × 128; 2 × 2 ×
2 mm3; 3380/56; no;
3 min 43 s
FA, MD Manual,
whole-cord
• JOA
• FU JOA at 3
months
• FA decreased at MCL: 0.50 vs. 0.60,
P = 0.001
• MD increased at MCL: 1.44 vs. 1.17,
P = 0.001
• FA, MD not correlated with JOA and not
predictive of outcome
High;
heterogeneous
subjects, correlation
coefﬁcients not
calculated
Mueller-Mang
et al. (2011);
prospective,
cross-sectional
HIV (20) vs. HCs
(20)
3 T; Siemens;
standard neck
coil; NR
• C2–C3
• 10 axial slices,
contiguous
• SE double shot EPI,
parallel = 2
• 6 directions
• b = 1000 s/mm2
180 mm2; 256 × 256;
0.7 × 0.7 × 3 mm3;
3700/98; no; 2 min
FA, MD, λ1, λ2,
λ3
Manual, 7 ROIs
at C2–3: central
GM, L/R ACs,
DCs, LCSTs
• None • No difference in metrics between HIV
and HCs
High; negative study
results, small voxels
likely have very low
SNR
Song et al.
(2011);
prospective,
cross-sectional
CSM (53) vs. HCs
(20)
1.5 T; Philips;
spine PAC; 23
mT/m, 150
mT/m/ms
• C2–C6
• Sagittal slices,
contiguous,
number NR
• ssEPI
• NEX = 4
• 6 directions
• b = 400 s/mm2
230 mm2; 128 × 128;
1.8 × 1.8 × 3 mm3;
NR; no
FA, MD Manual, ROIs
drawn at MCL
(CSM), at disk
levels (HCs)
• None • FA decreases at descending cervical
levels: P b 0.01
• MD increased (837 vs. 733, P b 0.01)
and FA decreased (736 vs. 776, P b 0.01)
High; no clinical
data, patients
followed for 6
months but
outcomes NR
Hori et al.
(2012);
prospective,
cross-sectional
CSM (50 total, 18
with cord
compression), no
HCs
3 T; Philips; NR;
NR
• C3–C6
• 30 axial slices,
contiguous
• Sequence NR
• 6 directions
• b = 400, 800, 1200,
1600, 2000 s/mm2
80 mm2; 64 × 64;
1.3 × 1.3 × 3 mm3;
6996/73; no; 7 min
FA, MD, MK,
RMSD
Manual,
whole-cord at
C3–4, C4–5,
C5–6
• None • Compressed cords (N = 18) had lower
FA (0.61 vs. 0.66, P = 0.006), lower MK
(0.80 vs. 0.91, P = 0.002), and higher
RMSD (8.4 vs. 8.3, P = 0.006)
High; 15/50 subjects
excluded due to
artifacts, no clinical
data, no HCs
Jeantroux et al.
(2012);
prospective,
cross-sectional
NMO (25) vs. HCs
(20)
1.5 T; Siemens;
head, spine
PACs; NR
• C1–C7
• 30 axial slices,
contiguous
• SE EPI
• 12 directions
• b = 800 s/mm2
230 mm2; 104 × 104;
2.2 × 2.2 × 5 mm3;
2700/71; no; 7 min
FA, MD Manual, NAWM
and
intralesional
(based on T2)
• None • Decreased FA in lesions (0.48,
P b 0.001) and NAWM (0.58, P b 0.05) vs.
HCs (0.61)
• Increased MD in lesions (1.29,
P b 0.001) and NAWM (1.11, P b 0.05) vs.
HCs (1.03)
High; no clinical
data, large voxels
Kerkovsky et al.
(2012);
prospective,
CSM (52 total, 20
with myelopathy)
vs. HCs (13)
1.5 T; Philips;
16-channel
head/neck PAC;
• Axial slices
(number, gap NR)
• ssEPI, SENSE = 2
• 15 directions
• FA = 25°
NR; NR; 4 mm thick;
3549/83; no; NR
FA, MD Manual,
whole-cord at
C2–3 and max.
• SSEPs
• MEPs
• FA decreased at MCL in myelopathic
subgroup (P = 0.001) and
non-myelopathic subgroup (P = 0.04)
High; no clinical
data (only EP), MRI
details NR
(continued on next page)
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Table 3 (continued)
Authors (year);
design
Subjects B0; vendor; coil;
gradients
Anatomical
region/position
DTI acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
DTI metrics ROI Clinical measures Key results Risk of bias; key
barriers to
translation
cross-sectional NR • b = 900 s/mm2 compression • No difference in FA, MD at C2–3
between groups
• EP measures only 67% sensitive in
myelopathy
Lindberg et al.
(2012);
prospective,
cross-sectional
CSM (15) vs. HCs
(10)
1.5 T; Siemens;
NR; NR
• C2–C7
• 12 sagittal slices,
contiguous
• ssEPI, SENSE = 2
• NEX = 4
• 2 sat bands
• 25 directions
• b = 900 s/mm2
180 mm2; 128 × 128;
1.4 × 1.4 × 3 mm3;
2000/95; no; 4 min
26 s
FA, MD, AD, RD Manual,
whole-cord
•
Presence/absence
of gait change or
hyperreﬂexia
• FA decreased (C2–C7): 0.50 vs. 0.54,
P = 0.02
• RD increased (C2–C7): 0.56 vs. 0.52,
P = 0.03
• FA decreased with descending vertebral
level (P value NR)
High; minimal
clinical data
Pessoa et al.
(2012);
prospective,
cross-sectional
MS (32) vs. NMO
(8) vs. HCs (17)
1.5 T; Siemens;
8-channel head
and neck PACs;
NR
• C2–C7
• 16 sagittal slices,
0.3 mm gap
• ssEPI
• 20 directions
• b = 400,800 s/mm2
260 mm2; 128 × 128;
2 × 2 × 3 mm3;
2800/88; no; NR
FA, MD, AD, RD Manual, 4 ROIs
at C2 and C7:
ACs, DCs, and
R/L LCs
• EDSS (NMO
subjects only)
• FA decreased, RD increased (only in AC
at C2) in NMO vs. MS (P b 0.05) and NMO
vs. HC (P b 0.05)
• In NMO, FA in DC at C2 correlates with
EDSS (r =−0.80, P = 0.02)
High; coarse clinical
data (NMO only),
large voxels
Petersen et al.
(2012);
prospective,
cross-sectional
cSCI (19) vs. HCs
(28)
3 T; Philips;
6-element
spine coil; NR
• C2, C5, T5, T12
• 6 axial slices per
region, gap NR
• ssEPI, partial Fourier
• NEX = 12
• Directions NR
• b = 750 s/mm2
120 × 30 mm2; 176 ×
44; 0.7 × 0.7 × 5
mm3; 4000/49; no;
30 min (for 3 regions)
FA, MD Manual, 5 ROIs:
whole-cord, L/R
LCSTs and DCs;
slices with SNR
b 20 excluded
• AIS
• SSEPs
• MEPs
• FA (C2) decreased in whole-cord, LCSTs,
and DCs (P b 0.005)
• FA (C2) correlates with AIS in each ROI:
whole-cord (r = 0.64, P = 0.001), LCSTs
(r = 0.50, P = 0.002), and DCs (r = 0.41,
P = 0.01)
• Mean FA of DCs correlates with tibial
SSEP amplitude (r = 0.46, P b 0.001)
High (diagnostic),
moderately high
(correlation); coarse
clinical data, long
acquisition time
Rocca et al.
(2012);
prospective,
cross-sectional
MS (35 total, 20
with fatigue, 15
without) vs. HCs
(20)
Same as Agosta et al. (2008b); • EDSS
• Fatigue Severity
Scale
• FA decreased, MD increased in all MS
vs. HCs (P b 0.001)
• No difference in FA, MD between MS
groups
• DTI metrics do not correlate with
clinical measures
High (diagnostic),
moderately high
(correlation); no
correlations found
Wang et al.
(2012);
prospective,
cross-sectional
CM (42) vs. HCs
(49)
3 T; Philips; CTL
coil; 80 mT/m,
200 mT/m/s
• C1–C7 or T6–T12
• Sagittal slices,
number NR,
contiguous
• SE ssEPI
• 6 directions
• b = 700 s/mm2
170 × 136 mm2; 96 ×
61; 1.6 × 1.9 ×
2 mm3; 5000/64; no;
30 min (for 3 regions)
FA, MD Manual,
rectangular ROIs
placed at MCL
(in CM) or
mid-disk levels
in HCs
• None • FA decreased, MD increased in CM with
T2w-HI vs. HCs (P b 0.05)
• Metrics not different in CM without
T2w-HI vs. HCs
High;
heterogeneous
subjects, no clinical
data
Cohen-Adad
et al. (2013);
prospective,
cross-sectional
ALS (29) vs. HCs
(21)
Same as Cohen-Adad et al. (2011) FA, MD, AD, RD Same as
Cohen-Adad
et al. (2011)
• ALSFRC-R
• TMS motor
threshold
• FA decreased in LCST: 0.51 vs. 0.60,
P b 0.0005
• FA correlates with ALSFRC-R (R = 0.38,
P = 0.04) and motor threshold
(R =−0.47, P = 0.02)
• Reduction in FA greatest at caudal levels
High; manual ROI
Gao et al.
(2013);
prospective,
cross-sectional
CSM (104), no HCs 3 T; GE;
8-channel
head/neck PAC
• C2–C7
• 27 axial slices,
contiguous
• ssEPI
• 2 sat bands
• High order shim
• 15 directions
• b = 1000 s/mm2
27 mm2; 96 × 96;
0.3 × 0.3 × 4 mm3;
6000/83; no; NR
FA, MD, λ1, λ2,
λ3
Manual, 3
regions of 10
voxels per slice
• JOA • FA, MD, λ2, λ3 differ between JOA
severity groups: P b 0.001
• FA, MD, λ2, λ3 differ with T1w/T2w
signal change
• FA correlates with JOA: r = 0.88,
P b 0.05
High; no HCs, small
voxels with low
SNR, small FOV
likely to have
aliasing
Jones et al.
(2013);
prospective,
longitudinal
CSM (30), no HCs 3 T; GE; cervical
spine coil
• C2–T1
• 24 axial slices,
contiguous
• ssEPI
• 6 directions
• b = 1000 s/mm2
180 mm2; 128 × 128;
1.4 × 1.4 × 4 mm3;
8100/94; no; 3 min
55 s
FA Manual, 3 ROIs:
DCs, L/R LCs at
C2–3, MCL,
C7–T1
• mJOA, Nurick,
NDI, SF-36
• FU at 2–12
months (N = 15)
• FA correlates with mJOA (r = 0.62,
P b 0.01) and Nurick (r =−0.46,
P = 0.01)
• Higher FA predicts post-op
improvement on NDI (r =−0.61,
P = 0.04)
Moderately high
(correlation), high
(prognostic); short
FU times, multiple
comparisons not
corrected
Koskinen et al.
(2013);
prospective,
cross-sectional
cSCI (28 total, 13
with surgical
ﬁxation hardware)
vs. HCs (40)
3 T; Siemens;
12-channel
head and
4-channel neck
PACs; NR
• C2–C6
• Axial slices,
number NR, 1.2
mm gap
• EPI
• 20 directions
• NEX = 4
• b = 1000 s/mm2
152 mm2; 128 × 128;
1.2 × 1.2 × 4 mm3;
4000/103; no; 5 min
50 s
FA, MD, AD, RD Manual,
whole-cord at
C2–3, lesion
(rostral edge),
and C3–4, C4–5,
C5–6 (HCs)
• ASIA motor and
sensory scores
• FIM
• Decreased FA at C2–3: 0.58 vs. 0.69,
P b 0.001
• Increased MD and RD at C2–3: P b 0.001
• FA, MD signiﬁcantly altered at lesion
level (P b 0.001)
• FA at lesion correlates with ASIA motor:
High (diagnostic),
moderately high
(correlation);
subjects not
age-matched with
HCs, 6 subjects
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r = 0.67, P b 0.01 excluded
Miraldi et al.
(2013);
prospective,
cross-sectional
RRMS (32) vs. HCs
(17)
1.5 T; Siemens;
8-channel
head/neck PAC;
NR
• C2–C7
• 16 axial slices,
0.3 mm gap
• ssEPI
• 20 directions
• b = 800 s/mm2
260 mm2; 128 × 128;
2 × 2 × 3 mm3;
2800/88; no; 15 min
FA, MD, AD, RD
(from FT)
Manual, 4 ROIs
in ACs, DCs, L/R
LCs, at C2 and
C7
• EDSS • Most metrics showed no difference
with controls
• No signiﬁcant correlation with EDSS
High; negative
results, high
variance of metrics
Naismith et al.
(2013);
prospective,
cross-sectional
Myelitis (37 total,
26 MS, 11 NMO)
vs. HCs (15)
3 T; Siemens; 2
or 4-channel
neck PAC; NR
• C1–2, C3–4,
C5–6
• 6 axial
slices/region,
contiguous
• rFOV ssEPI
• 25 directions
• Repeated 4×
• Shim: ﬁeld-map
• b = 600 s/mm2
72 × 29 mm2; 80 ×
32; 0.9 × 0.9 ×
5 mm3; 5 beats/99;
yes; 45 min
(4 acquisitions)
FA, MD, AD, RD Manual,
whole-cord and
L/R DCs and
LCSTs drawn on
each slice
• EDSS
• Vibration
threshold
• 25-foot TWT
• 9 hole peg
• FA, RD of DCs (but not LCSTs) correlate
with vibration (P b 0.01)
• FA, RD of DCs and LCSTs correlate with
9 hole peg (all P b 0.0001)
• FA, RD of whole cord (or tracts)
correlate with EDSS categories
(P b 0.0001)
High;
heterogeneous
subjects, 4 subjects
and 33% of ROIs
excluded due to
artifacts/SNR
Oh et al.
(2013a);
prospective,
cross-sectional
MS (124 total, 69
RRMS, 36 SPMS, 19
PPMS), no HCs
3 T; Philips; 2
element surface
PAC;
• C2–C6
• 30 axial slices,
contiguous
• Multi-slice SE ssEPI,
parallel = 2
• 16 directions
• b = 500 s/mm2
NR; NR; 1.5 × 1.5 ×
3 mm3; 4727/63; no;
NR
FA, MD, AD, RD Automatic
segmentation,
whole-cord at
C3–4 (11 slices)
• EDSS
• MSFC
• FA, MD, AD, RD more abnormal with
high vs. low EDSS in low or high lesion
count subjects (all P b 0.05 except AD in
high lesion count)
Moderately high;
convenience
sampling
enrollment
Oh et al.
(2013b);
prospective,
cross-sectional
MS (129 total, 74
RRMS, 36 SPMS, 19
PPMS) vs. HCs
(14)
Same as Oh et al. (2013a) • EDSS
• Hip ﬂexion
power
• Vibration
• FA, MD, AD, RD differed vs. HCs
(P b 0.05)
• FA, MD, RD differed from progressive
MS vs. RRMS (P b 0.05)
• FA, MD, RD correlate with EDSS
(P b 0.05)
• FA, RD correlate with vibration
(P b 0.05)
• MD, AD, RD correlate with hip ﬂexion
power (P b 0.05)
Moderately high
(diagnostic),
moderately low
(correlation);
diagnostic accuracy
NR
Raz et al. (2013);
prospective,
cross-sectional
RRMS (19) vs. HCs
(16)
3 T; Siemens;
4-channel neck
PAC
• C1–C4
• 20 axial slices,
contiguous
• SE
(twice-refocused) EPI
• NEX = 2
• 30 directions
• b = 500, 1000,
1500, 2000, 2500
s/mm2
160 mm2; 128 × 128;
1.3 × 1.3 × 3 mm3;
3100/110; no; 15 min
7 s
FA, MD, MK Manual,
whole-cord
from C1–C4, and
NAGM, NAWM
(DCs) at C2
• EDSS
• Disease duration
• WM at C2: decreased FA vs. HCs: 0.52
vs. 0.62, P = 0.01
• GM at C2: decreased MK vs. HCs: 1.11
vs. 1.16, P = 0.01
• Lesions: decreased FA, MK, increased
MD vs. NASC (P b 0.0001)
• Metrics in whole-cord and GM (but not
WM) differ between high EDSS vs. low
(P ≤ 0.01)
• No correlation between FA, MD, MK and
EDSS
Moderately high
(diagnostic),
moderately low
(correlation); no
correlations found
Uda et al.
(2013);
prospective,
cross-sectional
CSM (26) vs. HCs
(30)
3 T; Philips;
16-element
PAC; NR
• C2–T1
• 30 axial slices,
contiguous
• SS FSE
• NEX = 1
• 15 directions
• b = 1000 s/mm2
240 mm2; 160 × 160;
1.5 × 1.5 × 3 mm3;
8000/80; no; 4 min
54 s
FA, MD,
z-statistics
calculated per
level
Manual,
whole-cord at
disks, C2–T1
• None • FA varied with cervical level
(P b 0.0001) but increased at C7–T1
• MD had ROC AUC = 0.90, with
SE = 100%, SP = 75%, PPV = 90%, and
NPV = 100%
• FA had ROC AUC= 0.76, with SE= 95%,
SP = 50%
High; groups not
age-matched, no
clinical data
Von Meyenburg
et al. (2013);
prospective,
cross-sectional
MS (38 total, 15
RRMS, 13 SPMS, 10
PPMS), 28 HCs
3 T; Philips;
6-element
spine PAC
• C5
• 6 axial slices,
contiguous
• rFOV ssEPI
• Partial Fourier = 0.6
• 6 directions
• b = 750 s/mm2
120 × 30 mm2; 176 ×
44; 0.7 × 0.7 ×
5 mm3; 4000/49; no;
10 min
FA, MD Manual, 4 ROIs:
L/R LCs and DCs
• EDSS
• MEPs
• Decreased FA in all ROIs (all P ≤ 0.001)
• No differences in MD
• FA correlates with age (P b 0.05)
• Tract-speciﬁc FA correlates with
corresponding MEPs: r =−0.93–0.94, P
b 0.01
High; groups not
age-matched,
correlation with
EDSS NR
Banaszek et al.
(2014);
prospective,
cross-sectional
CSM (132) vs. HCs
(25)
1.5 T; GE;
16-channel
head/spine
PAC; 33 mT/m
• C2–C7
• Axial slices,
variable number,
contiguous
• SE ssEPI
• 2 acquisitions
• 14 directions
• b = 1000 s/mm2
160 mm2; 96 × 96;
1.6 × 1.6 × 4 mm3;
10,000/99; no;
5–7 min
FA, MD Manual,
whole-cord;
images divided
into 5 groups
based on cord
compression
• None • FA decreased at all levels (C2–C6) vs.
HCs (P b 0.0001)
• FA correlated with measures of cord
compression (P b 0.01)
• MD increased in most levels/subgroups
vs. HCs (P b 0.05)
High; no clinical
data, images at C6–7
excluded due to
artifacts
El Mendili et al.
(2014);
prospective,
longitudinal
ALS (29), no HCs 3 T; Siemens;
neck/spine coil;
NR
• C2–T2
• 8 axial slices,
mid-VB, variable
gap
• ssEPI, GRAPPA = 2
• Repeated 4×
• 64 directions
• b = 1000 s/mm2
128 mm2; 128 × 128;
1 × 1 × 5 mm3;
700/60; yes; 15 min
FA, MD, AD, RD;
FU MRI at 1
year
Manual, 4 ROIs:
ACs, DCs, L/R
LCSTs
• ALSFRS-R
• Muscle power
• FU at 1 year
• FA of LCSTs correlates with ALSFRS-R
leg (P b 0.001) and total (P = 0.04)
scores
• Baseline FA predicts ALSFRS-R leg
(P = 0.002) and total (P = 0.001) scores
at 1 year FU
• No change in DTI metrics at 1 year FU
Moderately high;
manual ROI
(continued on next page)
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Table 3 (continued)
Authors (year);
design
Subjects B0; vendor; coil;
gradients
Anatomical
region/position
DTI acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
DTI metrics ROI Clinical measures Key results Risk of bias; key
barriers to
translation
vs. baseline
Ellingson et al.
(2014);
prospective,
cross-sectional
CSM (48 total, 16
mJOA = 18) vs.
HCs (9)
3 T; Siemens;
CTL spine PAC
(2 elements);
NR
• Upper cervical
cord (HCs)
• MCL (CSM)
• Axial slices,
number NR
• rFOV ZOOMED-EPI
• 6 directions
• NEX = 15
• b = 500 s/mm2
NR; NR; NR; 5000/67;
no; NR
FA, MD, AD, RD,
ψ, SD(θ)
Manual,
whole-cord at
MCL or upper
cord (HCs)
• mJOA • FA diagnostic of mJOA b 18 vs.
mJOA = 18 with SE = 72%, SP = 75%
(AUC = 0.77)
• FA diagnostic of mJOA b 15 with
SE = 81%, SP = 92% (AUC = 0.95)
• FA correlates with mJOA: R2 = 0.41,
P b 0.0001
• SD(θ) correlates with mJOA: R2 = 0.41,
P b 0.0001
High; MRI details
NR, age/gender of
HCs NR, metrics at
MCL potentially
biased
Li et al. (2014);
prospective,
cross-sectional
CSM (14) vs. HCs
(14)
3 T; Philips; NR;
NR
• C3–C7
• Axial slices,
number/gap NR
• SE EPI
• 15 directions
• b = 600 s/mm2
NR; NR; 1 × 1.3 ×
7 mm3; 5 beats/60;
yes; NR
OE, wOE Manual,
whole-cord
• Muscle power
• Reﬂexes
• Sensory testing
• Diagnosis of symptomatic level with OE
had SE = 81%, SP = 67%, wOE had
SE = 81%, SP = 100%
High; groups not
age-matched, OE not
compared with
standard metrics
Rajasekaran et al.
(2014);
prospective,
cross-sectional
CSM (35) vs. HCs
(40)
1.5 T; Siemens;
NR; NR
• C1–T1
• 40 axial slices,
gap NR
• SE ssEPI
• 12 directions
• b = 500 s/mm2
220 mm2; 256 × 256;
0.9 × 0.9 × 4 mm3;
6000/85; no; NR
FA, MD, λ1, λ2,
λ3
Manual,
whole-cord, at
C1 and disks:
C2–T1
• Nurick • All metrics differed between CSM vs.
HCs at MCL: P b 0.01
• DTI metrics not different between high
and low Nurick grades
• No correlation between DTI metrics and
Nurick grades
High; coarse clinical
data, comparison vs.
HCs not at same
level (C1–T1) as
MCL
Toosy et al.
(2014);
prospective,
cross-sectional
MS (14) vs. HCs
(11)
1.5 T; GE; NR;
33 mT/m
• C1–C5
• 30 axial slices,
contiguous
• CO-ZOOM-EPI rFOV
• 60 directions
• b = 1000 s/mm2
70 × 47 mm2; 48 ×
32; 1.5 × 1.5 ×
5 mm3; 15 beats/96;
yes; NR
FA, MD, AD, RD Automatic
(registered to
template),
whole-cord and
lesions using
TFCE, P b 0.01
• EDSS
• 9 hole peg
• 25-foot TWT
• MSWS
• FA decreased, RD increased (P b 0.01)
• FA correlates with EDSS (R =−0.6,
P = 0.05) and TWT (R = 0.7, P = 0.02)
• RD correlates with EDSS (R = 0.7,
P = 0.01) and TWT (R =−0.6,
P = 0.05)
High (diagnostic),
moderately high
(correlation); 4
subjects excluded
(image processing)
Wang et al.
(2014);
prospective,
cross-sectional
ALS (24) vs. HCs
(16)
1.5 T; GE;
8-channel spine
coil; NR
• C2–C4
• 24 axial slices,
contiguous
• SE ssEPI, NEX = 4
• 6 directions
• b = 400 s/mm2
2240 mm2; 128 ×
128; 1.9 × 1.9 ×
4 mm3; 6000/min;
no; NR
FA, MD Manual, 5 ROIs:
DCs, L/R STs,
LCSTs at mid-VB
C2–C4
• ALSFRS-R
• mNorris
• EMG
• FA decreased in LCSTs at all levels
(P b 0.01), not DCs, STs
• MD increased in LCSTs at all levels
(P b 0.05), not DCs, STs
• DTI metrics not correlated with clinical
measures
High; large voxels
(difﬁcult to assess
individual tracts),
manual ROI
Wen et al.
(2014a);
prospective,
cross-sectional
CSM (15) vs. HCs
(25)
3 T; Philips;
head/neck PAC;
NR
• C1–C7
• 12 axial slices
mid-VB or
mid-disk
• ssEPI with spatial
presaturation
• 15 directions
• b = 600 s/mm2
880 mm2; 80 × 64;
1 × 1.3 × 4 mm3; 5
beats/60; yes; 24 min
FA, MD, AD, RD Manual, ACs,
LCs, DCs at MCL
• mJOA
• SSEPs
• FA in HCs higher in DCs and LCs than
ACs (P b 0.05)
• FA decreased selectively in LCs and DCs
at MCL, but not in ACs (P b 0.05)
High; groups not
age-matched, only
severe CSM subjects
included
Wen et al.
(2014b);
prospective,
longitudinal
CSM (45) vs. HCs
(20)
Same as Wen et al. (2014a) Manual,
whole-cord
• mJOA
• SSEPs
• Recovery ratio
(6 min–2 years
FU)
• Reduced mean FA: 0.65 vs. 0.52,
P b 0.001
• FA correlates with mJOA: R2 = 0.33,
P = 0.02
• FA predicts good mJOA recovery ratio:
P = 0.03
High; groups not
age-matched, coarse
clinical data, 2
inconsistent
deﬁnitions of mJOA
recovery rate
Zhou et al.
(2014);
prospective,
cross-sectional
CSM (19) vs. HCs
(19)
3 T; Siemens;
NR; NR
• C1–C7
• 16 axial slices,
gap NR
• SE ssEPI, NEX = 2
• 20 directions
• b = 600 s/mm2
8128 × 124 mm2;
128 × 124; 1 × 1 ×
5 mm3; 5000/106;
yes; 24 min
FA Manual,
whole-cord at
C2, MCL
• JOA • FA decreased at C2 (0.60 vs. 0.67,
P = 0.01) and MCL (0.51 vs. 0.66,
P b 0.001)
• Amplitude of right pre-central and
post-central gyri oscillations correlate
weakly with FA at C2 (P b 0.05)
High; primarily
brain fMRI study,
with cord DTI as
secondary measure
204
A
.R.M
artin
etal./N
euroIm
age:Clinical10
(2016)
192–238
Abbas et al.
(2015);
prospective,
cross-sectional
Pott Disease (30
total, 15 with
paraplegia, 15
without), no HCs
3 T; Siemens;
NR; NR
• 1 VB above to 1
VB below lesion
• 25 axial slices, 2
mm gap
• SPAIR, NEX = 4
• 20 directions
• b = 700 s/mm2
1280 mm2; 128 ×
128; 2.2 × 2.2 ×
5 mm3; 4100/66; no;
NR
FA, MD Manual, central
GM/WM at 3
levels: 1 VB
above, at lesion,
and 1 VB below
• Jain and Sinha
score
• Presence of
paraplegia
• FA higher above vs. below lesion in all
subjects (P b 0.05)
• No difference between metrics with or
without paraplegia
High;
non-standard/coarse
clinical data, large
voxels
Iglesias et al.
(2015);
prospective,
cross-sectional
ALS (21) vs. HCs
(21)
3 T; Siemens;
neck/spine coil;
NR
• C2–T2
• 8 axial slices,
mid-VB, variable
gap
• ssEPI, GRAPPA = 2
• Repeated 2×
• 64 directions
• b = 1000 s/mm2
1128 mm2; 128 ×
128; 1 × 1 × 5 mm3;
700/60; yes; 10 min
FA, MD, AD, RD Manual, 4 ROIs:
ACs, DCs, L/R
LCSTs
• SSEPs
• ALSFRS-R
• 9 hole peg
• Muscle power
• 58% of ALS group had abnormal MD, RD
values (outside 95% CI) in DCs
• DTI metrics only correlated with N9
amplitude, not N20
• DTI metrics not correlated with clinical
measures
High; 3 subjects
excluded due to
artifacts, no
correlation with
clinical scores
Maki et al.
(2015);
prospective,
cross-sectional
CSM (20) vs. HCs
(10)
3 T; GE; 8
channel neck
PAC; NR
• C1–T1
• 15 axial slices,
mid-VB/mid-disk,
variable gap
• rFOV SE ssEPI,
NEX = 16
• 6 directions
• b = 700 s/mm2
140 × 30 mm2; 176 ×
44; 0.7 × 0.7 ×
5 mm3; 3000/75; no;
NR
FA Manual, 2 ROIs:
DCs, LCs one
slice above MCL
• JOA • FA decreased in LCs (0.59 vs. 0.71,
P = 0.01) and DCs (0.58 vs. 0.72,
P b 0.01) but ranges overlap
• FA correlates with JOA: r = 0.48,
P = 0.03 for both LCs, DCs
• FA correlates with JOA lower extremity
subscore in LCs (r = 0.76, P b 0.01) and
DCs (r = 0.74, P b 0.01)
• ICC for ROI selection: 0.72–0.80
High; groups not
age-matched,
manual
tract-speciﬁc ROIs
had only moderate
reliability
Oh et al. (2015);
prospective,
cross-sectional
MS (102 total, 66
RRMS, 24 SPMS, 12
PPMS) vs. HCs
(11)
Same as Oh et al. (2013a) FA, RD Same as Oh
et al. (2013a)
• EDSS
• MSFC
• Vibration
• Hip ﬂexion
• OCT retinal
measures
• RD (but not FA) decreased in
progressive MS vs. RRMS (P = 0.03)
• FA, RD correlate with several measures
of retinal layers (P b 0.01)
• DTI metrics do not independently
correlate with clinical measures in
multivariate regression
Moderately high
(diagnostic),
moderately low
(correlation); no
correlation found
Vedantam et al.
(2015);
retrospective,
cross-sectional
aSCI (12) vs. HCs
(12)
1.5 T; GE; CTL
spine coil; NR
• C1–T1 • Sequence NR
• 15/25 directions
(19/5 subjects)
• b = 500/600 s/mm2
190 mm2; 128 × 128;
1.5 × 1.5 mm2
(thickness NR);
5000/98; no; NR
FA Manual,
whole-cord and
LCSTs, C1–C2
• ASIA motor and
sensory scores
• AIS
• FA decreased at C1–2 in whole-cord
(0.61 vs. 0.67, P b 0.01) and LCSTs (0.66
vs. 0.70, P = 0.04)
• FA of LCSTs correlates with AIS
(r = 0.71, P = 0.01), and upper limb
motor score (r = 0.67, P = 0.01)
• DTI metrics did not correlate with
sensory scores
High; MR pulse
sequence NR,
manual ROIs
Yan et al. (2015);
prospective,
cross-sectional
Chiari I with
Syringomyelia
(23) vs. HCs (8)
1.5 T; Philips;
16-channel NC
coil;
• C2–T1
• Axial slices,
number/gap NR
• EPI
• 15 directions
• b = 400 s/mm2
224 mm2; 112 × 109;
2 × 2 × 2 mm3;
2170/59; no; 10 min
FA Manual,
whole-cord at
syrinx and
above/below
• None • No difference in FA above/below syrinx
vs. HCs
• FA at syrinx decreased vs. HCs: 0.43 vs.
0.53, P b 0.05
• FA decreased at syrinx in symptomatic
patients vs. asymptomatic: 0.37 vs. 0.45,
P b 0.05
High; large voxels
(and thinly
stretched cord),
deﬁnition of
symptomatic NR
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(Nair et al., 2010; Oh et al., 2013a,b, 2015; Toosy et al., 2014), where-
as the other 57 studies introduced potential bias by performingman-
ual ROI selection without blinding procedures. The most common
automated method was a simple segmentation procedure, followed
by extraction from the whole cord. Nair et al. (2010) used FA values
of each subject to create a WM skeleton, and then used this map to
draw ROIs from C1 to C6, in a method that is somewhat similar to
tractography-based ROI selection. Toosy et al. (2014) performed
automated segmentation and registration to a spinal cord template,
and subsequently extracted whole-cord ROIs and also hyperintense
lesions using an automated threshold-free cluster enhancement
(TFCE) algorithm. In addition, 7 studies utilized a semi-automatic al-
gorithm to perform spinal cord segmentation, but then performed
manual exclusion of edge voxels that were subject to partial volume
effects with contamination from CSF (Agosta et al., 2007a, 2008b,
2009a,b; Benedetti et al., 2010; Manconi et al., 2008; Valsasina
et al., 2007), which could introduce bias in the samemanner as man-
ual ROI selection. Another study performed random ROI placement
to avoid issues of potential bias, but did not report the exact method
of randomization (Kamble et al., 2011). Among the 16 DTI FT studies,
6 utilized automatic ROI selection based on the FT output, although 4
of these used manual seed points to initiate the FT algorithm and 1
did not report details on the use of seed points (Hatem et al.,
2010). Budzik et al. (2011) performed semi-automated FT without
manual seed points and extracted whole-cord ROIs automatically.
Among the MT studies, 14 of the 25 studies utilized automatic or
semi-automatic analysis methods to extract MTR or MTCSF, with
only a minority of studies using manual ROI selection. Rather than
exclude edge voxels manually, many of these studies excluded
voxels based on a preset threshold of MTR b 10%. The single MWF
study used manual ROI selection. The 11 MRS studies were all
single-voxel ROIs, with relatively straightforward analysis methods.
All of the fMRI studies used a complex series of steps in data analysis,
and 7/8 of the reviewed studies made statistical assumptions
without correcting for multiple comparisons, leading to potentially
biased results. All of the fMRI studies manually divided the cord
into quadrants or hemi-cords.
3.5. Evidence regarding diagnostic utility
Ninety-ﬁve of the 104 studies included in the reviewmade compar-
isons between pathological subjects and healthy controls. Among these
95 studies, 88 had a high risk of bias, and 7 had a moderately high risk.
The vast majority of these studies (89/95) only reported group differ-
ences and did not calculate diagnostic accuracy in terms of SE, SP, PPV,
or NPV. Group comparisons between pathological subjects and healthy
controls frequently showed similarities across different diseases includ-
ing decreased FA, increasedMD, increased RD, decreasedMK, decreased
MTR, increased MTCSF, and decreased NAA concentration, suggesting
various clinical pathologies share common underlying injury mecha-
nisms of demyelination, axonal loss, and GM loss. All 6 of the studies
that reported diagnostic accuracy (SE, SP) results utilized DTI, with 4
showing moderate utility of DTI metrics in diagnosing CSM, 1 in CM,
and 1 in MS. In CSM, the reported values of SE and SP of DTI metrics
ranged from 50 to 100%, but tended to exceed those reported for T2w-
HI. However, none of the reported values for diagnostic accuracy were
sufﬁciently high to compete with the gold standard for CSM diagnosis,
which is based upon clinical signs of myelopathy along with imaging
evidence of any amount of cord compression (typically using conven-
tionalMRI). The evidence for diagnostic utility in the CM andMS studies
was also not sufﬁcient to consider DTI superior to existing diagnostics.
Two studies (both using DTI) computed z-statistics for metrics at each
vertebral level to determine if an individual measurement was normal
or abnormal. Results pertaining to diagnostic utility are summarized
for each clinical pathology in Table 9.3.6. Evidence regarding biomarker utility
A total of 67 studies assessed correlation of MRI metrics with
measures of clinical impairment. The risk of bias was high in 40 of
these studies, moderately high in 21, and moderately low in 6.
Most of these studies (57/67) performed univariate or multivariate
correlations, although 10 studies took the simplistic approach of di-
viding subjects into categories of severity (above/below artibrary
thresholds) and then comparing group differences in metrics.
Among these studies, the majority (38/67, 57%) only investigated
correlations with a single coarse clinical measure, such as Expanded
Disability Status Scale (EDSS), Japanese Orthopedic Association
(JOA), modiﬁed JOA (mJOA), amyotrophic lateral sclerosis (ALS)
Functional Rating Scale (ALSFRS), or ASIA Impairment Scale (AIS),
rather than employing a battery of assessments or using more
detailed measures of impairment such as ASIA motor/sensory scores.
The majority of DTI studies reporting biomarker utility results
focused on the metric FA, which was particularly successful in CSM
with signiﬁcant results in 5/5 studies correlating with JOA or mJOA
(Spearman r = 0.48–0.88, Pearson R = 0.57–0.64) (Ellingson et al.,
2014; Gao et al., 2013; Jones et al., 2013; Maki et al., 2015; Wen
et al., 2014b) and in SCI in 4/4 studies correlating with ASIA motor/
sensory scores (r = 0.59–0.74, R = 0.78–0.92) (Cheran et al., 2011;
Cohen-Adad et al., 2011; Koskinen et al., 2013; Vedantam et al.,
2015), but slightly less successful in MS with signiﬁcant results in
only 7/15 studies correlating with EDSS (r = −0.37–0.51,
R = −0.60) (Agosta et al., 2007a; Benedetti et al., 2010; Naismith
et al., 2013; Oh et al., 2013a,b; Toosy et al., 2014; Valsasina et al.,
2005), with negative results in 8 studies (Agosta et al., 2005;
Ciccarelli et al., 2007; Hodel et al., 2013; Miraldi et al., 2013; Oh
et al., 2015; Raz et al., 2013; Rocca et al., 2012; Ukmar et al., 2012).
Other metrics had limited success in MS correlating with EDSS,
with signiﬁcant results for MD in 3/13 studies (Oh et al., 2013a,b;
Valsasina et al., 2005), RD in 4/8 studies (Naismith et al., 2013; Oh
et al., 2013a,b; Toosy et al., 2014), MTR in 6/15 studies (Agosta
et al., 2007b; Bozzali et al., 1999; Kearney et al., 2014; Lycklama
et al., 2000; Oh et al., 2013a,b), MTCSF in 2/2 studies (Fatemi et al.,
2005; Zackowski et al., 2009), and the number of active voxels
using fMRI in 1/3 studies (Valsasina et al., 2010) whereas no correla-
tion was found between EDSS and the DKI metric MK (1 study) (Raz
et al., 2013) and theMRSmetric NAA (or relative NAA concentration)
in 5/5 studies. Three studies used longitudinal imaging and clinical
data collection to assess if changes in MRI metrics over time reﬂected
changes in clinical status, but the results were negative in 2/2 studies
using DTI in ALS and 1 study using MWF inMS. Results for biomarker
utility, divided by clinical pathology, are summarized in Table 9.3.7. Evidence regarding predictive utility
Longitudinal studies that assessed predictive utility of advanced
MRI metrics were only conducted in a total of 10 studies involving
MS (5), ALS (2), CSM (2), and CM (1). Among these, 6 utilized DTI,
3 used MRS, 1 used MT, and 1 used MWF. The risk of bias among
these studies was assessed as high in 8 and moderately high in 2.
Four additional studies collected longitudinal clinical data but did
not report prediction of outcomes using baseline MRI metrics.
Among the 10 studies investigating predictive utility, 5 employed a
detailed battery of clinical assessments (Bellenberg et al., 2013; El
Mendili et al., 2014; Freund et al., 2010; Ikeda et al., 2013; Jones
et al., 2013). Baseline FA showed weak to moderate correlations
with clinical outcomes such as ALSFRS in ALS (1 study), mJOA recov-
ery ratio in CSM (1/2 studies), and EDSS in MS (2/2 studies), but not
mJOA in CSM (1 study). Ratios involving NAA were predictive of
outcome in ALS (1 study) andMS (1/2 studies). Results for predictive
utility are summarized in Table 9.
Table 4
Summary of DTI ﬁber tractography (FT) studies.
Authors (year);
design
Subjects B0; vendor; coil;
gradients
Anatomical
region/position
DTI acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
FT metrics FT method; ROI Clinical measures Key results Risk of bias; key
barriers to translation
Facon et al. (2005);
prospective,
cross-sectional
See Table 3 None Vector-based tracing;
none
See Table 3 • FT only used in 3 subjects to assist
with ROI
High; Detailed FT
method NR, no
quantitative analysis
using FT
Renoux et al.
(2006);
prospective,
cross-sectional
See Table 3 None DPTools using
FA N 0.17, angle b 45°;
none
See Table 3 • Areas of myelitis with T2
hyper-intensity (and low FA)
tended to show ‘spreading ﬁbers’ or
‘broken ﬁbers’
• FT had optimal results with
b = 500 s/mm2
High; no quantitative
analysis using FT
Ciccarelli et al.
(2007);
prospective,
longitudinal
MS (14 acute,
lesion at C1–C3)
vs. HCs (13)
1.5 T; GE; NR; 33
mT/m
• C1–C7
• 30 axial slices,
contiguous
• CO-ZOOM-EPI rFOV
• 31 directions
• b = 1000 s/mm2
70 × 47 mm2; 48 ×
32; 1.5 × 1.5 ×
5 mm3; 15
heartbeats/90; yes;
AT NR
Connectivity
index, FA, MD,
AD, RD (from
FT)
4 seed points (ACs,
DCs, L/R LCSTs), FT
with FA N 0.1; C1–C3
for each FT bundle
• EDSS
• 9-hole peg
• 25-foot TWT
• MSWS-12
• FU: 3–6 min
EDSS
• Decreased connectivity in LCSTs
and DCs
(P = 0.03)
• Decreased FA in LCSTs (P = 0.006)
and DCs
(P = 0.02)
• MD, AD, RD not different than HCs
• Connectivity and FA of DCs
correlates with 9-hole peg test
(P b 0.05, r value NR)
High (diagnostic),
moderately high
(correlation); min FA,
max angle NR, no
prediction of EDSS
Hatem et al. (2009);
prospective,
cross-sectional
Syringomyelia
(28) vs. HCs (19)
1.5 T; Siemens;
NR; 40 mT/m
• C1–C7
• 12 sagittal slices,
contiguous
• ssEPI
• GRAPPA parallel
factor = 2
• 25 directions
• b = 1000 s/mm2
179 mm2; 128 ×
128; 1.4 × 1.4 ×
3 mm3; 2100/97;
no; 4 min 37 s
FA, MD (from
FT)
MedINRIA, with
FA N 0.2; manual, 5
ROIs: whole-cord,
L/R/A/P hemi-cords at
C3–4, C6–7
• Thermal sensory
tests
• Laser EPs
• FA reduced in all ROIs: P b 0.05
• MD not different than HCs
• FA at C3–4 (but not C6–7)
correlates with thermal: r =−0.63,
P b 0.01
High; 9 subjects
excluded due to
artifacts, only sensory
clinical data
van Hecke et al.
(2009);
prospective,
cross-sectional
See Table 3 FA, MD, AD,
RD, ψ (from
FT)
Streamline-based FT,
manual seed points,
FA N 0.3, angle b 20°;
whole-cord based on
FT
• None • FT segmentation had improved
ICC vs. manual ROI: 0.96 vs. 0.79
(for FA)
• Decreased FA, ψ in MS with lesions
(P b 0.01) and without (P b 0.02)
High; no clinical data,
diagnostic accuracy
NR
Hatem et al. (2010);
prospective,
cross-sectional
Syringomyelia
(37) vs. HCs (21)
Same as Hatem et al. (2009) FA, MD (from
FT), number of
FT ﬁbers
MedINRIA, with
FA N 0.2; whole-cord
based on FT, A/P
hemi-cords
• Pain scores
• Mechanical,
vibration, thermal
• Laser EPs
• SSEPs
• FA (r =−0.64, P = 0.02) and
number of FT ﬁbers (r =−0.75,
P = 0.02) correlate with average
daily pain scores
High; correlation
with sensory testing
NR, only sensory
clinical data
Xiangshui et al.
(2010);
prospective,
cross-sectional
See Table 3 None GE Functool, FA N 0.18,
angle b 45°; none
• None • Subjects with only dural
indentation on T2w had normal FT
• FT appeared distorted in subjects
with cord compression on T2w
High; no quantitative
analysis using FT
Budzik et al. (2011);
prospective,
cross-sectional
CSM (20) vs. HCs
(15)
1.5 T; Philips;
Sense spine coil;
NR
• C1–C7
• 12 sagittal slices,
contiguous
• ssEPI with SPIR,
partial Fourier
• 25 directions
• b = 900 s/mm2
200 mm2; 128 ×
128; 1.6 × 1.6 ×
3 mm3; 2010/94;
FA, MD (from
FT N 10 mm)
Semi-automated, no
seed points;
whole-cord based on
FT at C2–3, MCL or
• JOACMEQ • FA decreased at compressed level
vs. C4–C7 in HCs: 0.40 vs. 0.50,
P = 0.0003
• FA at compressed level correlates
High; FT parameters
(min FA, max angle)
NR
(continued on next page)
207
A
.R.M
artin
etal./N
euroIm
age:Clinical10
(2016)
192–238
Table 4 (continued)
Authors (year);
design
Subjects B0; vendor; coil;
gradients
Anatomical
region/position
DTI acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
FT metrics FT method; ROI Clinical measures Key results Risk of bias; key
barriers to translation
no; 3 min 33 s C4–C7 (HCs) with detailed UE (P b 0.001) and LE
(P b 0.001) scores
• FA negatively correlated with age:
P = 0.04
Lee et al. (2011);
prospective,
longitudinal
See Table 3 FT: intact,
waist, partial,
or broken
PRIDE, FA N 0.1, angle
b 27°; whole-cord at
MCL based on FT
See Table 3 • Tractography patterns not
correlated with JOA
High; heterogeneous
subjects, FT analysis
uses subjective
categories
Ukmar et al. (2012);
prospective,
cross-sectional
MS (27 total, 9
RRMS, 9 SPMS, 9
PPMS) vs. HCs
(18)
1.5 T; Philips;
NR; 33 mT/m,
slew = 150
mT/m/s
• C1–C7, 40 axial
slices, contiguous
• Sequence NR, fat
sat, SENSE = 2
• 32 directions
• b = 1000 s/mm2
224 mm2; 112 ×
112; 2 × 2 × 2 mm3;
6731/91; no; 4 min
2 s
FA (manual
ROI), FDI
DTI Studio, FA N 0.25,
angle b 70°; manual,
whole-cord, C1–C7
• EDSS • No difference in FA vs. HCs
• FDi decreased in MS: 12 vs. 16,
P b 0.01
• No correlation of metrics with
EDSS
High; large voxels,
groups not
age-matched, no
correlation found
Wang et al. (2012);
prospective,
cross-sectional
See Table 3 FT: amount of
compression
PRIDE, FA N 0.2; none See Table 3 • FT normal in all 49 HCs
• FT slightly compressed in 25/27
without T2w-HI
• FT showed various degrees of
severe compression in CM with
T2w-HI
High; subjective
analysis of FT, large
voxels
Gao et al. (2013);
prospective,
cross-sectional
See Table 3 FT: deformed,
thinning, or
broken
NR; no ROI, qualitative
impression of MCL
See Table 3 • FT deformed in 28/31 mild (JOA
13–16) subjects, thinning in 10/27
moderate (JOA 9–12) and 19/25
severe (JOA 5–8) subjects, broken
in 18/21 serious (JOA 0–4)
High; DTT method
NR, subjective FT
categorization
Hodel et al. (2013);
prospective,
cross-sectional
Myelitis (40
total, 25 MS, 11
NMO, 4 other)
vs. HCs (12)
3 T; Philips;
16-channel
head/neck PAC;
NR
• C1–C7
• 11 coronal slices
• rFOV ZOOMED-EPI,
fat sat, partial
Fourier, NEX = 3
• 15 directions
• b = 600 s/mm2
42 × 170 mm2; 23 ×
96; 1.8 × 1.8 ×
2.5 mm3; 3
beats/39; yes; 7 min
30 s
FA, MD, AD,
RD,Ψ (from
FT)
Manual seed and
termination points at
C1, C7, using FMRIB;
whole-cord based on
FT
• EDSS
• Pyramidal score
• Sensory score
• FA andΨ signiﬁcantly decreased
in overall cohort and all subgroups
except MS with acute cervical
lesions
• Excluding active lesions, FA
correlates with sensory score:
r =−0.4, P = 0.01
High; groups not
age-matched,
heterogeneous
subjects, large voxels
Rajasekaran et al.
(2014);
prospective,
cross-sectional
See Table 3 FT: intact,
waist, partial,
or broken
Method NR, manual
seed points at C1–2,
FA N 0.2; none
See Table 3 • FT results showed 4 waist, 21
partially broken, and 10 completely
broken
• No correlation between FT results
and Nurick grade
High; FT method NR,
no correlation found
Abbas et al. (2015);
prospective,
cross-sectional
See Table 3 None Method NR; none See Table 3 • 13/15 subjects without paraplegia
had decreased FT thickness below
lesion, and 14/15 had some
disruption
• 4/15 subjects with paraplegia had
decreased FT thickness below
lesion, 6/15 had some disruption,
and 2/15 had complete cessation of
FT
High; minimal
clinical data, FT
method NR, only
qualitative
assessment of FT
Cui et al. (2015);
prospective,
cross-sectional
CSM (23) vs. HCs
(20)
3 T; Philips;
head/neck coil;
NR
• C1–C7
• 12 axial slices,
gap NR
• rFOV SE ssEPI, fat
sat
• 15 directions
• b = 600 s/mm2
80 × 36 mm2; 80 ×
28; 1 × 1.3 ×
7 mm3; 5 beats/60;
yes; 24 min
FA, MD, AD,
RD (from FT),
FD
TrackVis, manual seed
points at C2, angle b
35°; 7 ROIs from FT:
whole-cord, L/R ACs,
LCs, DCs
• JOA
• Hand 10 second
test
• Decreased FA in LCs, DCs: P b 0.001
• MD, AD, RD higher in all columns:
P b 0.05
• Decreased FD: 0.29 vs. 0.32,
P b 0.05
High; correlation
with clinical
measures NR
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Table 5
Summary of MT studies.
Authors (year);
design
Subjects B0; vendor; coil Anatomical
region/position
MT acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
MT metrics ROI Clinical measures Key results Risk of bias; key
barriers to translation
Silver et al. (1997);
prospective,
cross-sectional
MS (12 total, 8
RRMS, 4 SPMS)
vs. HCs (12)
1.5 T; NR; neck
PAC
• C1–C7
• 3 sagittal slices,
contiguous
• FSE ± MT pre-pulse
(sinc, 1 kHz offset, 20 ms,
1430°), NEX = 8
NR; 256 × 192; 5
mm thick; 1600/17;
no; 17 min 40 s
MTR Manual, ellipse
drawn on
mid-sagittal image
from C1–C3
• EDSS • Decreased MTR: 18 vs. 19,
P = 0.0004
• No correlation between MTR and
EDSS
High; no correlation
with EDSS,
mid-sagittal ROI
misses key WM tracts
Bozzali et al.
(1999);
prospective,
cross-sectional
MS (90) vs. HCs
(20)
1.5 T; NR;
tailored cervical
PAC
• C1–C7
• 20 axial slices
(contiguous)
• 17 sagittal slices
(0.3 mm gap)
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), NEX = 2,
FA = 20°
Axial: 250 mm2;
192 × 256; 1 × 1 ×
3 mm3; 640/10; no;
NR; sagittal: 280
mm2; 224 × 256;
1 × 1 × 5 mm3;
640/10; no; NR
MTR,
histogram
peak, location
Manual, whole-cord • EDSS • Axial data more sensitive to
pathology
• Decreased MTR (axial): 44 vs. 46,
P = 0.001
• Patients with EDSS ≥ 4.0 had lower
MTR: P = 0.02
High; correlation
coefﬁcient not
calculated
Filippi et al.
(2000);
prospective,
cross-sectional
MS (96 total, 52
RRMS, 33 SPMS,
11 PPMS) vs. HCs
(21)
1.5 T; Siemens;
tailored cervical
PAC
• C1–C7
• Slice
orientation,
number, gap NR
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), FA = 20°,
NEX = 2
192 × 250 mm2;
256 × 256; 1 × 1 ×
5 mm3; 640/12; no;
NR
MTR,
histogram
peak, location
Semi-automatic,
whole-cord,
excluding voxels
with MTR b 10%
• EDSS • Decreased MTR in MS patients:
44% vs. 46% P = 0.006
• Peak location and height were
independent predictors of EDSS ≥
4.0 in multivariate analysis
High; correlation
coefﬁcient not
calculated
Lycklama et al.
(2000);
prospective,
cross-sectional
MS (65 total, 14
RRMS, 34 SPMS,
17 PPMS) vs. HCs
(9)
1.0 T; Siemens;
quadrature head
coil
• Brain-C1
• 22 axial slices, 3
mm gap
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.6 ms, 500°), FA = 30°,
NEX = 2
NR; NR; 3 mm thick;
700/10; no; NR
MTR Manual, whole-cord
excluding edge
voxels at C1
• EDSS • Decreased MTR: 30 vs. 33, P b 0.01
• MTR correlates weakly with EDSS:
r =−0.25, P b 0.05
High; coarse clinical
data, weak
correlation with EDSS
Rovaris et al.
(2000);
prospective,
cross-sectional
MS (77 total, 40
RRMS, 28 SPMS, 9
PPMS), no HCs
1.5 T; Siemens;
tailored cervical
PAC
• C1–C7
• 20 axial slices,
contiguous
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), FA = 20°,
NEX = 2
250 mm2; 192 ×
256; 1 × 1 × 3 mm3;
640/10; no; NR
MTR,
histogram
peak, location
Semi-automatic,
whole-cord,
excluding voxels
with MTR b 10%
• EDSS • No difference in mean MTR,
histogram height between RRMS,
SPMS, and PPMS
• Peak location signiﬁcantly
different for RRMS N SPMS N PPMS,
P = 0.01
• Peak location corresponds with
EDSS ≥ 3, P b 0.001
High; correlation
coefﬁcients not
calculated
Inglese et al.
(2001);
prospective,
cross-sectional
LHON (14) vs.
HCs (20)
1.5 T; NR;
standard cervical
coil; NR
• C1–C4
• 20 axial slices,
0.3 mm gap
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
16 ms, 850°), FA = 20°
250 mm2; 256 ×
256; 1 × 1 × 5 mm3;
640/10; no; NR
MTR,
histogram
peak, location
Manual, whole-cord • None • No signiﬁcant differences in MTR
or histogram metrics vs. HCs
High; no group
differences found, no
clinical data
Rocca et al. (2001);
prospective,
cross-sectional
CADASIL (25) vs.
HCs (14)
1.5 T; NR;
tailored cervical
PAC
• C1\\C7
• 24 axial slices
(contiguous)
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), FA = 20°
NR; NR; 5 mm thick;
792/10; no; NR
MTR,
histogram
peak, location
Semi-automatic,
whole-cord,
excluding voxels
with MTR b 10%
• Rankin score • No difference in MTR or histogram
location
• MTR peak height lower in
CADASIL: P = 0.02
• MTR correlates with Rankin
disability: r =−0.4, P = 0.05
High (diagnostic),
moderately high
(correlation); coarse
clinical data, results
are NS if corrected
Rovaris et al.
(2001a);
prospective,
cross-sectional;
high
Migraine (16) vs.
HCs (17)
Same as Rovaris et al. (2000) •
Presence/absence
of aura
• No differences in mean MTR or
histogram metrics
High; no group
differences found,
minimal clinical data
Rovaris et al.
(2001b);
prospective,
cross-sectional
PPMS (91) vs.
SPMS (36) vs.
HCs (30)
Same as Rovaris et al. (2000) MTR,
histogram
peak
Same as Rovaris et al. (2000) • Mean MTR decreased vs. HCs:
42 vs. 46, P b 0.001
• Peak height decreased vs. HCs:
61 vs. 72, P = 0.001
• Peak height increased vs. SPMS:
61 vs. 57, P = 0.003
• No metric had univariate
correlation with EDSS
Moderately high
(diagnostic),
moderately low
(correlation); coarse
clinical data, no
correlations found
Filippi et al.
(2002);
prospective,
cross-sectional
PPMS (26) vs.
HCs (15)
1.5 T; Siemens;
tailored cervical
PAC
• C1–C7
• 24 axial slices
(contiguous)
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), FA = 20°,
NEX = 2
250 mm2; 256 ×
256; 1 × 1 × 5 mm3;
640/12; no; NR
MTR,
histogram
peak, location
Semi-automatic,
whole-cord,
excluding voxels
with MTR b 10%
• EDSS
• fMRI brain
activations
• Decreased MTR: 40 vs. 46,
P b 0.001
• Decreased peak height: 62 vs. 112,
P b 0.001
• Decreased peak location: 35 vs. 40,
High; no correlations
with EDSS, utility of
correlations with
brain fMRI activation
is unclear
(continued on next page)
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Table 5 (continued)
Authors (year);
design
Subjects B0; vendor; coil Anatomical
region/position
MT acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
MT metrics ROI Clinical measures Key results Risk of bias; key
barriers to translation
P = 0.003
• MTR does not correlate with EDSS
• MTR metrics correlate moderately
with fMRI activation of several
motor areas
Rovaris et al.
(2004);
prospective,
cross-sectional
CIS (45) vs. HCs
(27)
Same as Rovaris et al. (2000) • No signiﬁcant differences in
metrics vs. HCs
• 3/45 subjects had mean MTR 2 SDs
below mean of HCs
High; no group
differences found
Fatemi et al.
(2005);
prospective,
cross-sectional
AMN (17 total, 9
full AMN, 8
X-ALD
hetero-zygotes)
vs. HCs (10)
1.5 T; Philips;
2 element neck
PAC
• C1–C3
• 32 axial slices
(contiguous)
• 3D GE with MT
pre-pulse (sinc, 15 ms,
5 offsets 10–63 kHz),
FA = 7°
225 × 48 mm3; 256
× 256 × 32; 1 × 1 ×
1.5 mm3; 50/13; no;
NR
MTCSF Manual, DCs • EDSS
• R, L 1st toe
vibration
• Standing
balance test
• MTCSF increased in AMN (34) vs.
X-ALD (30) vs. controls (27):
P b 0.0001
• DC MTCSF correlates with EDSS
(r = 0.62, P = 0.01), vib. Sense
(r = 0.75, P = 0.002), and balance
sway (r = 0.62, P = 0.01)
High (diagnostic),
moderately high
(correlation); manual
ROI, DCs only
Agosta et al.
(2006);
prospective,
cross-sectional
Neuro-borreliosis
(Lyme Disease)
(20) vs. HCs (11)
1.5 T; Siemens;
tailored cervical
PAC
• C1–C7
• 24 axial slices
(contiguous)
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), FA = 20°
250 mm2; 256 ×
256; 1 × 1 × 5 mm3;
640/12; no; NR
MTR Semi-automatic,
whole-cord,
excluding voxels
with MTR b 10%
• None • No difference in cervical cord MTR Moderately high; no
group difference
found
Rocca et al. (2006);
prospective,
cross-sectional
Isolated myelitis
(24) vs. HCs (15)
1.5 T; Siemens;
NR
• C1–C7
• 20 axial slices
(gap NR)
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), FA = 20°
NR; NR; 5 mm thick;
640/12; no; NR
MTR Semi-automatic,
whole-cord,
excluding voxels
with MTR b 10%
• EDSS
• 9 hole peg
• Finger-tapping
•MTR decreased in myelitis vs. HCs:
36 vs. 41, P b 0.0001
• MTR decreased in cervical vs.
thoracic myelitis: 35 vs. 37,
P = 0.01
• No correlation between MTR and
clinical measures
• Various correlations between MTR
and brain fMRI activations
High (diagnostic),
moderately high
(correlation); no
correlations with
clinical measures
Agosta et al.
(2007b);
prospective,
cross-sectional
RRMS (18) vs.
HCs (13)
1.5 T; Siemens;
tailored cervical
PAC
• C1–C7
• 20 axial slices
(contiguous)
• 2D GE ± MT pre-pulse
(Gaussian, 1.5 kHz offset,
7.7 ms, 500°), FA = 20°
180 mm2; 128 ×
128; 1.4 × 1.4 ×
4 mm3; 600/25; no;
NR
MTR Manual, GM
(avoiding edge
voxels)
• EDSS • Decreased GMMTR: 23.5 vs. 24.8,
P = 0.009
• GM MTR correlates with EDSS:
r =−0.48, P = 0.048
High (diagnostic),
moderately high
(correlation); coarse
clinical data
Rovaris et al.
(2008);
prospective,
cross-sectional
RRMS (23) vs.
HCs (10)
Same as Rovaris et al. (2001b) EDSS No difference in metrics vs. HCs
No correlation in metrics with brain
T2w lesions
High; no group
differences found,
correlation with EDSS
NR
Zackowski et al.
(2009);
prospective,
cross-sectional
MS (42) vs. HCs
(18)
3 T; Philips;
2-element
surface PAC
• C2–C6
• 40 contiguous
axial slices
• GE ± MT pre-pulse
(sinc-Gauss, 1.5 kHz
offset, 24 ms), FA = 9°,
SENSE = 2
NR; NR; 0.6 × 0.6 ×
2.25 mm3; 110/13;
no; NR
MTCSF Manual, 3 ROIs in
each slice: DCs and
R/L LCs; GM ROI in 5
slices at C2–3
• EDSS
• Vibration
• Posture sway
• Ankle power
• Walk speed
• MTCSF of LC (but not DC, GM)
increased in MS vs. HCs: 0.55 vs.
0.50, P = 0.008
• MTCSF of DC correlates with
vibration (r = 0.58, P b 0.001),
sway (r = 0.32, P = 0.02), EDSS
(r = 0.41, P b 0.05)
• MTCSF of LC correlates with ankle
strength (r =−0.45, P = 0.003),
walk speed (r =−0.51, P b 0.001),
and EDSS (r = 0.59, P b 0.05)
High; groups not
age-matched, manual
tract-speciﬁc ROIs
Cohen-Adad et al.
(2011);
cSCI (14) vs. HCs
(14)
3 T; Siemens;
multi-channel
• C2–T2
• 52 axial slices,
• 3D GE ± MT pre-pulse
(Gaussian, 1.2 kHz offset,
230 mm2; 256 ×
256; 0.9 × 0.9 ×
MTR Manual, 4 ROIs:
ACs, DCs, L/R LCs;
• ASIA motor and
sensory scores
• Decreased MTR: 26 vs. 32,
P b 0.0001
High (diagnostic),
moderately high
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prospective,
cross-sectional
head, neck, spine
PACs
0.4 mm gap 10 ms) 2 mm3; 28/3.2; no;
10 min
lesion levels
skipped in cSCI
• MTR correlates with total ASIA
score: r = 0.59, P = 0.04
• MTR of ACs/LCs more speciﬁcally
predicts motor score (P = 0.03),
dorsal region predicts sensory score
(P = 0.03)
(correlation); manual
tract-speciﬁc ROIs
Cohen-Adad et al.
(2013);
prospective,
cross-sectional
ALS (29) vs. HCs
(21)
Same as Cohen-Adad et al. (2011) • ALSFRS-R
• TMS motor
threshold
• Reduction in MTR greatest at
caudal levels
• MTR not correlated with ALSFRS-R
High; manual
tract-speciﬁc ROIs,
groups not
gender-matched
Oh et al. (2013a);
prospective,
cross-sectional
MS (124 total, 69
RRMS, 36 SPMS,
19 PPMS), no HCs
3 T; Philips; 2
element surface
PAC
• C2–C6
• 30 axial slices,
contiguous
• 3D GE T2*w EPI ± MT
pre-pulse (1.5 kHz offset,
sinc-Gauss shape),
FA = 9°, SENSE = 2
NR; NR; 0.6 × 0.6 ×
3 mm3; 121/12.5;
no; NR
MTR Automatic
segmentation,
whole-cord at C3–4
(11 slices)
• EDSS
• MSFC
• MTR decreased in high vs. low
EDSS in high lesion count subjects
(P = 0.003)
• No difference in MTR in high
lesion count subjects
Moderately high;
diagnostic accuracy
NR
Oh et al. (2013b);
prospective,
cross-sectional
MS (129 total, 74
RRMS, 36 SPMS,
19 PPMS) vs. HCs
(14)
Same as Oh et al. (2013a) • EDSS
• Hip ﬂexion
power
• Vibration
• Decreased MTR in total MS vs.
HCs: 30 vs. 31, P = 0.04
• Decreased MTR in progressive MS
vs. RRMS: 0.28 vs. 0.31, P b 0.001
• MTR correlates with EDSS
(P = 0.02) and vibration (P = 0.05)
in multivariate regression
Moderately high
(diagnostic),
moderately low
(correlation); no
diagnostic accuracy
El Mendili et al.
(2014);
prospective,
longitudinal
ALS (29), no HCs 3 T; Siemens;
neck/spine coil;
NR
• C2–T2
52 axial slices,
gap NR
• 3D GE ± MT pre-pulse
(Gaussian, 1.2 kHz offset,
10 ms)
230 mm2; 256 ×
256; 0.9 × 0.9 ×
2 mm3; 28/3.2; no;
5 min
MTR Manual, 4 ROIs:
ACs, DCs, L/R LCSTs
• ALSFRS-R
• Muscle power
• FU at 1 year
• MTR at 1 year decreased from
baseline: 30 vs. 33, P = 0.003
• No correlation between change in
MTR and change in clinical scores
• Baseline MTR not predictive of
1 year outcome
Moderately high; no
correlation/prediction
found, manual ROIs
Kearney et al.
(2014);
prospective,
cross-sectional
MS (133 total, 22
CIS, 29 RRMS, 28
SPMS, 28 PPMS)
vs. HCs (26)
3 T; Philips; 16
channel
neuro-vascular
coil
• C1–C7
• 22 axial slices
• 3D spoiled GE ± MT
pre-pulse (Gaussian, 1
kHz offset, 16 ms),
FA = 20° NEX = 2,
SENSE = 2
180 × 240 mm2;
240 × 320; 0.8 ×
0.8 × 5 mm3;
36/3.5,5.9; no; NR
MTR Semi-automatic,
outer cord, WM,
GM at C2–3 (3
slices)
• EDSS
• 25-foot TWT
• 9 hole peg
• ASIA motor,
sensory
• WMMTR decreased in all
subgroups vs. controls (P b 0.05)
• MTR correlates with EDSS in GM
(r =−0.34), WM (r =−0.32),
outer cord (r =−0.41)
• Cord CSA showed stronger
correlations with all clinical
measures (e.g. R =−0.60 with
EDSS) than MTR
Moderately high
(diagnostic),
moderately low
(correlation); CSA
outperformed MTR
Kearney et al.
(2015);
prospective,
cross-sectional
MS (92 total, 34
RRMS, 29 SPMS,
29 PPMS) vs. HCs
(28)
Same as Kearney et al. (2014) Semi-automatic,
whole-cord, lesions
• EDSS
• MSFC
• 9 hole peg
• PASAT
• TWT
• Whole-cord MTR decreased in
SPMS (P = 0.01) and PPMS
(P = 0.004) vs. HCs
• No difference in whole-cord or
lesion MTR between subgroups
• MTR not independently associated
with disability (CSA, lesion load
were stronger multivariate factors)
Moderately high
(diagnostic),
moderately low
(correlation); no
correlations with
disability found
Oh et al. (2015);
prospective,
cross-sectional
MS (102 total, 66
RRMS, 24 SPMS,
12 PPMS) vs. HCs
(11)
Same as Oh et al. (2013a) Same as Oh et al.
(2013a)
• EDSS
• MSFC
• Vibration
• Hip ﬂexion
• OCT of retina
• MTR not different between total
MS vs. HCs
• MTR decreased in progressive MS
vs. RRMS: P b 0.001
• MTR not correlated with retinal
layer measures
• MTR not correlated with clinical
measures
Moderately high
(diagnostic),
moderately low
(correlation); no
group difference vs.
HCs, no correlations
found
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The vastmajority of studies included in this reviewhadhigh ormod-
erately high risk of bias, leading to a low baseline quality of evidence for
each of the speciﬁc ﬁndings listed in Table 10. For the speciﬁc ﬁnding
that FA is decreased in terms of group differences between patients
and healthy controls in ALS, CSM, myelitis, MS, neuromyelitis optica
(NMO), and SCI, the overall quality of evidence was neither upgraded
nor downgraded, and remained low. Other metrics MD, RD, MK, MTR,
MTCSF, and NAA also showed group differences between patients and
healthy subjects in various clinical conditions, but the quality of
evidence for these metrics was downgraded to very low due to a low
level of evidence (MK, MTCSF) or inconsistent results between studies
(MD, RD, MTR, NAA). There was insufﬁcient evidence available to
make any recommendations regarding the diagnostic utility (in terms
of detecting group differences) of AD, standard deviation of primary
eigenvector orientation (SD(θ)), orientation entropy (OE), tractography
pattern, MWF, and fMRI-based metrics due to a lack of evidence, incon-
sistent results, andwide conﬁdence intervals inmanyof the studies. The
overall quality of evidence for diagnostic accuracy (sensitivity and
speciﬁcity) was also insufﬁcient, which was downgraded 2 levels due
to highly inconsistent results. In terms of biomarker utility, only FA
demonstrated consistent results, and the quality of evidence was
upgraded 1 level to moderate for showing a dose–response gradient.
The evidence for other MRI metrics as biomarkers was inconsistent
and imprecise, leading to a ﬁnding of insufﬁcient evidence. Finally, the
evidence regarding the predictive utility for all MRI metrics was incon-
sistent and imprecise, leading to a rating of insufﬁcient.4. Discussion
It is an exciting time in spinal cord imaging, as the emergence of
powerful new MRI techniques has inspired a large number of early
clinical studies of pathological spine conditions. The excellent research
conducted to date has demonstrated tremendous potential for all of
these techniques to elucidate aspects of the microstructure or function
within the human spinal cord, adding numerous insights into the
pathophysiology of several neurological diseases. Among the 5 new
techniques addressed in this review, DTI has thus far generated the
most research, comprising 66% of the included studies and showing a
sharp increase within the past 6 years, particularly using ROI-based
analysis (Fig. 2). This increase in interest is most likely related to the
promising results that DTI studies have demonstrated, particularly
with moderate evidence that FA is a biomarker for disability in numer-
ous pathologies (Table 10). The correlation of FA with impairment
appears to be strongest in diseases that are conﬁned to the spinal cord
(e.g. CSM), which is consistent with the concept that disability in
more distributed diseases (e.g. MS) is caused by injury to both the
brain and the spinal cord. Low evidence was also found suggesting
that FA shows group differences compared with healthy controls in
several conditions, but insufﬁcient evidence was available to suggest
that DTI provides improved diagnostic accuracy or prediction of
outcomes over established methods. A very low level of evidence was
found for group differences using other DTI metrics MD and RD, MT
metrics MTR and MTCSF, and the MRS metric of NAA concentration. It
is unclear based on the current body of evidence if these metrics have
substantial diagnostic value, due to a lack of strong evidence and sub-
stantial inconsistencies in results to date. The lack of well-designed
studies to determine the diagnostic utility of the advanced MRI
techniques, with 93% having a high risk of bias and only 6% reporting
sensitivity and speciﬁcity, suggests a profound knowledge gap for future
research. Furthermore, several studies in the review suggested that the
simple quantitative measure of spinal cord CSA (quantifying atrophy)
outperforms all of the advanced MRI metrics in terms of diagnostic
and biomarker utility (Kearney et al., 2014, 2015; Oh et al., 2013b,
Table 7
Summary of MRS studies.
Authors (year);
design
Subjects B0; vendor; coil Anatomical
region/position
MRS acquisition Voxel size; TR/TE (ms);
cardiac gating; AT
MRS metrics Clinical
measures
Key results Risk of bias; key barriers to
translation
Ciccarelli et al.
(2007);
prospective,
longitudinal
MS (14 acute,
lesion at C1–C3)
vs. HCs (13)
1.5 T; GE; saddle
coil
• Single voxel, C1–C3 • PRESS
• Sat bands (NR)
• NSA = 192 (w
CHESS)
• Shim method: NR
• Phantom scanned
using same voxel
6 × 8 × 50 mm3 (variable
to ﬁt cord); 3
heartbeats/30; yes (delay
NR); NR
Absolute values and
ratios for: NAA, Cre, Cho,
Myo
• EDSS
• 9-hole peg
• 25-foot TWT
• MSWS-12
• FU: EDSS at
3–6 months
• Decreased NAA: 4.1 vs. 6.7,
P b 0.0001
• No difference in Myo, Cho, Cre
• Correlations found with EDSS: Myo
(r = 0.64, P = 0.02), Cho (r = 0.65,
P = 0.01), Cre (r = 0.75, P = 0.003)
• Cre correlates with upper limb
metrics (P b 0.05) and MSWS-12
High (diagnostic),
moderately high
(correlation); no prediction
of FU EDSS, high variance of
metrics
Holly et al. (2009);
prospective,
cross-sectional
CSM (21) vs. HCs
(13)
1.5 T; Siemens;
neck coil
• Single voxel, C2 • PRESS
• NSA = 256
• Shim method:
manual (18–28 Hz)
10 × 10 × 20 mm3
(variable to ﬁt cord);
1500 or 3000/30; no;
3–5 min shimming +
3 min 40 s
NAA/Cre, Cho/Cre,
presence of Lac peak
• mJOA • Decreased NAA/Cre: 1.27 vs. 1.83,
P b 0.0001
• No difference in Cho/Cre
• No correlation between NAA/Cre
and mJOA
• 7/21 CSM patients had lactate peak
vs. no controls, P b 0.05
High (diagnostic),
moderately high
(correlation); boxplot
shows low SE/SP
Ciccarelli et al.
(2010a);
prospective,
cross-sectional
MS (14, 6 min
within lesion
onset at C1–C3)
vs. HCs (13)
Same as Ciccarelli et al. (2007) ResNAA (NAA not
explained by AD, CSA
parameters)
Same as
Ciccarelli et al.
(2007)
• Decreased NAA: 4.2 vs. 5.9,
P = 0.03
• ResNAA correlates with EDSS (R2
= 0.5, P = 0.03), TWT (R2 = 0.4,
P = 0.02), and MSWS-12 (R2 = 0.4,
P = 0.01)
High; high variance of
metrics, requires MRS, DTI
in same ROI
Ciccarelli et al.
(2010b);
prospective,
longitudinal
Same as Ciccarelli et al. (2007) Absolute NAA; FU MRS
studies at 1, 3, 6 months
Same as
Ciccarelli et al.
(2007)
• Increase in NAA from 1 month to 6
months in patients that recover
following acute MS: P = 0.001
• Baseline NAA and NAA change over
1st month not predictive of outcome
High; weak results for
correlation and prediction
Marliani et al.
(2010);
prospective,
cross-sectional
RRMS (15) vs.
HCs (10)
3 T; GE;
8-channel spine
PAC (upper 4
elements)
• Single voxel, C2–C3 • PRESS
• NSA = 400 (CHESS),
16 (no water
suppression)
• Automatic
shimming
7 × 9 × 35 mm3
(variable); 2000/35; no;
14 min
NAA/Cre, NAA/Cho,
Cho/Cre, Myo/Cre
• EDSS • All metabolite ratios signiﬁcantly
altered in RRMS (P = 0.002 to 0.04)
• No metabolite ratios correlate with
EDSS
High; no correlation with
EDSS found, diagnostic
accuracy NR
Carew et al. (2011a);
prospective,
cross-sectional
ALS (14) vs. HCs
(16)
3.0 T; Siemens;
head/neck/spine
PACs
• C1–C2 • PRESS
• NSA = 256 (CHESS),
4 (no water
suppression)
• Automatic
shimming with B0
mapping
8 × 5 × 35 mm3;
2000/35; no; 12 min
Ratios between Cho,
Myo, NAA, Cre
• ALSFRS-R
• FVC
• Decreased NAA/Cre: 0.75 vs. 1.25,
P = 0.0007
• Decreased Cho/Cre: 0.40 vs. 0.50,
P = 0.007
• NAA/Myo correlates with FVC:
r = 0.66, P = 0.01
• Metrics not signiﬁcantly correlated
with ALSFRS-R
High; 4/30 subjects
excluded due to technical
problems, no correlation
with ALSFRS-R found
(continued on next page)
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Table 7 (continued)
Authors (year);
design
Subjects B0; vendor; coil Anatomical
region/position
MRS acquisition Voxel size; TR/TE (ms);
cardiac gating; AT
MRS metrics Clinical
measures
Key results Risk of bias; key barriers to
translation
Carew et al. (2011b);
prospective,
cross-sectional
SOD1 (24) vs. ALS
(23) vs. HCs (29)
Same as Carew et al. (2011a) • None
(asymptomat-
ic population)
• SOD1 vs. HCs shows decreased
NAA/Cre (P = 0.001), decreased
Myo/Cre (P = 0.02)
• SOD1 vs. ALS shows increased
NAA/Cho (P = 0.002)
High; 12 metric calculations
excluded due to technical
issues
Bellenberg et al.
(2013);
prospective,
longitudinal
MS (22) vs. HCs
(17)
1.5 T; Siemens;
head/neck coil
PAC
• Single voxel, C3–C5
(variable, to include
MS lesions)
• PRESS
• 8 adjacent sat bands
• NSA = 128 (CHESS),
16 (no water
suppression)
• Shim method: NR
8 × 10 × 40 mm3;
1500/30; yes (300 ms
delay); AT NR
Absolute values and
ratios for: NAA, Cre, Cho,
Myo; MRI study
repeated at 1 year FU
• EDSS
•Max. walking
distance
• MSFC
• 25-foot TWT
• 9-hole peg
• FU at 1 year,
2 years
• Decreased NAA, NAA/Cre
(P b 0.01), Cho/Cre (P = 0.026)
• Increased Myo (P = 0.001),
Myo/Cre (P = 0.002)
• NAA correlates with age:
r =−0.482, P = 0.003
• No correlation with clinical
measures
• No signiﬁcant changes in MRS
metrics over 1 year FU
• MS patients that worsened after 1
year had lower baseline NAA/Cre
(P = 0.024) and higher Cho
(P = 0.021)
High (diagnostic,
prognostic), moderately
high (correlation); no
correlation found, weak
prediction of outcome
Ikeda et al. (2013);
prospective,
longitudinal
ALS (19) vs. HCs
(20)
1.5 T; Siemens;
NR
• Single voxel, C1–C3 • PRESS
• NSA = 400 (CHESS)
• Shim method:
automatic
6 × 8 × 40 mm3;
1500/50; no; 15 min
NAA/Cre, Cho/Cre,
Myo/Cre, NAA/Myo
• ALSFRS-R
• FVC
• EMG
• Data
captured 6
min prior, 6
min after
• Decreased NAA/Cre, NAA/Myo,
increased Myo/Cre: ALS vs. HCs and
with vs. without EMG denervation
(P b 0.01)
• NAA/Cre and NAA/Myo correlate
with ALSFRS-R: r = 0.79, P b 0.01
and ρ= 0.76, P b 0.01 respectively
• NAA/Cre and NAA/Myo predict
decline of ALSFRS-R: r =−0.70,
P b 0.01 and ρ=−0.78, P b 0.01
High (diagnostic,
prognostic), moderately
high (correlation); long
acquisition time difﬁcult for
ALS population
Salamon et al.
(2013);
prospective,
cross-sectional
CSM (21 total, 11
with T2w-HI, 10
without) vs. HCs
(11)
3 T; Siemens; NR • Single voxel, C2 • PRESS
• NSA = 256 (CHESS),
4 (no water
suppression)
• 6 sat bands
• Shim method:
manual
7 × 7 × 35 mm3;
2000/30; no; NR
NAA/Cre, Glu/Cre,
Cho/Cre, Myo/Cre, (Lip
+ Lac)/Cre, Cho/NAA
• mJOA • Cho/NAA increased in CSM
(P b 0.01)
• Cho/NAA correlates with mJOA:
R =−0.45, P b 0.01
High; coarse clinical data,
age/gender of HCs NR
Taha Ali and Badawy
(2013);
prospective,
cross-sectional
CSM (24) vs. HCs
(11)
1.5 T; Siemens;
neck circular
surface coil
• Single voxel, C2 • PRESS
• NSA = 512 (CHESS)
• Multiple very
selective sat bands
placed
10 × 10 × 15–20 mm3;
2000/36; yes, 4 min 54 s
NAA, Cho, Cre, Lac,
NAA/Cre, Cho/Cre
• None • NAA/Cr decreased: 1.34 vs. 1.82,
P b 0.0001
• Lactate peak present in 9/24 CSM
subjects, no HCs
High; no clinical data,
diagnostic accuracy only
provided for lactate
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Table 8
Summary of fMRI studies.
Authors (year);
design
Subjects B0; vendor; coil Anatomical
region/position
fMRI acquisition FOV; matrix; voxel
size; TR/TE (ms);
cardiac gating; AT
fMRI metrics ROI Clinical
measures
Key results Risk of bias; key
barriers to translation
Stroman et al.
(2004);
prospective,
cross-sectional
cSCI (27) vs.
HCs (15)
1.5 T; GE; spine
PAC
• T11-conus
• 5 axial slices,
mid-disk or
mid-VB
• Single-shot FSE
• PD-weighted, SEEP contrast
• 3 sat bands: ant, L, and R
• 8.25 s/volume
• Block-design, thermal stimulus
(10C, 32C) to legs
120 × 120 mm2;
128 × 128; 0.9 × 0.9
mm2, thickness NR;
8250/34; no; NR
Activation maps;
co-registered with
template, group
activation for
voxels active in ≥3
subjects
L1–S1 cord • AIS
grade
• Activation in lumbar cord seen in all cSCI
subjects
• Complete SCI subjects showed
decreased ipsilateral dorsal activation and
increased bilateral ventral activation
(P values NR)
High; minimal clinical
data, activations not
corrected, only
qualitative analysis of
group activations
Agosta et al.
(2008a);
prospective,
cross-Sectional
RRMS or SPMS
(24) vs. HCs
(10)
1.5 T; Siemens;
Phased-array
spine coil
• C5–C8 cord
• 9 axial slices
(mid-VB or
mid-disk), gap
adjusted to ﬁt
• Multishot Turbo SE, FA = 120°
• PD-weighted, SEEP contrast
• 2 sat bands (ant. and post.)
• 13 s/volume
• Block-design, tactile stimulus
to right hand
100 × 100 mm2;
256 × 244; 0.4 ×
0.4 × 7 mm3;
2850/11; no; NR
Frequency of
activation; mean SI
change (active
voxels)
Manual, 5
regions (R ant.,
L ant., R post., L
post., central)
• EDSS • Increased mean SI change (active
voxels): 3.4% vs. 2.7%, P = 0.03
• Decreased frequency of ipsilateral
activation: P = 0.003
• Decreased frequency of posterior
activation: P = 0.02
High; coarse clinical
data, activations not
corrected, correlation
with EDSS NR
Agosta et al.
(2008b);
prospective,
cross-Sectional
RRMS or SPMS
(25) vs. HCs
(12)
Same as Agosta et al. (2008a) • Increased mean SI change (active
voxels): 3.9% vs. 3.2%, P = 0.02
• Mean SI change correlates with mean
cord FA: r =−0.48, P = 0.04
• Average SI change correlates with cord
FA: r =−0.48, P = 0.04
High; coarse clinical
data, activations not
corrected, correlation
with EDSS NR
Agosta et al.
(2009b);
prospective,
cross-Sectional
PPMS (23) vs.
HCs (18)
Same as Agosta et al. (2008a) • Increased mean SI change (active
voxels): 3.3% vs. 2.6%, P = 0.05
• Decreased frequency of posterior
activation (P b 0.001)
• Mean SI change correlates with mean
cord FA: r =−0.58, P = 0.001
High; coarse clinical
data, activations not
corrected, correlation
with EDSS NR
Valsasina et al.
(2010);
prospective,
cross-sectional
MS (49 total,
30 RRMS, 19
SPMS) vs. HCs
(19)
Same as Agosta et al. (2008a) • RRMS (P = 0.05) and SPMS (P = 0.02)
had increased cord activation
• Severe disability corresponded to
increased activation vs. controls
(P = 0.004) and mild disability
(P = 0.04)
High; coarse clinical
data, activations not
corrected, correlation
coefﬁcients NR
Cadotte et al.
(2012);
prospective,
cross-sectional
cSCI (18) vs.
HCs (20)
3.0 T; GE and
Siemens; NR
• Brainstem and
C1–T1
• 9 sagittal slices,
contiguous
• ssFSE (HASTE) multi-echo,
partial Fourier
• PD-weighted, SEEP contrast
• 9 s/volume
• Thermal (44C) stimulus, L/R
above and below injury
280 × 210 mm2;
192 × 144; 1.5 ×
1.5 × 2 mm3;
9000/38; no; 7 min
12 s
Number of positive
and negative active
voxels per
dermatome;
connectivity
analysis
Manual, 4
quadrants
• ASIA
sensory
score
• Increased number of active voxels in
incomplete cSCI in dermatome of normal
sensation
• Number of active voxels correlates with
degree of sensory impairment: R2 = 0.93,
P b 0.001
• Increased number of intraspinal
connections in cSCI vs. HCs
High; sensory-only
paradigm, requires
thermal stimulator
Rocca et al.
(2012);
prospective,
cross-sectional
MS (35 total,
20 with
fatigue, 15
without) vs.
HCs (20)
Same as Agosta et al. (2008a) • EDSS
• Fatigue
Severity
Scale
• No difference in number of active voxels
between MS groups or HCs
• MS without fatigue had more
distributed activation outside ipsilateral
dorsal quadrant vs. MS with fatigue and
HCs (P b 0.05)
• Bilateral recruitment correlated with
severity of fatigue: r =−0.34, P = 0.04
High; activations not
corrected (no
activations in 30% of
subjects at p b 0.001),
altered recruitment
not clearly deﬁned
Valsasina et al.
(2012);
prospective,
cross-sectional
Progressive
MS (34 total,
18 SPMS, 16
PPMS) vs. HCs
(17)
Same as Agosta et al. (2008a) • Activation increased vs. HCs: P = 0.003
• Activation increased in SPMS vs. PPMS:
P = 0.05
• No correlation between activation and
EDSS
High; coarse clinical
data, activations not
corrected, no
correlation with EDSS
found
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Table 9
Summary of studies by clinical pathology.
Clinical
pathology
Number of studies by imaging
technique
Key ﬁndings
ROI
DTI
DTI
FT
MT MWF MRS fMRI Diagnostic utility Biomarker utility (correlation with disability) Predictive utility
ALS 7 2 3 • FA decreased (7/7 studies), speciﬁcally in LCSTs (4/4 studies)
• MTR (in LCSTs) was decreased in ALS (1 study)
• NAA decreased in ALS (3/3 studies)
• FA correlated with ALSFRS (r =−0.55–0.74, R = 0.38, 4/6 studies)
• NAA/Cre correlates with ALSFRS (r = 0.79, 1/2 studies) and FVC
(r = 0.66, 1 study)
• FA, MD changes over 1 year not correlated with change in ALSFRS
(2/2 studies)
• MTR does not correlate with ALSFRS (1 study)
• FA predicted ALSFRS at 1 year (1 study)
• NAA/Cre and NAA/Myo predict ALSFRS at 1
year (r =−0.70–0.78, 1 study)
aSCI 3 • MD decreased (2/3 studies)
• FA decreased (2/3 studies)
• FA correlates with one or more components of ASIA motor score
(2/2 studies)
CM 3 3 • FA decreased and MD increased at MCL (2/3 studies)
• FA had higher SE (73%) and SP (100%) than T2w-HI (1 study)
• No correlation of FA, MD, FT with JOA (1 study) • FA, MD did not predict JOA outcome
(1 study)
cSCI 4 1 2 • FA decreased above (4/4 studies) and below (3/3 studies) injury site
• FA at lesion correlates with ASIA motor score (r = 0.67, 1 study)
• FA, RD outside lesion correlates with ASIA motor/sensory scores
(r = 0.66–0.74, 1 study)
• MTR decreasd above/below injury (1 study)
• fMRI shows increased bilateral activation in cSCI vs. HCs (2/2 studies)
• MTR correlates with ASIA motor/sensory score (r = 0.59, 1 study)
• Number of active voxels correlates with sensory impairment
(R = 0.96, 1 study)
CSM 18 5 3 • FA had SE = 72–95%, SP = 50–100% to detect myelopathy (4 studies)
• MD had SE = 13–100%, SP = 50–80% to detect myelopathy (3 studies)
• OE had SE = 81%, SP = 67% to detect myelopathy (1 study)
• FA reduced at compressed level (12/12 studies), above compression
(2/5 studies), and below compression (1/3 studies)
• MD increased at compressed level (8/10 studies), above compression
(1/4 studies), and below compression (1/3 studies)
• MK decreased in overall cord (1 study)
• NAA/Cre reduced (2/3 studies), Cho/NAA increased (1 study)
• Lactate peak present in 33% of subjects (1 study)
• FA correlates with JOA/mJOA (r = 0.48–0.88, R = 0.57–0.64, 5/5
studies)
• SD(θ) correlates with mJOA (R = 0.64, 1 study)
• Tractography pattern only correlated with clinical scale (JOA/Nurick)
in 1/3 studies
• NAA/Cre ratio not correlated with mJOA (1 study)
• Cho/NAA correlated with mJOA (R =−0.45, 1 study)
• FA predicts improvement on NDI
(r =−0.61) but not mJOA (1 study)
• FA predicts mJOA recovery ratio N 50%
(P = 0.03, 1 study)
MS 19 3 16 1 5 5 • FA has SE = 87%, SP = 92% for diagnosis (1 study)
• FA reduced in whole-cord (11/12 studies), NAWM (6/8 studies), and in
lesions (3/3 studies)
• MD increased in whole-cord (7/10 studies), NAWM (2/5 studies),
lesions (2/3 studies)
• RD increased in whole-cord (4/6 studies)
• FA decreased in progressive MS vs. RRMS (4 studies)
• MK decreased in NAGM and lesions (1 study)
• MTR decreased in whole-cord (8/11), WM (2/2), GM (1/2 studies)
• MTR decreased in progressive MS vs. RRMS (2/3 studies)
• MTCSF increased in WM (1 study)
• MWF not different vs. HCs (1 study)
• Decreased NAA (4/4 studies)
• Increased number of active voxels (2/6 studies)
• Increased mean SI change in active voxels (3/3 studies)
• Increased distribution of activation outside expected ipsilateral dorsal
horn (2/2 studies)
• FA correlates with EDSS (r =−0.37–0.51, R =−0.60, 7/15 studies),
TWT (R = 0.70, 1 study)
• FA of LCST correlates with MEPs (r =−0.93, 1 study)
• MD correlates with EDSS (r = 0.37, 3/13 studies)
• RD correlates with EDSS (R = 0.7, 4/8 studies) and TWT (R=−0.6, 1
study)
• MK does not correlate with EDSS (1 study)
• MTR correlates with EDSS (r =−0.25–0.48, 6/15 studies)
• MTCSF of LCs correlates with EDSS (r = 0.59), walk speed
(r =−0.51), ankle strength (r =−0.45) (1 study)
• MTCSF of DCs correlates with EDSS (r = 0.59), vibration (r = 0.58),
postural sway (r = 0.32) (1 study)
• Change in MWF over 1 year, 2 years not correlated with change in
EDSS (1 study)
• NAA does not correlate with EDSS (5 studies)
• Number of active voxels correlates with EDSS (1/3 studies)
• FA predicts EDSS at 6 months–3 years FU
(r =−0.40, 2/2 studies)
• RD predicts EDSS, 9 hole peg, and TWT at 6
months FU (P b 0.05, 1 study)
• MWF not predictive of EDSS at 1 year, 2
years (1 study)
• NAA predicts decrease in EDSS at 6
months–1 year FU (1/2 studies)
Myelitis 2 2 1 • Diagnostic utility:
• FA decreased at lesion site (3/3 studies)
• MTR decreased at lesion site (1 study)
• FA, RD correlate with EDSS (P b 0.0001) and 9 hole peg (P b 0.0001)
(1 study)
• FA correlates with sensory score (r =−0.40, 1 study)
• MTR does not correlate with clinical measures EDSS, 9 hole peg,
ﬁnger-tapping (1 study)
NMO 2 • FA decreased in NAWM (2/2) and lesions (1/1)
• FA decreased in NAWM vs. MS (1 study)
• MD increased in NAWM (1/1) and lesions (1/1)
• FA correlates with EDSS (r =−0.80, 1 study)
Syringo-myelia 1 2 • FA decreased at syrinx vs. HCs (2/2 studies)
• FA decreased between symptomatic vs. asymptomatic subjects (1 study)
• FA not different above/below syrinx (1 study)
• FA correlates with thermal sensation in 1/2 ROIs (r =−0.63, 1/2
studies)
• FA (r =−0.64, P = 0.02) and number of FT ﬁbers (r =−0.75,
P = 0.02) correlate with average daily pain scores (1 study)
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the clinical uptake of these techniques.4.1. Interpreting the evidence in the context of risk of bias
Unfortunately, the vast majority of studies (98/104, 94%) completed
to date have a high or moderately high risk of bias, indicating the
relative immaturity of the research in the ﬁeld thus far. Although we
were unable to determine precisely how many of the studies were
based on a priori hypotheses (often due to ambiguous reporting of
methods), it was obvious that most studies were highly exploratory,
as they frequently analyzed numerous metrics and ROIs/levels without
statistical correction to avoid type I errors. The early nature of the body
of evidence is also apparent in the fact that 86% of studies failed to
explicitly use randon/consecutive enrolment methods, and 41% did
not perform age/gender matching in group comparisons or analysis
for these potential confounders when assessing correlations or predic-
tion of outcomes. Comparing the risk of bias between the 5 advanced
MRI techniques, it was found to be lowest in MT studies, rated as mod-
erately low in 20%,moderately high in 32%, and high in 48%, primarily as
a result of more reliable, consistent acquisitionmethods and a tendency
to more frequently utilize automated analysis techniques. However, in
spite of these advantages, the results of theMT studies (most commonly
using themetricMTR) showed considerably less consistent results com-
paredwith theDTImetric FA in termsof detecting group differences and
correlating with impairment. As a result, the overall quality of evidence
for MTR (and MTCSF) to demonstrate group differences in various
clinical conditions was considered very low, and the evidence for their
utility as biomarkers was insufﬁcient (Table 10). This is suggestive
that MTR is, overall, a weaker marker of pathological changes in the
diseases studied than FA, although these metrics appear to measure
separate components of microstructural change (Cohen-Adad et al.,
2011;Wheeler-Kingshot et al., 2002), and the differences in consistency
of results could alternatively be explained by technical factors. The risk
of bias among DTI studies was assessed as high in 75% and moderately
high in another 20%, largely as a result of problems with acquisition
methods such as very large voxels (39%) and a lack of automated/
objective analyses (86%). The lack of a substantial number of high
quality DTI studies led to a low baseline level of evidence for FA, MD,Table 10
Evidence summary.
Key question Speciﬁc ﬁnding
1) Diagnostic utility: Does the MRI technique provide
metrics that demonstrate group differences or
improved sensitivity/speciﬁcity in the diagnosis of
spinal pathologies?
FA is decreased in terms of grou
patients and healthy controls in
CSM, myelitis, MS, NMO, and SC
MD, RD, MK, MTR, MTCSF, and
differences between patients an
various clinical conditions
AD, SD(θ), OE, tractography pat
metrics demonstrate group diff
and healthy controls in various
Quantitative metrics based on s
techniques can be used for diag
accuracy (sensitivity and speciﬁ
2) Biomarker utility: Does the advanced MRI technique
generate quantitative metrics that correlate with
neurological/functional impairment and/or show
longitudinal changes that correlate with changes in
impairment in spinal pathologies?
FA shows moderate correlation
a number of clinical conditions
NMO, and SCI
MD, RD, MTR, MTCSF, NAA are
for clinical impairment in vario
3) Predictive utility: Does the advanced MRI technique
generate metrics that predict neurological, functional,
or quality of life outcomes in spinal pathologies?
FA, RD, and NAA are predictive
CSMRD, andMK to demonstrate group differences and utility as a biomarker
(Table 10). The quality of evidence for FA as a biomarker was upgraded
tomoderate due to a “dose–response gradient” (a term used in GRADE)
as it shows consistent and relatively strong correlations with impair-
ment, whereas the evidence for MD, RD, and MK were downgraded to
very low in terms of diagnostic utility (showing group differences)
and insufﬁcient in terms of value as biomarkers. The risk of bias in
MRS studies was high in 64% and moderately high in the remaining
36%, related to technical problems with acquisitions that resulted in
the exclusion of subjects and wide conﬁdence intervals in reported
metrics. NAA showed very promising results in some studies, but the
overall evidence was again downgraded to very low in terms of group
differences and insufﬁcient for correlation with impairment due to in-
consistent results and imprecise estimates of effect. The single MWF
study and all of the spinal fMRI studies were deemed to have a high
risk of bias, primarily relating to difﬁculties in acquiring reliable images
and the use of liberal statistical assumptions. As a result, none of the
metrics investigated in these studies were deemed to have thus far
demonstrated utility in terms of the three key questions.4.2. The design of imaging studies for clinical translation
The incorporation of detailed clinical assessments into translational
study protocols provides a richer and more objective characterization
of patients' functional impairments compared with coarse clinical
tools such as EDSS, JOA, mJOA, ALSFRS, and AIS. The majority of studies
that investigated biomarker utility (57%) and half of the prognostic
studies employed only a single coarse measure of impairment. The use
of these summary measures of disability risks misrepresenting the
degree towhich the spinal cord and speciﬁcWMtracts are truly injured,
as these measures are imprecise, and results can be strongly inﬂuenced
by counfounding factors, such as reporting bias (in self-reported
measures) or brain involvement in distributed CNS diseases (e.g. MS).
If considerable noise and inaccuracies are present in the clinical assess-
ments, the process of trying to identify meaningful correlations with
MRI metrics can become futile. The additional use of electrophysiology
(EP) tests can be used to augment the clinical information, although
it is important that these test do not replace detailed neurological/
functional assessments, as in some cases they may not be sufﬁcientlyQuality of evidence
Baseline Upgrade/downgrade Final
p differences between
the clinical conditions ALS,
I
Low None Low
NAA demonstrate group
d healthy controls in
Low Downgrade: inconsistency (1) Very low
tern, MWF, and fMRI
erences between patients
clinical conditions
Low Downgrade: inconsistency (1),
imprecision of estimates (1)
Insufﬁcient
tate-of-the-art MRI
nosis with high diagnostic
city)
Low Downgrade: inconsistency (2) Insufﬁcient
with clinical impairment in
: ALS, CSM, MS, myelitis,
Low Upgrade: dose–response
gradient
Moderate
weak-moderate biomarkers
us clinical conditions
Low Downgrade: inconsistency (1),
imprecision of estimates (1)
Insufﬁcient
of outcome in MS, ALS, and Low Downgrade: inconsistency (1),
imprecision of estimates (1)
Insufﬁcient
218 A.R. Martin et al. / NeuroImage: Clinical 10 (2016) 192–238sensitive or speciﬁc (Kerkovsky et al., 2012). However, it should be
noted that a trend appears to be emerging, with many recent studies
employing a broader array of clinical tests. Future studies that generate
ﬁne-grained clinical data using a battery of assessments are more likely
to identify important correlations with disability, and such high ﬁdelity
data may even have the power to show strong relationships between
MRI changes in individual WM tracts and focal neurological deﬁcits
that uniquely occur in each speciﬁc disease.
4.3. State-of-the-art spinal cord MRI acquisition techniques: a work in
progress
“The only thing that is constant is change.” — Heraclitus, 500 BC.
Although many technological advances have been made, the state-of-
the-art spinal cord MRI techniques addressed in this review remain a
work in progress, with many technical hurdles remaining. All of these
imaging techniques are much more difﬁcult to implement in the spinal
cord than other regions, such as the brain,which has attractedmany tal-
entedMRI physicists and engineers to take on this challenge. The issues
of magnetic ﬁeld inhomogeneity and physiological motion, leading to
various artifacts and image distortions, remain signiﬁcant barriers to
high quality data collection for all of the techniques. DTI, most common-
ly based on spin echo EPI sequences, is an inherently noisy technique
that typically requires large voxels and/or theuse ofmultiple excitations
to achieve acceptable SNR, both of which can increase partial volume
effects at the cord periphery. The substantial variability in acquisition
methods used by spinal cord DTI research groups indicates that this
community is far from reaching consensus on the optimal approach to
this difﬁcult problem. The most common DTI sequence employed was
ssEPI (59%), which tends to allow short acquisition times (b5 min in
themajority of reviewed studies; Tables 3, 4). 11/69 studies took advan-
tage of these short scan times and used the approach of performing
multiple ssEPI acquisitions and averaging the results ofﬂine to improve
SNR, using coregistration and motion correction tools. However, it
should be noted that EPI involves important tradeoffs, as it is strongly
affected by susceptibility artifact due to inhomogeneity in themagnetic
ﬁeld. This effect can cause image distortions, particularly at the level of
intervertebral disk spaces, which is exaggerated when herniated disks
obliterate the anterior CSF, potentially introducing bias or invalidating
metrics calculated in the compressed portion of the spinal cord in
conditions such as CSM. For example, Kerkovsky et al. (2012) report
decreased FA in patients with spinal cord encroachment (effacement
on the CSF) that have neck pain or radiculopathy but no objective
signs of myelopathy. This result could represent sub-clinical changes
in the spinal cord microstructure, but could alternatively be explained
by increased susceptibility artifact. In recent years, there has been
increased use of rFOV techniques, although this approach was only
utilized in 13% of the reviewed studies. These sequences are based on
2D radiofrequency (RF) excitation (Finsterbusch, 2009; Saritas et al.,
2008) or oblique refocusing pulses (Dowell et al., 2009; Wilm et al.,
2009), and allow the use of a smaller FOV with higher resolution
while avoiding aliasing problems and decreasing distortions, albeit at
a cost of increased acquisition time. Only a fraction of DTI studies
(23%) employed cardiac gating, likely because most groups felt that
the reduction in motion artifacts is not worth the increased acquisition
time and added complexity of setting up cardiacmonitoring equipment.
Two diffusion studies collected data with multiple b-values and com-
putedmeasures of diffusion kurtosis, which is a dimensionless measure
of the deviation from a Gaussian probability curve, with a positive value
reﬂecting a sharper peak and heavier tails (Hori et al., 2012; Raz et al.,
2013). Both studies identiﬁed positiveMK in all subjects, with patholog-
ical subjects in CSM (Hori et al., 2012) andMS (Raz et al., 2013) showing
group decreases in MK. However, it is unclear if DKI measures are
sufﬁciently more powerful than simple DTI metrics to justify the
added acquisition time required for multiple b-values. However, the
optimal number of diffusion-sensitizing directions has not beenestablished for DKI, but it may be possible that DKI can be performed
with a smaller number of directions, possibly offsetting the need for
multiple b-values. As mentioned above, all of the MT studies utilized
similar acquisition methods such as GE sequences (except for the
earliest study (Silver et al., 1997)), MT pre-pulse parameters, and reso-
lution. The single WMF study was exploratory in nature, and further
reﬁnements in spinal cord MWF image acquisition, including decreased
scan time, are needed prior to the initiation of more advanced clinical
studies using this method. MRS, particularly of the spinal cord, is
prone to motion artifact and low SNR, typically requiring relatively
long acquisition times due to the use of complex shimming methods,
a high number of signal averages, and cardiac gating to obtain useful
data. The magnetic ﬁeld inhomogeneity within the spinal canal makes
it difﬁcult to shim the B0 ﬁeld, usually requiring high-order shimming
procedures to attempt to compensate. As a result, there is line broaden-
ing in the metabolite peaks and decreases amplitude, making detection
difﬁcult. MRS studies had the highest use of cardiac gating at 45%
compared to other techniques in this review. The MRS results demon-
strate signiﬁcant variations in metabolite concentrations and ratios,
even among healthy individuals (Holly et al., 2009; Ikeda et al., 2013;
Salamon et al., 2013), suggesting that noise may still be a major limita-
tion. However, it may also be the case that there naturally exists a wide
range of normal in the concentrations and ratios of the molecules that
MRS captures, in which case it will be difﬁcult for MRS to make strong
assertions about individual patients, even with further technical
improvements. However, MRS provides unique information compared
with the other advanced MRI techniques, and further development
may allow quantiﬁcation of important CNSmolecules such as glutamate
(not reliably detected with current methods), which may suggest an
important role for MRS to compliment the other more anatomically
speciﬁc techniques. All 8 of the spinal fMRI studies used a fast or turbo
SE pulse sequence with SEEP contrast, compared with T2*-weighted
EPI that is typically used in brain fMRI based on BOLD contrast. FSE is
commonly employed in spinal fMRI to compensate for severe inhomo-
geneity of the magnetic ﬁeld within the spinal canal, but the readouts
from this technique are considerably slower than EPI, increasing the
effects of physiological motion artifacts. The time to acquire each vol-
ume of images in the reviewed studies ranged from 8 to 13 s, collecting
between 5 and 9 slices (axial orientation in 7 studies, sagittal in 1) per
volume, indicating the relatively low temporal resolution compared
with brain fMRI, in which an entire brain volume can be acquired in 2
to 4 s. Furthermore, the signal change relating to altered neural activity
is frequently only 2–3% (Stroman et al., 2004), requiring high SNR to
reliably differentiate active voxels from background noise. The overall
results of the spinal fMRI studies did not show convincing changes in
activation patterns in speciﬁc pathologies (only minor loss of ipsilateral
focal activation), possibly due to technical problems achieving sufﬁcient
SNR. If, however, reliable activations can be detectedwith better tempo-
ral resolution and shorter acquisition time, fMRI will likely make a
signiﬁcant impact, with obvious applications in conditions such as SCI
to detect new activity and connectivity as regeneration therapies (e.g.
stem cells) are studied. In summary, all 5 of the state-of-the-art spinal
cord MRI techniques continue to face technical issues that require
further innovations, and clinical studies face the limitation of needing
to freeze on a speciﬁc acquisition methodology over the period of time
required to complete data collection, even if itmay not include the latest
and greatest technical advances.
4.4. State-of-the-art imaging deserves state-of-the-art analysis
The majority of DTI, MT, MWF, and fMRI studies included in this
review used manual methods of ROI selection to extract quantitative
metrics, with only 25/93 (27%) using automated or semi-automated
ROI selection. In addition to being slow and imprecise, unblinded
manual ROI selection is an obvious source of potential bias in studies,
as the technician selecting the ROI can arbitrarily include or omit
219A.R. Martin et al. / NeuroImage: Clinical 10 (2016) 192–238pixels of high or low signal (often present at the edge of the cord due
to partial volume effects), and it is impossible to blind the technician
in many scenarios (e.g. compressive myelopathy). The very low rate
of objective analysis techniques for DTI studies (14%), compared
with 56% of MT studies, is possibly due to greater problems with
partial volume effects at the edge of the cord in DTI, where contam-
ination with CSF causes an increase in isotropic diffusion and a
corresponding decrease in FA, prompting 7 DTI studies to employ
manual exclusion of edge voxels after performing semi-automated
segmentation to identify the spinal cord. Furthermore, most studies
(73/104, 70%) included in this review reported whole-cord metrics,
which average the effects of a speciﬁc disease process across all GM
and WM. Analyzing whole-cord metrics lacks the speciﬁcity of
measuring changes in individual anatomical areas, such as WM
tracts (which might be differentially affected in a certain disease),
and it also potentially dilutes the sensitivity to detect small changes:
a 10% change present in the WMmight only show a 5% change in the
whole-cord metric, which may no longer be statistically signiﬁcant.
To optimize the sensitivity and speciﬁcity of these techniques, the
ideal solution is to analyze only the tissue that is most affected by a
certain disease, such as the anterior horn GM and/or the lateral
corticospinal tracts in ALS. Several groups are actively developing
tools for this purpose, which can perform a series of complex data
processing steps and automatically extract quantitative metrics
from GM, WM, and speciﬁc WM-tracts (Cohen-Adad et al., 2014),
even correcting for partial volume effects at the cord periphery
(Levy et al., 2015). Tract-speciﬁc metrics, which were available in
only 22/104 studies (21%), also have the advantage of potentially
characterizing gradations of injury to each anatomical area within
the cord, potentially correlating with or predicting focal neurological
deﬁcits. Fiber tractography (FT) is an interesting alternative to ROI-
based quantitative analyses of DTI data. The DTI studies that
employed FT were listed separately from ROI studies in Table 4,
primarily to identify trends and commonalities among the methods
used within FT studies. Among the FT studies reviewed, only 38%
extracted quantitative metrics from the region deﬁned by the FT
results. The utility of FT in quantitative assessment of the spinal
cord is controversial, as some have suggested that using FT to
automatically deﬁne ROIs is inherently biased (Cohen-Adad et al.,
2011), and most FT algorithms require manual seed points, as was
identiﬁed in our review (only 1/16 studies did not require seed
points). However, one study in this review reported improved
measures of inter-observer reliability using FT-based ROIs vs. manu-
al ROIs, again supporting the importance of automated, objective
analysis methods (Van Hecke et al., 2009). Other studies derived
quantitative measures from the FT output, such as number of
ﬁbers, ﬁber density, or ﬁber length (as surrogates for number of in-
tact axons). However, the FT analysis is typically based on liberal
assumptions of what constitutes a ﬁber, using low thresholds for
minimum FA of 0.10–0.30 and angle of b20–70° when calculating
connections between voxels. The result is a very loose representa-
tion of the actual white matter that should be interpreted with
caution. An alternative to using tractography to measure the organi-
zation of the white matter is to perform quantitative analysis of the
directionality of the eigenvectors, which was performed in 2 studies
using OE and SD(θ). These alternative methods are highly quantita-
tive, and may turn out to be more reliable than tractography in
characterizing white matter changes, but greater data is needed to
fully deﬁne their value. Half of the FT studies, all of which involved
various forms of compressive myelopathy, only reported descrip-
tions of the pattern of tracked ﬁbers such as the degree of deforma-
tion or disruption. However, assignment of these descriptors is
highly subjective and WM compression may be more accurately
represented by geometric measurements (e.g. maximum spinal
cord compression ratio). In comparing MT techniques, the use of
MTR may have a theoretical advantage over MTCSF, as the CSF isprone to ﬂow artifact that causes signal dropout, which could poten-
tially bias results, but this was not an obvious drawback in the 2
studies that employed MTCSF. The calculation of MTR requires an
added post-processing step, as images with and without an MT
prepulse need to be co-registered accurately, but this is relatively
straightforward with modern tools. No major technical challenges
were identiﬁed in the analysis techniques employed by MWF and
MRS studies, except for the use of manual ROIs in the WMF study
(Laule et al., 2010). In all of the reviewed fMRI studies, time-series
data were analyzed by convolving with a canonical hemodynamic
response function, and activation maps (based on a p-value thresh-
old or a clustering algorithm) were created. Due to challenges in
obtaining robust activations, most of the spinal fMRI studies used
an uncorrected threshold of P b 0.05 for each voxel so that a greater
number of activations could be identiﬁed, with the exception of
one study (Cadotte et al., 2012). This uncorrected analysis runs
a high risk of identifying false activations, particularly when
hundreds of voxels are included, and therefore the results of these
studies must be interpreted with caution. All of the fMRI studies
also usedmanual ROI selection, typically dividing the cord into quad-
rants manually, contributing another potential source of bias to the
analysis.
4.5. Statistical analysis: a big data problem
Appropriate statistical analysis for complex clinical studies using
quantitative MRI techniques is far from straightforward. This data
can involve a large number of metrics, including multiple DTI indices
or the output from multi-modal acquisitions, and the values might
be extracted from numerous ROIs located in individual WM tracts
at many rostro-caudal levels of the spinal cord. Furthermore, the
above-mentioned trend toward using multiple clinical measures to
fully characterize disability suggests that future studies will need to
employ multivariate analyses with an increasing number of inde-
pendent and dependent variables. The analysis of these studies
quickly becomes a big data problem, and help from an experienced
statistician is advisable to correctly design robust multivariate
analyses that incorporate a priori variables of interest and potential
confounding factors such as age and gender. It is of paramount
importance that a priori hypotheses are clearly stated beforehand,
to avoid an excess number of comparisons and misrepresentation
of the complex data to make unfounded conclusions. Among the
studies reviewed, there were many cases where no correction was
made for multiple comparisons, leading to ﬁndings that would not
have been identiﬁed as signiﬁcant with proper correction. In some
cases, studies went as far as reporting conclusions that were clearly
overstated or unfounded, which must be avoided in future transla-
tional research that will form the basis for clinical adoption of
these techniques.
4.6. Limitations of this study
This systematic review attempted to perform an exhaustive re-
view of all clinical studies utilizing the 5 advanced spinal cord MRI
techniques. A large number of citations were analyzed in an attempt
to identify all relevant articles, but it is still possible that relevant
studies were missed, including those not available in English. On
the other hand, the large scope of this review made it more difﬁcult
to discuss all of the subtleties involved in these MRI techniques.
Also, the inclusion criteria arbitrarily excluded cohorts with fewer
than 24 subjects or fewer than 12 pathological subjects. This thresh-
old was originally set at 20 total subjects and 10 pathological sub-
jects, but it was increased because the number of studies identiﬁed
using the lower threshold was far greater than 100, which would
have made the tables excessively long and the discussion even
more difﬁcult. However, we did not increase the threshold higher
Fig. 3. Key points.
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Studies that only analyzed the quantitative metrics apparent diffu-
sion coefﬁcient (ADC), generated from DWI, or CSA, derived from
anatomical images, were also excluded for the purpose of focusing
this review on new techniques. Spinal cord DWI has been in clinical
use for many years for the detection of infarction and abscess,
but the simple metric of ADC (equivalent to MD in DTI) may have
value in speciﬁc applications as a measure of microstructural tissue
changes. CSA is clearly a powerful quantitative metric that relates
to cord atrophy, which should be considered for use in addition to
the advanced MRI metrics in multivariate models. The search strate-
gy excluded research that only studied healthy subjects, as these
studies and those with smaller cohorts of pathological subjects
tended to show less robust methodology and clinical relevance.
This review also focused solely on advanced spinal cord imaging
techniques, but several groups studying spinal cord pathologies
have investigated imaging changes in brainmicrostructure and func-
tion, in part due to the relative simplicity of implementing these
imaging protocols in the brain (Freund et al., 2013; Kowalczyk
et al., 2012; Mikulis et al., 2002). Furthermore, this review was
focused on the 5 most promising spinal cord imaging techniques
identiﬁed by the recent expert panel, but several others are emerg-
ing that may make a substantial impact to this ﬁeld, including
perfusion imaging, susceptibility weighted imaging, T1 relaxometry,
neurite orientation dispersion and density imaging (NODDI), and
myelin g-ratio (Stikov et al., 2015).
4.7. Future directions
The path to clinical translation of technological innovations, such as
new MRI techniques, invariably includes numerous challenges and
there remains signiﬁcant work to successfully bring these techniques
into clinical use. Translational research typically involves a process
that begins with small exploratory studies and transitions to large,
carefully designed clinical trials, and several of the state-of-the-art
spinal cord MRI techniques reviewed in this paper have demonstrated
sufﬁciently strong results and are ready for this next step. Looking
forward, the spinal cord imaging community will continue to drive
these powerful techniques forward, with several key steps happening
concurrently: 1) larger clinical studies with speciﬁc hypothesis-driven
research questions will be designed and conducted to assess for clinical
utility; 2) acquisition techniques will continue to evolve and be reﬁned
to maximize signal-to-noise ratio (SNR) and resolution while minimiz-
ing distortions, artifacts, and acquisition times; and 3) powerful data
analysis toolswill be developed that can automatically extract quantita-
tive data from the GM, WM, and speciﬁc WM tracts. The long path to
clinical translation is not easy, but in the coming years, we can expect
many further innovations in this burgeoning ﬁeld, which will hopefully
lead to major improvements in the diagnosis and management of
patients with spinal cord pathologies.
New techniques and innovations are also emerging that could dra-
matically alter the course of research in this ﬁeld, but were not utilized
by any of the studies in this review. For example, the development of
high strength gradients for DTI, highlighted by the human connectome
project that uses 300 mT/m gradients (200 mT/m/ms slew rate) — 8
times stronger than most clinical hardware, have provided new
insights, such as mapping the axon diameter distribution in the
human spinal cord (Duval et al., 2015). Recently, the introduction of
inhomogenously broadened MT (ihMT) imaging has demonstrated
much higher speciﬁcity for myelin imaging than previous MT
techniques (although the signal dropout is less pronounced requiring
subtraction between images, which decreases SNR substantially),
which will likely spur new clinical studies to investigate its utility
(Girard et al., 2015). Chemical Exchange Saturation Transfer (CEST)
effect is a particular case of MT imaging, which can quantify the bio-
chemical composition of tissues based on labile protons (hydroxyl,amide, amine, and sulfhydryl moieties). Feasibility in the human spinal
cord and application in MS patients have recently been demonstrated
(Kim and Cercignani, 2014). In addition, none of the 104 studies that
were reviewed used 7 T ﬁeld strength, but with the proliferation
of 7 T research systems and the recent announcement of 7 T clinical
scanners, it is inevitable that new clinical studies at ultra-high ﬁeld
strength are coming soon and these could potentially show substantial
improvements that strengthen the case for clinical utility. Analysis tech-
niquesmay also undergo a revolution with the introduction of machine
learning, as complex multivariate data from healthy and pathological
subjects could be used to train classiﬁers, potentially increasing
diagnostic sensitivity and speciﬁcity.
However, optimism for novel MRI methods must be tempered with
practicality. Even if the clinical utility of one or more of these quantita-
tive MRI techniques is clearly demonstrated, a considerable hurdle will
still remain before widespread clinical adoption will occur. The concept
of quantitative MRI has been used in the research domain for several
years (e.g. CSA for MS), but is largely foreign to clinicians, and the
exactmethod andworkﬂow for its use needs to be carefully considered,
or these new techniquewill be quickly abandoned. Radiologists, neurol-
ogists, and spine surgeons that have busy clinical practices are unlikely
to sit at an imaging workstation and perform manual tasks to generate
quantitative metrics, so data analysis will need to be fully automated,
robust, and seamlessly integrated. The perception that new analysis
methods are time consuming, unreliable, or inaccurate will render
these newmethods unacceptable. Thus it is essential that sophisticated,
automatic analysis tools be developed in parallel with advances in the
imaging techniques themselves.5. Conclusions
The current body of evidence of clinical studies using spinal cordDTI,
MT, MWF, MRS, and fMRI is relatively limited, indicating the early stage
of this translational research effort. However, moderate evidence
indicates that the quantitative DTI metric FA successfully correlates
with impairment in a number of neurological disorders. Low evidences
suggests that FA shows tissue injury (in terms of group differences) in a
number of disorders, but the evidence is insufﬁcient to support its use as
a diagnostic test or as a predictor of clinical outcomes. Very low
evidence exists for other metrics to show pathological changes in
terms of group differences in the spinal cord, including MD, RD, MK,
MTR, MTCSF, and NAA, and the evidence is insufﬁcient to determine if
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a clinical context. DTI has produced the most substantial results to date,
but acquisition methods, data processing, and interpretation require
further reﬁnement, followed by standardization and cross-vendor vali-
dation, before this technology is ready for widespread clinical adoption.
The path to clinical translation of these complex MRI techniques is not
straightforward, and future translational studies are required that
have clear a priori hypotheses, large enrolment numbers, short scan
times, high quality acquisition techniques, detailed clinical assessments,
automated analysis techniques, and robust multivariate statistical anal-
yses (Fig. 3). It is also important to keep in mind that the deﬁnition of
clinical utility is to be able to make assertions about individual patients,
not just achieve signiﬁcant group differences, setting a very high stan-
dard for success. However, much progress has already been made, and
the spinal cord imaging community will undoubtedly make many
great achievements in the years to come.
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AC anterior column
AD axial diffusivity
ADC apparent diffusion coefﬁcient
AIS ASIA impairment scale
ALS amyotrophic lateral sclerosis
ALSFRS ALS functional rating scale
ALSFRS-R revised version of ALSFRS
aSCI acute SCI
ASIA American Spinal Injury Association
BMS benign MS
BOLD blood oxygen level-dependent
CADASIL cerebral autosomal dominant arteriopathy with subcortical
infacts and leukoencephalopathy
CHESS chemical selective saturation
Cho choline (concentration)
Cre creatinine (concentration)
CM compressive myelopathy
CO-ZOOM contiguous slice zonally oblique multislice
CSA cross-sectional area
cSCI chronic spinal cord injury
CSM cervical spondylotic myelopathy
CTL cervical, thoracic, lumbar
DC dorsal column
DK diffusion kurtosis
DTI diffusion tensor imaging
EDSS expanded disability status scale
EPI echo planar imaging
FA fractional anisotropy; ﬂip angle
FD ﬁber density
FDi ﬁber density index
FIM functional independence measure
fMRI functional MRI
FOV ﬁeld of view
FSE fast spin echo
FVC forced vital capacity
FT ﬁber tractography
FU follow-up
GE gradient echo; General Electric
GM gray matter
GRAPPA generalized autocalibrating partial parallel acquisition
HASTE half-Fourier acquisition single-shot turbo spin-echo
HC healthy control
ICC intraclass correlation coefﬁcient
ISRT International Spinal Research Trust
JOA Japanese Orthopedic Association scale
Lac lactate (concentration)LC lateral column
LCST lateral corticospinal tract
LHON Leber's hereditary optic neuropathy
λ1 primary eigenvector
λ2 secondary eigenvector
λ3 tertiary eigenvector
MCL maximally compressed level
MD mean diffusivity
MEP motor evoked potential
mJOA modiﬁed JOA scale
MK mean kurtosis
mNorris modiﬁed Norris scale
MRI magnetic resonance imaging
MRS magnetic resonance spectroscopy
MS multiple sclerosis
MSFC MS functional composite scale
MSWS MS walking scale
MT magnetization transfer
MTCSF MT ratio between tissue and CSF
MTR MT ratio with and without pre-pulse
MWF myelin water fraction
Myo myo-inositol
NAA n-acetylaspartate
NAGM normal appearing GM
NASC normal appearing spinal cord
NAWM normal appearing WM
NEX number of excitations
NMO neuromyelitis optica
NPV negative predictive value
NR not reported
NS non-signiﬁcant
NSA number of signal averages
OCT optical coherence tomography
OE orientation entropy
PAC phased array coil
PASAT paced auditory serial addition test
prospective, cross-sectional prospective, cross-sectional
PD proton density
PL prospective, longitudinal
PRESS point-resolved spectroscopy
PPMS primary progressive MS
PPV positive predictive value
RC retrospective, cross-sectional
RD radial diffusivity
ResNAA residual n-acetyl aspartate concentration
rFOV reduced ﬁeld of view
RL retrospective, longitudinal
ROI region of interest
RLS restless leg syndrome
RMSD root mean squared displacement
RRMS relapsing–remitting MS
Ψ difference of AD–MD
SCI spinal cord injury
SD standard deviation
SD(θ) standard deviation of the angle between primary eigenvectors
SE spin echo; sensitivity
SEEP signal enhancement by extravascular protons
SENSE sensitivity enconding parallel acquisition
SP speciﬁcity
SPGR spoiled gradient echo
SPMS secondary progressive MS
SSEP somatosensory evoked potential
STIR short-tau inversion recovery
STT spino-thalamic tract
ssEPI single shot EPI
T1w T1-weighted image
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WfL Wings for Life
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# Searches
1 Diffusion Tensor Imaging/[New MeSH as of 2010]
2 Diffusion Magnetic Resonance Imaging/
3 (Diffusion adj1 Tensor? adj1 Imag*).mp.
4 (diffusion adj1 weight* adj1 imag*).mp.
5 (diffusion adj2 MRI?).mp.
6 (diffusion adj2 MR?).mp.
7 (diffusion adj2 tractogra*).mp.
8 (diffusion adj1 coefﬁcien*).mp.
9 (diffusion adj1 co-efﬁcien*).mp.
10 (dti adj2 tractogra*).mp.
11 dti.tw,kw.
12 (high* adj1 angular* adj1 resolut* adj1 diffusion*).mp.
13 hardi.tw,kw.
14 (magneti#at* adj2 transfer*).mp.
15 exp magnetic resonance spectroscopy/or electron spin resonance spectroscopy/o
16 (magnetic adj1 resonan* adj1 spectroscop*).mp.
17 (mr adj spectroscop*).mp.
18 (mri adj spectroscop*).mp.
19 (functional adj2 (mri or mris or magnetic resonan*)).mp.
20 fmri?.mp.
21 myelin water fraction*.mp.
22 1H-MRS.mp.
23 ADC.tw,kw.
24 ADT.tw,kw.
25 (apparent adj1 diffus* adj1 coefﬁcien*).mp.
26 (apparent adj1 diffus* adj1 tensor*).mp.
27 (DTI or DTIs).mp.
28 (fraction* adj1 anisotrop*).mp.
29 (mean adj1 diffusivit*).mp.
30 mrs.tw,kw.
31 mt ratio?.mp.
32 mtcsf.mp.
33 MTR.mp.
34 MWF.mp.
35 MWFI.mp.
36 (NMR adj1 spectroscop*).mp.
37 exp Magnetic Resonance Spectroscopy/
38 (saturat* adj1 spectroscop*).mp.
39 press.tw,kw.
40 (proton* adj1 MRS).mp.
41 tractograph*.mp.
42 or/1–41 [Advanced MRI & related terms]
43 exp Spine/
44 exp Spinal Diseases/
45 exp Spinal Cord/
46 exp Spinal Cord Diseases/
47 exp spinal cord injuries/
48 exp spinal cord/and exp wounds/
49 exp spinal cord/and in.fs.
50 exp paraplegia/or brown-sequard syndrome/
51 exp quadriplegia/
52 ((spine or spinal) adj3 injur*).mp.
53 ((spine or spinal) adj3 compress*).mp.
54 ((spine or spinal) adj3 contus*).mp.
55 ((spine or spinal) adj3 damag*).mp.
56 ((spine or spinal) adj3 disrupt*).mp.
57 ((spine or spinal) adj3 disfunct*).mp.
58 ((spine or spinal) adj3 dysfunct*).mp.
59 ((spine or spinal) adj3 hemisect*).mp.
60 ((spine or spinal) adj3 hemi-sect*).mp.
61 ((spine or spinal) adj3 isch?em*).mp.
62 ((spine or spinal) adj3 lacerat*).mp.
63 ((spine or spinal) adj3 lesion*).mp.
64 ((spine or spinal) adj1 monoplegi*).mp.Acknowledgments
This project was supported by the Fellowship awarded to A.R.M.
generously provided by the Ontario Ministry of Health — Clinician
Investigator Program (MOH-CIP). In particular, we would like to
acknowledge support fromWings for Life, International Spinal Research
Trust, CNF, AOSpine and the Rick Hansen Foundation.Results Search type
4098 Advanced
11,877 Advanced
7767 Advanced
5821 Advanced
3832 Advanced
5861 Advanced
719 Advanced
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25 Advanced
299 Advanced
4963 Advanced
228 Advanced
187 Advanced
2232 Advanced
r nuclear magnetic resonance, biomolecular/ 183,850 Advanced
138,238 Advanced
3945 Advanced
55 Advanced
23,954 Advanced
23,159 Advanced
80 Advanced
1246 Advanced
6071 Advanced
1634 Advanced
5429 Advanced
27 Advanced
5049 Advanced
4331 Advanced
1462 Advanced
11,830 Advanced
203 Advanced
2 Advanced
1455 Advanced
330 Advanced
0 Advanced
30,893 Advanced
183,850 Advanced
16 Advanced
16,439 Advanced
522 Advanced
2342 Advanced
280,204 Advanced
112,919 Advanced
96,616 Advanced
81,714 Advanced
105,248 Advanced
38,997 Advanced
7428 Advanced
1446 Advanced
11,667 Advanced
7169 Advanced
44,641 Advanced
12,835 Advanced
976 Advanced
1755 Advanced
227 Advanced
3 Advanced
947 Advanced
826 Advanced
9 Advanced
2513 Advanced
33 Advanced
6521 Advanced
0 Advanced
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65 ((spine or spinal) adj3 myelopath*).mp. 367 Advanced
66 ((spine or spinal) adj3 (cut or cuts or cutting)).mp. 175 Advanced
67 ((spine or spinal) adj3 (sever or severed or severs or severing)).mp. 81 Advanced
68 ((spine or spinal) adj3 shock*).mp. 321 Advanced
69 ((spine or spinal) adj3 syndrom*).mp. 1797 Advanced
70 ((spine or spinal) adj3 transect*).mp. 2791 Advanced
71 ((spine or spinal) adj3 wound*).mp. 942 Advanced
72 ((spine or spinal) adj3 impair*).mp. 729 Advanced
73 paraplegi*.mp. 17,288 Advanced
74 paraparesis.mp. 5451 Advanced
75 parapareses.mp. 17 Advanced
76 monoplegi*.mp. 148 Advanced
77 hemiplegi*.mp. 14,156 Advanced
78 quadriplegi*.mp. 8758 Advanced
79 quadriparesis.mp. 972 Advanced
80 quadripareses.mp. 2 Advanced
81 tetraplegi*.mp. 3213 Advanced
82 tetraparesis.mp. 1034 Advanced
83 tetrapareses.mp. 5 Advanced
84 brown sequard* syndrom*.mp. 476 Advanced
85 traumatic myelopath*.mp. 55 Advanced
86 brown-sequard* disease*.mp. 1 Advanced
87 brown-sequard* paraly*.mp. 0 Advanced
88 hemicord* syndrome*.mp. 3 Advanced
89 hemi-cord* syndrome*.mp. 0 Advanced
90 hemiparaplegic syndrome*.mp. 0 Advanced
91 hemi-paraplegic syndrome*.mp. 0 Advanced
92 hemispinal cord syndrome*.mp. 0 Advanced
93 hemi-spinal cord syndrome*.mp. 0 Advanced
94 locked in syndrome*.mp. 507 Advanced
95 lockedin syndrome*.mp. 1 Advanced
96 (central cord? adj3 compress*).mp. 1 Advanced
97 (central cord? adj3 contus*).mp. 2 Advanced
98 (central cord? adj3 damag*).mp. 5 Advanced
99 (central cord? adj3 dysfunc*).mp. 2 Advanced
100 (central cord? adj3 disfunc*).mp. 0 Advanced
101 (central cord? adj3 disrupt*).mp. 0 Advanced
102 (central cord? adj3 fractur*).mp. 4 Advanced
103 (central cord? adj3 hemisect*).mp. 2 Advanced
104 (central cord? adj3 hemi-sect*).mp. 0 Advanced
105 (central cord? adj3 injur*).mp. 32 Advanced
106 (central cord? adj3 isch?em*).mp. 1 Advanced
107 (central cord? adj3 lacer*).mp. 0 Advanced
108 (central cord? adj3 lesion*).mp. 11 Advanced
109 (central cord? adj3 myelopath*).mp. 1 Advanced
110 (central cord? adj3 sever*).mp. 2 Advanced
111 (central cord? adj3 shock*).mp. 0 Advanced
112 (central cord? adj3 transect*).mp. 0 Advanced
113 (central cord? adj3 trauma*).mp. 50 Advanced
114 (central cord? adj3 wound*).mp. 0 Advanced
115 ﬂaccid paralysis.mp. 1508 Advanced
116 autonomic dysreﬂexi*.mp. 702 Advanced
117 (hemisection* adj4 cord?).mp. 542 Advanced
118 (hemi-section* adj4 cord?).mp. 8 Advanced
119 Central Nervous System/and exp wounds/ 1040 Advanced
120 Central Nervous System/and in.fs. 633 Advanced
121 (injur* adj3 central nervous system*).mp. 2173 Advanced
122 or/43–121 [Spine/Spinal Cord injuries] 363,737 Advanced
123 42 and 122 4153 Advanced
124 remove duplicates from 123 4033 Advanced
125 animals/not (animals/and humans/) 3,949,562 Advanced
126 124 not 125 3589 Advanced
127 limit 124 to human 3575 Advanced
128 126 or 127 3589 Advanced
129 limit 128 to (“all infant (birth to 23 months)” or “all child (0 to 18 years)” or “newborn infant (birth to 1 month)” or “infant
(1 to 23 months)” or “preschool child (2 to 5 years)” or “child (6 to 12 years)” or “adolescent (13 to 18 years)”)
789 Advanced
130 128 not 129 2800 Advanced
131 limit 128 to (“all adult (19 plus years)” or “young adult (19 to 24 years)” or “adult (19 to 44 years)” or “young adult and adult (19–24
and 19–44)” or “middle age (45 to 64 years)” or “middle aged (45 plus years)” or “all aged (65 and over)” or “aged (80 and over)”)
2417 Advanced
132 130 or 131 3240 Advanced
133 limit 132 to english language 2945 Advanced
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vid MEDLINE(R) in-process & other non-indexed citations June 01, 2015#1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
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4
4
4
4
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5
5
5
5
5
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6
6
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6Searches Results Search typeDiffusion Tensor Imaging/[New MeSH as of 2010] 0 Advanced
Diffusion Magnetic Resonance Imaging/ 0 Advanced
(Diffusion adj1 Tensor? adj1 Imag*).mp. 1298 Advanced
(diffusion adj1 weight* adj1 imag*).mp. 947 Advanced
(diffusion adj2 MRI?).mp. 612 Advanced
(diffusion adj2 MR?).mp. 782 Advanced
(diffusion adj2 tractogra*).mp. 125 Advanced
(diffusion adj1 coefﬁcien*).mp. 4040 Advanced
(diffusion adj1 co-efﬁcien*).mp. 2 Advanced0 (dti adj2 tractogra*).mp. 63 Advanced
1 dti.tw,kw. 935 Advanced
2 (high* adj1 angular* adj1 resolut* adj1 diffusion*).mp. 41 Advanced
3 hardi.tw,kw. 35 Advanced
4 (magneti#at* adj2 transfer*).mp. 200 Advanced
5 exp magnetic resonance spectroscopy/or electron spin resonance spectroscopy/or nuclear magnetic
resonance, biomolecular/
0 Advanced6 (magnetic adj1 resonan* adj1 spectroscop*).mp. 1558 Advanced
7 (mr adj spectroscop*).mp. 273 Advanced
8 (mri adj spectroscop*).mp. 9 Advanced
9 (functional adj2 (mri or mris or magnetic resonan*)).mp. 3383 Advanced
0 fmri?.mp. 4239 Advanced
1 myelin water fraction*.mp. 10 Advanced
2 1H-MRS.mp. 71 Advanced
3 ADC.tw,kw. 940 Advanced
4 ADT.tw,kw. 316 Advanced
5 (apparent adj1 diffus* adj1 coefﬁcien*).mp. 693 Advanced
6 (apparent adj1 diffus* adj1 tensor*).mp. 0 Advanced
7 (DTI or DTIs).mp. 970 Advanced
8 (fraction* adj1 anisotrop*).mp. 838 Advanced
9 (mean adj1 diffusivit*).mp. 262 Advanced
0 mrs.tw,kw. 1344 Advanced
1 mt ratio?.mp. 7 Advanced
2 mtcsf.mp. 0 Advanced
3 MTR.mp. 151 Advanced
4 MWF.mp. 22 Advanced
5 MWFI.mp. 0 Advanced
6 (NMR adj1 spectroscop*).mp. 7065 Advanced
7 exp Magnetic Resonance Spectroscopy/ 0 Advanced
8 (saturat* adj1 spectroscop*).mp. 44 Advanced
9 press.tw,kw. 2535 Advanced
0 (proton* adj1 MRS).mp. 32 Advanced
1 tractograph*.mp. 485 Advanced
2 or/1–41 [Advanced MRI & related terms] 24,201 Advanced
3 exp Spine/ 0 Advanced
4 exp Spinal Diseases/ 0 Advanced
5 exp Spinal Cord/ 0 Advanced
6 exp Spinal Cord Diseases/ 0 Advanced
7 exp spinal cord injuries/ 0 Advanced
8 exp spinal cord/and exp wounds/ 0 Advanced
9 exp spinal cord/and in.fs. 0 Advanced
0 exp paraplegia/or brown-sequard syndrome/ 0 Advanced
1 exp quadriplegia/ 0 Advanced
2 ((spine or spinal) adj3 injur*).mp. 2966 Advanced
3 ((spine or spinal) adj3 compress*).mp. 611 Advanced
4 ((spine or spinal) adj3 contus*).mp. 94 Advanced
5 ((spine or spinal) adj3 damag*).mp. 134 Advanced
6 ((spine or spinal) adj3 disrupt*).mp. 25 Advanced
7 ((spine or spinal) adj3 disfunct*).mp. 1 Advanced
8 ((spine or spinal) adj3 dysfunct*).mp. 100 Advanced
9 ((spine or spinal) adj3 hemisect*).mp. 27 Advanced
0 ((spine or spinal) adj3 hemi-sect*).mp. 1 Advanced
1 ((spine or spinal) adj3 isch?em*).mp. 150 Advanced
2 ((spine or spinal) adj3 lacerat*).mp. 3 Advanced
3 ((spine or spinal) adj3 lesion*).mp. 469 Advanced
4 ((spine or spinal) adj1 monoplegi*).mp. 0 Advanced
5 ((spine or spinal) adj3 myelopath*).mp. 34 Advanced
6 ((spine or spinal) adj3 (cut or cuts or cutting)).mp. 5 Advanced
7 ((spine or spinal) adj3 (sever or severed or severs or severing)).mp. 5 Advanced
8 ((spine or spinal) adj3 shock*).mp. 15 Advanced
9 ((spine or spinal) adj3 syndrom*).mp. 121 Advanced
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9Searches Results Search type0 ((spine or spinal) adj3 transect*).mp. 119 Advanced
1 ((spine or spinal) adj3 wound*).mp. 35 Advanced
2 ((spine or spinal) adj3 impair*).mp. 86 Advanced
3 paraplegi*.mp. 807 Advanced
4 paraparesis.mp. 342 Advanced
5 parapareses.mp. 0 Advanced
6 monoplegi*.mp. 23 Advanced
7 hemiplegi*.mp. 783 Advanced
8 quadriplegi*.mp. 186 Advanced
9 quadriparesis.mp. 149 Advanced
0 quadripareses.mp. 0 Advanced
1 tetraplegi*.mp. 234 Advanced
2 tetraparesis.mp. 63 Advanced
3 tetrapareses.mp. 0 Advanced
4 brown sequard* syndrom*.mp. 46 Advanced
5 traumatic myelopath*.mp. 5 Advanced
6 brown-sequard* disease*.mp. 0 Advanced
7 brown-sequard* paraly*.mp. 1 Advanced
8 hemicord* syndrome*.mp. 0 Advanced
9 hemi-cord* syndrome*.mp. 0 Advancedhemiparaplegic syndrome*.mp. 0 Advanced
hemi-paraplegic syndrome*.mp. 0 Advanced
hemispinal cord syndrome*.mp. 0 Advanced
hemi-spinal cord syndrome*.mp. 0 Advanced
locked in syndrome*.mp. 47 Advanced
lockedin syndrome*.mp. 0 Advanced
(central cord? adj3 compress*).mp. 2 Advanced
(central cord? adj3 contus*).mp. 0 Advanced
(central cord? adj3 damag*).mp. 0 Advanced
(central cord? adj3 dysfunc*).mp. 0 Advanced0 (central cord? adj3 disfunc*).mp. 0 Advanced
1 (central cord? adj3 disrupt*).mp. 0 Advanced
2 (central cord? adj3 fractur*).mp. 0 Advanced
3 (central cord? adj3 hemisect*).mp. 0 Advanced
4 (central cord? adj3 hemi-sect*).mp. 0 Advanced
5 (central cord? adj3 injur*).mp. 4 Advanced
6 (central cord? adj3 isch?em*).mp. 0 Advanced
7 (central cord? adj3 lacer*).mp. 0 Advanced
8 (central cord? adj3 lesion*).mp. 3 Advanced
9 (central cord? adj3 myelopath*).mp. 2 Advanced
0 (central cord? adj3 sever*).mp. 0 Advanced
1 (central cord? adj3 shock*).mp. 0 Advanced
2 (central cord? adj3 transect*).mp. 0 Advanced
3 (central cord? adj3 trauma*).mp. 3 Advanced
4 (central cord? adj3 wound*).mp. 0 Advanced
5 ﬂaccid paralysis.mp. 141 Advanced
6 autonomic dysreﬂexi*.mp. 46 Advanced
17 (hemisection* adj4 cord?).mp. 26 Advanced
18 (hemi-section* adj4 cord?).mp. 2 Advanced
19 Central Nervous System/and exp wounds/ 0 Advanced
20 Central Nervous System/and in.fs. 0 Advanced
21 (injur* adj3 central nervous system*).mp. 174 Advanced
22 or/43–121 [Spine/Spinal Cord injuries] 6559 Advanced
23 42 and 122 109 Advanced
24 remove duplicates from 123 109 Advanced1A.2. Embase
Embase Classic + Embase 1947 to 2015 June 01# Searches Results Search typediffusion tensor imaging/ 14,569 Advanced
diffusion weighted imaging/ 22,215 Advanced
(Diffusion adj1 Tensor? adj1 Imag*).mp. 15,954 Advanced
(diffusion adj1 weight* adj1 imag*).mp. 24,527 Advanced
(diffusion adj2 MRI?).mp. 6695 Advanced
(diffusion adj2 MR?).mp. 9770 Advanced
(diffusion adj2 tractogra*).mp. 1120 Advanced
(diffusion adj1 coefﬁcien*).mp. 23,049 Advanced
(diffusion adj1 co-efﬁcien*).mp. 48 Advanced(continued on next page)
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8Searches Results Search type0 (dti adj2 tractogra*).mp. 628 Advanced
1 dti.tw,kw. 10,119 Advanced
2 (high* adj1 angular* adj1 resolut* adj1 diffusion*).mp. 316 Advanced
3 hardi.tw,kw. 280 Advanced
4 (magneti#at* adj2 transfer*).mp. 2957 Advanced
5 exp magnetic resonance spectroscopy/or electron spin resonance spectroscopy/or nuclear magnetic resonance, biomolecular/ 255,182 Advanced
6 (magnetic adj1 resonan* adj1 spectroscop*).mp. 112,219 Advanced
7 (mr adj spectroscop*).mp. 5999 Advanced
8 (mri adj spectroscop*).mp. 169 Advanced
9 (functional adj2 (mri or mris or magnetic resonan*)).mp. 55,177 Advanced
0 fmri?.mp. 39,897 Advanced
1 myelin water fraction*.mp. 135 Advanced
2 1H-MRS.mp. 3375 Advanced
3 ADC.tw,kw. 10,338 Advanced
4 ADT.tw,kw. 3399 Advanced
5 (apparent adj1 diffus* adj1 coefﬁcien*).mp. 7945 Advanced
6 (apparent adj1 diffus* adj1 tensor*).mp. 28 Advanced
7 (DTI or DTIs).mp. 10,204 Advanced
8 (fraction* adj1 anisotrop*).mp. 8487 Advanced
9 (mean adj1 diffusivit*).mp. 2489 Advanced
0 mrs.tw,kw. 21,904 Advanced
1 mt ratio?.mp. 258 Advanced
2 mtcsf.mp. 2 Advanced
3 MTR.mp. 2077 Advanced
4 MWF.mp. 483 Advanced
5 MWFI.mp. 1 Advanced
6 (NMR adj1 spectroscop*).mp. 42,596 Advanced
7 exp Magnetic Resonance Spectroscopy/ 98,902 Advanced
8 (saturat* adj1 spectroscop*).mp. 18 Advanced
9 press.tw,kw. 215,401 Advanced
0 (proton* adj1 MRS).mp. 758 Advanced
1 tractograph*.mp. 4691 Advanced
2 or/1–41 [Advanced MRI & related terms] 619,716 Advanced
3 spine disease/ 13,890 Advanced
4 exp spine injury/ 34,151 Advanced
5 exp spinal cord disease/ 227,506 Advanced
6 exp spinal cord injury/ 59,313 Advanced
7 exp spinal cord injury/ 59,313 Advanced
8 brown sequard syndrome/ 732 Advanced
9 central cord syndrome/ 238 Advanced
0 cervical spinal cord injury/ 2498 Advanced
1 spinal cord compression/ 13,212 Advanced
2 spinal cord transsection/ 2835 Advanced
3 spinal cord transverse lesion/ 730 Advanced
4 paraplegia/ 22,702 Advanced
5 quadriplegia/ 14,032 Advanced
6 ((spine or spinal) adj3 injur*).mp. 66,147 Advanced
7 ((spine or spinal) adj3 compress*).mp. 17,094 Advanced
8 ((spine or spinal) adj3 contus*).mp. 1342 Advanced
9 ((spine or spinal) adj3 damag*).mp. 2680 Advanced
0 ((spine or spinal) adj3 disrupt*).mp. 315 Advanced
1 ((spine or spinal) adj3 disfunct*).mp. 5 Advanced
2 ((spine or spinal) adj3 dysfunct*).mp. 1392 Advanced
3 ((spine or spinal) adj3 hemisect*).mp. 1291 Advanced
4 ((spine or spinal) adj3 hemi-sect*).mp. 17 Advanced
5 ((spine or spinal) adj3 isch?em*).mp. 4226 Advanced
6 ((spine or spinal) adj3 lacerat*).mp. 46 Advanced
7 ((spine or spinal) adj3 lesion*).mp. 13,137 Advanced
8 ((spine or spinal) adj1 monoplegi*).mp. 0 Advanced
9 ((spine or spinal) adj3 myelopath*).mp. 556 Advanced
0 ((spine or spinal) adj3 (cut or cuts or cutting)).mp. 297 Advanced
1 ((spine or spinal) adj3 (sever or severed or severs or severing)).mp. 148 Advanced
2 ((spine or spinal) adj3 shock*).mp. 599 Advanced
3 ((spine or spinal) adj3 syndrom*).mp. 2872 Advanced
4 ((spine or spinal) adj3 transect*).mp. 3661 Advanced
5 ((spine or spinal) adj3 wound*).mp. 984 Advanced
6 ((spine or spinal) adj3 impair*).mp. 1440 Advanced
7 paraplegi*.mp. 31,389 Advanced
8 paraparesis.mp. 6426 Advanced
9 parapareses.mp. 34 Advanced
0 quadriplegi*.mp. 15,727 Advanced
1 quadriparesis.mp. 1554 Advanced
2 quadripareses.mp. 2 Advanced
3 tetraplegi*.mp. 5329 Advanced
4 tetraparesis.mp. 1567 Advanced
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3Searches Results Search type5 tetrapareses.mp. 10 Advanced
6 brown sequard* syndrom*.mp. 863 Advanced
7 traumatic myelopath*.mp. 76 Advanced
8 brown-sequard* disease*.mp. 1 Advanced
9 brown-sequard* paraly*.mp. 2 Advanced
0 hemicord* syndrome*.mp. 3 Advanced
1 hemi-cord* syndrome*.mp. 1 Advanced
2 hemiparaplegic syndrome*.mp. 1 Advanced
3 hemi-paraplegic syndrome*.mp. 0 Advanced
4 hemispinal cord syndrome*.mp. 1 Advanced
5 hemi-spinal cord syndrome*.mp. 0 Advanced
6 locked in syndrome*.mp. 1010 Advanced
7 lockedin syndrome*.mp. 6 Advanced
8 (central cord? adj3 (compress* or contus* or damag* or disfunct* or dysfunct* or disrupt* or fractur* or hemisect* or hemi-sect*
or injur* or isch?emi* or lacerat* or lesion* or myelopath* or sever* or shock* or transect* or trauma* or wound*)).mp.
155 Advanced9 ﬂaccid paralysis.mp. 3389 Advanced
00 autonomic dysreﬂexi*.mp. 1133 Advanced
01 or/43–100 315,291 Advanced
02 42 and 101 7829 Advanced
03 (exp animals/or exp animal experimentation/or nonhuman/) not ((exp animals/or exp animal experimentation/or nonhuman/)
and exp human/)
6,051,284 Advanced04 102 not 103 6955 Advanced
05 limit 102 to human 6444 Advanced
06 104 or 105 6955 Advanced
07 limit 106 to (embryo bﬁrst trimesterN or infant bto one yearN or child bunspeciﬁed ageN or preschool child b1 to 6 yearsN or
school child b7 to 12 yearsN or adolescent b13 to 17 yearsN)
1005 Advanced08 106 not 107 5950 Advanced
09 limit 106 to (adult b18 to 64 yearsN or aged b65+ yearsN) 2828 Advanced
10 108 or 109 6316 Advanced
11 limit 110 to embase 6012 Advanced
12 limit 111 to (book or book series or conference abstract or conference proceeding or “conference review”) 1180 Advanced
13 111 not 112 4832 Advanced
14 limit 113 to english language 4413 Advanced
15 remove duplicates from 114 4387 Advanced1A.3. CCTR
EBM reviews — Cochrane central register of controlled trials April 2015# Searches Results Search typeDiffusion Tensor Imaging/[New MeSH as of 2010] 38 Advanced
Diffusion Magnetic Resonance Imaging/[MeSH] 147 Advanced
diffusion tensor imaging/ 38 Advanced
diffusion weighted imaging/ 0 Advanced
(Diffusion adj1 Tensor? adj1 Imag*).mp. 157 Advanced
(diffusion adj1 weight* adj1 imag*).mp. 219 Advanced
(diffusion adj2 MRI?).mp. 98 Advanced
(diffusion adj2 MR?).mp. 149 Advanced
(diffusion adj2 tractogra*).mp. 15 Advanced0 (diffusion adj1 coefﬁcien*).mp. 139 Advanced
1 (diffusion adj1 co-efﬁcien*).mp. 0 Advanced
2 (dti adj2 tractogra*).mp. 5 Advanced
3 dti.tw,kw. 139 Advanced
4 (high* adj1 angular* adj1 resolut* adj1 diffusion*).mp. 0 Advanced
5 hardi.tw,kw. 3 Advanced
6 (magneti#at* adj2 transfer*).mp. 65 Advanced
7 exp magnetic resonance spectroscopy/or electron spin resonance spectroscopy/or nuclear magnetic resonance, biomolecular/ 471 Advanced
8 (magnetic adj1 resonan* adj1 spectroscop*).mp. 736 Advanced
9 (mr adj spectroscop*).mp. 116 Advanced
0 (mri adj spectroscop*).mp. 11 Advanced
1 (functional adj2 (mri or mris or magnetic resonan*)).mp. 1409 Advanced
2 fmri?.mp. 1210 Advanced
3 myelin water fraction*.mp. 2 Advanced
4 1H-MRS.mp. 54 Advanced
5 ADC.tw,kw. 133 Advanced
6 ADT.tw,kw. 196 Advanced
7 (apparent adj1 diffus* adj1 coefﬁcien*).mp. 121 Advanced
8 (apparent adj1 diffus* adj1 tensor*).mp. 1 Advanced
9 (DTI or DTIs).mp. 139 Advanced
0 (fraction* adj1 anisotrop*).mp. 108 Advanced(continued on next page)
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1Searches Results Search type1 (mean adj1 diffusivit*).mp. 23 Advanced
2 mrs.tw,kw. 657 Advanced
3 mt ratio?.mp. 12 Advanced
4 mtcsf.mp. 1 Advanced
5 MTR.mp. 50 Advanced
6 MWF.mp. 17 Advanced
7 MWFI.mp. 0 Advanced
8 (NMR adj1 spectroscop*).mp. 72 Advanced
9 exp Magnetic Resonance Spectroscopy/ 471 Advanced
0 (saturat* adj1 spectroscop*).mp. 0 Advanced
1 press.tw,kw. 2661 Advanced
2 (proton* adj1 MRS).mp. 20 Advanced
3 tractograph*.mp. 29 Advanced
4 or/1–43 [Advanced MRI & related terms] 6486 Advanced
5 exp spinal cord injury/ 751 Advanced
6 brown sequard syndrome/ 0 Advanced
7 central cord syndrome/ 0 Advanced
8 cervical spinal cord injury/ 0 Advanced
9 spinal cord compression/ 75 Advanced
0 spinal cord transsection/ 0 Advanced
1 spinal cord transverse lesion/ 0 Advanced
2 paraplegia/ 152 Advanced
3 quadriplegia/ 124 Advanced
4 ((spine or spinal) adj3 injur*).mp. 1434 Advanced
5 ((spine or spinal) adj3 compress*).mp. 255 Advanced
6 ((spine or spinal) adj3 contus*).mp. 4 Advanced
7 ((spine or spinal) adj3 damag*).mp. 43 Advanced
8 ((spine or spinal) adj3 disrupt*).mp. 2 Advanced
9 ((spine or spinal) adj3 disfunct*).mp. 0 Advanced
0 ((spine or spinal) adj3 dysfunct*).mp. 96 Advanced
1 ((spine or spinal) adj3 hemisect*).mp. 0 Advanced
2 ((spine or spinal) adj3 hemi-sect*).mp. 0 Advanced
3 ((spine or spinal) adj3 isch?em*).mp. 39 Advanced
4 ((spine or spinal) adj3 lacerat*).mp. 1 Advanced
5 ((spine or spinal) adj3 lesion*).mp. 139 Advanced
6 ((spine or spinal) adj1 monoplegi*).mp. 0 Advanced
7 ((spine or spinal) adj3 myelopath*).mp. 9 Advanced
8 ((spine or spinal) adj3 (cut or cuts or cutting)).mp. 12 Advanced
9 ((spine or spinal) adj3 (sever or severed or severs or severing)).mp. 0 Advanced
0 ((spine or spinal) adj3 shock*).mp. 9 Advanced
1 ((spine or spinal) adj3 syndrom*).mp. 92 Advanced
2 ((spine or spinal) adj3 transect*).mp. 4 Advanced
3 ((spine or spinal) adj3 wound*).mp. 30 Advanced
4 ((spine or spinal) adj3 impair*).mp. 70 Advanced
5 paraplegi*.mp. 324 Advanced
6 paraparesis.mp. 60 Advanced
7 parapareses.mp. 0 Advanced
8 quadriplegi*.mp. 245 Advanced
9 quadriparesis.mp. 5 Advanced
0 quadripareses.mp. 0 Advanced
1 tetraplegi*.mp. 141 Advanced
2 tetraparesis.mp. 5 Advanced
3 tetrapareses.mp. 0 Advanced
4 brown sequard* syndrom*.mp. 0 Advanced
5 traumatic myelopath*.mp. 1 Advanced
6 brown-sequard* disease*.mp. 0 Advanced
7 brown-sequard* paraly*.mp. 0 Advanced
8 hemicord* syndrome*.mp. 0 Advanced
9 hemi-cord* syndrome*.mp. 0 Advanced
0 hemiparaplegic syndrome*.mp. 0 Advanced
1 hemi-paraplegic syndrome*.mp. 0 Advanced
2 hemispinal cord syndrome*.mp. 0 Advanced
3 hemi-spinal cord syndrome*.mp. 0 Advanced
4 locked in syndrome*.mp. 3 Advanced
5 lockedin syndrome*.mp. 0 Advanced
6 (central cord? adj3 (compress* or contus* or damag* or disfunct* or dysfunct* or disrupt* or fractur* or hemisect* or hemi-sect*
or injur* or isch?emi* or lacerat* or lesion* or myelopath* or sever* or shock* or transect* or trauma* or wound*)).mp.
0 Advanced7 ﬂaccid paralysis.mp. 4 Advanced
8 autonomic dysreﬂexi*.mp. 21 Advanced
9 exp spinal cord injuries/ 751 Advanced
00 exp spinal cord/and exp wounds/ 32 Advanced
01 exp spinal cord/and in.fs. 7 Advanced
02 Central Nervous System/and exp wounds/ 10 Advanced
03 Central Nervous System/and in.fs. 3 Advanced
04 exp spine disease/ 0 Advanced
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5Searches Results Search type05 exp spine injury/ 0 Advanced
06 or/45–105 2334 Advanced
07 44 and 106 25 Advanced
08 limit 107 to medline records 11 Advanced
09 limit 107 to embase records 12 Advanced
10 108 or 109 23 Advanced
11 107 not 110 2 Advanced1A.4. CDSR
EBM reviews — Cochrane database of systematic reviews 2005 to April 2015# Searches Results Search type[Diffusion Tensor Imaging/[New MeSH as of 2010]] 0 Advanced
[Diffusion Magnetic Resonance Imaging/[MeSH]] 0 Advanced
[diffusion tensor imaging/] 0 Advanced
[diffusion weighted imaging/] 0 Advanced
(Diffusion adj1 Tensor? adj1 Imag*).mp. 2 Advanced
(diffusion adj1 weight* adj1 imag*).mp. 9 Advanced
(diffusion adj2 MRI?).mp. 8 Advanced
(diffusion adj2 MR?).mp. 9 Advanced
(diffusion adj2 tractogra*).mp. 0 Advanced0 (diffusion adj1 coefﬁcien*).mp. 1 Advanced
1 (diffusion adj1 co-efﬁcien*).mp. 0 Advanced
2 (dti adj2 tractogra*).mp. 1 Advanced
3 dti.tw,kw. 14 Advanced
4 (high* adj1 angular* adj1 resolut* adj1 diffusion*).mp. 0 Advanced
5 hardi.tw,kw. 0 Advanced
6 (magneti#at* adj2 transfer*).mp. 3 Advanced
7 [exp magnetic resonance spectroscopy/or electron spin resonance spectroscopy/or nuclear magnetic resonance, biomolecular/] 0 Advanced
8 (magnetic adj1 resonan* adj1 spectroscop*).mp. 21 Advanced
9 (mr adj spectroscop*).mp. 1 Advanced
0 (mri adj spectroscop*).mp. 0 Advanced
1 (functional adj2 (mri or mris or magnetic resonan*)).mp. 30 Advanced
2 fmri?.mp. 22 Advanced
3 myelin water fraction*.mp. 0 Advanced
4 1H-MRS.mp. 0 Advanced
5 ADC.tw,kw. 3 Advanced
6 ADT.tw,kw. 6 Advanced
7 (apparent adj1 diffus* adj1 coefﬁcien*).mp. 1 Advanced
8 (apparent adj1 diffus* adj1 tensor*).mp. 0 Advanced
9 (DTI or DTIs).mp. 15 Advanced
0 (fraction* adj1 anisotrop*).mp. 0 Advanced
1 (mean adj1 diffusivit*).mp. 0 Advanced
2 mrs.tw,kw. 290 Advanced
3 mt ratio?.mp. 0 Advanced
4 mtcsf.mp. 0 Advanced
5 MTR.mp. 2 Advanced
6 MWF.mp. 0 Advanced
7 MWFI.mp. 0 Advanced
8 (NMR adj1 spectroscop*).mp. 0 Advanced
9 [exp Magnetic Resonance Spectroscopy/] 0 Advanced
0 (saturat* adj1 spectroscop*).mp. 0 Advanced
1 press.tw,kw. 624 Advanced
2 (proton* adj1 MRS).mp. 1 Advanced
3 tractograph*.mp. 1 Advanced
4 or/1–43 [Advanced MRI & related terms] 972 Advanced
5 [exp spinal cord injury/] 0 Advanced
6 [brown sequard syndrome/] 0 Advanced
7 [central cord syndrome/] 0 Advanced
8 [cervical spinal cord injury/] 0 Advanced
9 [spinal cord compression/] 0 Advanced
0 [spinal cord transsection/] 0 Advanced
1 [spinal cord transverse lesion/] 0 Advanced
2 [paraplegia/] 0 Advanced
3 [quadriplegia/] 0 Advanced
4 ((spine or spinal) adj3 injur*).mp. 177 Advanced
5 ((spine or spinal) adj3 compress*).mp. 40 Advanced
6 ((spine or spinal) adj3 contus*).mp. 8 Advanced
7 ((spine or spinal) adj3 damag*).mp. 34 Advanced(continued on next page)
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1Searches Results Search type8 ((spine or spinal) adj3 disrupt*).mp. 5 Advanced
9 ((spine or spinal) adj3 disfunct*).mp. 0 Advanced
0 ((spine or spinal) adj3 dysfunct*).mp. 13 Advanced
1 ((spine or spinal) adj3 hemisect*).mp. 0 Advanced
2 ((spine or spinal) adj3 hemi-sect*).mp. 0 Advanced
3 ((spine or spinal) adj3 isch?em*).mp. 18 Advanced
4 ((spine or spinal) adj3 lacerat*).mp. 3 Advanced
5 ((spine or spinal) adj3 lesion*).mp. 28 Advanced
6 ((spine or spinal) adj1 monoplegi*).mp. 0 Advanced
7 ((spine or spinal) adj3 myelopath*).mp. 6 Advanced
8 ((spine or spinal) adj3 (cut or cuts or cutting)).mp. 2 Advanced
9 ((spine or spinal) adj3 (sever or severed or severs or severing)).mp. 0 Advanced
0 ((spine or spinal) adj3 shock*).mp. 3 Advanced
1 ((spine or spinal) adj3 syndrom*).mp. 17 Advanced
2 ((spine or spinal) adj3 transect*).mp. 2 Advanced
3 ((spine or spinal) adj3 wound*).mp. 10 Advanced
4 ((spine or spinal) adj3 impair*).mp. 14 Advanced
5 paraplegi*.mp. 39 Advanced
6 paraparesis.mp. 13 Advanced
7 parapareses.mp. 0 Advanced
8 quadriplegi*.mp. 33 Advanced
9 quadriparesis.mp. 0 Advanced
0 quadripareses.mp. 0 Advanced
1 tetraplegi*.mp. 14 Advanced
2 tetraparesis.mp. 4 Advanced
3 tetrapareses.mp. 0 Advanced
4 brown sequard* syndrom*.mp. 1 Advanced
5 traumatic myelopath*.mp. 2 Advanced
6 brown-sequard* disease*.mp. 0 Advanced
7 brown-sequard* paraly*.mp. 0 Advanced
8 hemicord* syndrome*.mp. 0 Advanced
9 hemi-cord* syndrome*.mp. 0 Advanced
0 hemiparaplegic syndrome*.mp. 0 Advanced
1 hemi-paraplegic syndrome*.mp. 0 Advanced
2 hemispinal cord syndrome*.mp. 0 Advanced
3 hemi-spinal cord syndrome*.mp. 0 Advanced
4 locked in syndrome*.mp. 3 Advanced
5 lockedin syndrome*.mp. 0 Advanced
6 (central cord? adj3 (compress* or contus* or damag* or disfunct* or dysfunct* or disrupt* or fractur* or hemisect* or hemi-sect*
or injur* or isch?emi* or lacerat* or lesion* or myelopath* or sever* or shock* or transect* or trauma* or wound*)).mp.
6 Advanced7 ﬂaccid paralysis.mp. 10 Advanced
8 autonomic dysreﬂexi*.mp. 7 Advanced
9 [exp spinal cord injuries/] 0 Advanced
00 [exp spinal cord/and exp wounds/] 0 Advanced
01 [exp spinal cord/and in.fs.] 0 Advanced
02 [Central Nervous System/and exp wounds/] 0 Advanced
03 [Central Nervous System/and in.fs.] 0 Advanced
04 [exp spine disease/] 0 Advanced
05 [exp spine injury/] 0 Advanced
06 or/45–105 306 Advanced
07 44 and 106 40 Advanced
08 limit 107 to full systematic reviews 31 Advanced1
Appendix B. Ratings of risk of bias for individual studies
Authors (year) Study
purpose
All studies Diagnostic
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Prognostic studies Risk of bias
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design
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confounding
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Acquisition
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highly
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Metrics derived
using automated/
blinded
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Range
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reported
Univariate or
multivariate
correlations
reported
Similar
point in
course of
disease
Follow-up
N80%
Follow-up
long
enough for
outcomes
to occur
Accounts for
known
prognostic
factors
Abbas et al.
(2015)
Diagnostic ✔ – ✔ ✔ – – ✔ – – High
Correlation High
Agosta et al.
(2005)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Agosta et al.
(2006)
Diagnostic ✔ ✔ ✔ ✔ ✔ – ✔ – Moderately
high
Agosta et al.
(2007a)
Correlation ✔ – ✔ – – – ✔ ✔ – – ✔ ✔ High
Prognostic High
Agosta et al.
(2007b)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – ✔ High
Correlation Moderately
high
Agosta et al.
(2008a)
Diagnostic ✔ ✔ ✔ – – – ✔ – High
Agosta et al.
(2008b)
Diagnostic ✔ ✔ ✔ – – – ✔ – High
Agosta et al.
(2009a)
Correlation ✔ ✔ ✔ – – – ✔ ✔ High
Agosta et al.
(2009b)
Diagnostic ✔ ✔ ✔ – – – ✔ – High
Banaszek et al.
(2014)
Diagnostic ✔ – ✔ – – – ✔ – High
Bellenberg
et al. (2013)
Diagnostic ✔ ✔ ✔ – – ✔ ✔ – ✔ – ✔ – – High
Correlation Moderately
high
Prognostic High
Benedetti et al.
(2010)
Diagnostic ✔ ✔ ✔ ✔ – – ✔ – ✔ High
Correlation Moderately
high
Bozzali et al.
(1999)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – – High
Correlation High
Budzik et al.
(2011)
Diagnostic ✔ ✔ ✔ – – – ✔ – – High
Correlation High
Cadotte et al.
(2012)
Diagnostic ✔ – ✔ – – ✔ ✔ – ✔ High
Correlation High
Carew et al.
(2011a)
Diagnostic ✔ – ✔ – – ✔ ✔ – ✔ High
Correlation High
Carew et al.
(2011b)
Diagnostic ✔ ✔ ✔ – – ✔ – – High
Cheran et al.
(2011)
Diagnostic ✔ – ✔ ✔ ✔ – ✔ – ✔ High
Correlation Moderately
high
Ciccarelli et al.
(2007)
Diagnostic ✔ – ✔ ✔ ✔/–
DTI/MRS
–/✔ DTI/MRS ✔ – ✔ High
Correlation Moderately
high
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prognostic
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Ciccarelli et al.
(2010a)
Diagnostic ✔ – ✔ – ✔/–
DTI/MRS
–/✔ DTI/MRS ✔ – ✔ High
Correlation High
Ciccarelli et al.
(2010b)
Correlation ✔ – ✔ – – ✔ ✔ ✔ – ✔ – ✔ High
Prognostic High
Cohen-Adad
et al. (2011)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – ✔ High
Correlation Moderately
high
Cohen-Adad
et al. (2013)
Diagnostic ✔ – ✔ – ✔ – ✔ – ✔ High
Correlation High
Cruz et al.
(2009)
Diagnostic – ✔ ✔ – – – – – High
Cui et al.
(2015)
Diagnostic ✔ – ✔ – – ✔ ✔ – High
Demir et al.
(2003)
Diagnostic ✔ – ✔ – – – ✔ ✔ High
El Mendili
et al. (2014)
Correlation ✔ ✔ ✔ – ✔ – ✔ ✔ ✔ ✔ ✔ ✔ Moderately
high
Prognostic Moderately
high
Ellingson et al.
(2014)
Diagnostic ✔ – ✔ – – – ✔ ✔ ✔ High
Correlation High
Facon et al.
(2005)
Diagnostic ✔ – – – ✔ – ✔ ✔ High
Fatemi et al.
(2005)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – ✔ High
Correlation Moderately
high
Filippi et al.
(2000)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – – High
Correlation High
Filippi et al.
(2002)
Diagnostic ✔ ✔ ✔ – ✔/–
DTI/fMRI
– ✔ – ✔ High
Correlation Moderately
high (MT),
high
(fMRI)
Freund et al.
(2010)
Prognostic ✔ ✔ ✔ – ✔ – ✔ ✔ ✔ ✔ ✔ Moderately
high
Gao et al.
(2013)
Correlation ✔ – ✔ – – – ✔ ✔ High
Hatem et al.
(2009)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Hatem et al.
(2010)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Hesseltine
et al. (2006)
Diagnostic ✔ ✔ ✔ – ✔ – – ✔ High
Hodel et al.
(2013)
Diagnostic ✔ ✔ – – – – ✔ – ✔ High
Correlation High
Holly et al.
(2009)
Diagnostic ✔ ✔ ✔ – – ✔ ✔ – ✔ High
Correlation Moderately
high
Hori et al.
(2012)
Diagnostic ✔ – ✔ ✔ – – – – High
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Iglesias et al.
(2015)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Ikeda et al.
(2013)
Diagnostic ✔ ✔ ✔ – – ✔ ✔ – ✔ ✔ – ✔ – High
Correlation Moderately
high
Prognostic High
Inglese et al.
(2001)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – High
Jeantroux et al.
(2012)
Diagnostic ✔ ✔ ✔ – – – ✔ – High
Jones et al.
(2013)
Correlation ✔ ✔ ✔ – ✔ – ✔ ✔ ✔ ✔ – ✔ Moderately
high
Prognostic High
Kamble et al.
(2011)
Diagnostic ✔ – ✔ – – – ✔ – High
Kearney et al.
(2014)
Diagnostic ✔ ✔ ✔ – ✔ ✔ ✔ – ✔ Moderately
high
Correlation Moderately
low
Kearney et al.
(2015)
Diagnostic ✔ ✔ ✔ – ✔ ✔ ✔ – ✔ Moderately
high
Correlation Moderately
low
Kerkovsky
et al. (2012)
Diagnostic ✔ ✔ ✔ – – – ✔ – High
Koskinen et al.
(2013)
Diagnostic ✔ – ✔ ✔ ✔ – ✔ – ✔ High
Correlation Moderately
high
Laule et al.
(2010)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ ✔ ✔ ✔ ✔ High
Correlation High
Prognostic High
Lee et al.
(2011)
Diagnostic ✔ ✔ ✔ ✔ – – ✔ – – ✔ – – – High
Correlation High
Prognostic High
Li et al. (2014) Diagnostic ✔ – ✔ – – – ✔ ✔ High
Lindberg et al.
(2012)
Diagnostic ✔ – ✔ – ✔ – – – High
Lycklama et al.
(2000)
Diagnostic ✔ – ✔ – – – ✔ – ✔ High
Correlation High
Maki et al.
(2015)
Diagnostic ✔ – ✔ – ✔ – ✔ – ✔ High
Correlation High
Mamata et al.
(2005)
Diagnostic ✔ – ✔ – – – – – High
Manconi et al.
(2008)
Diagnostic ✔ – ✔ ✔ – – ✔ – High
Marliani et al.
(2010)
Diagnostic ✔ – ✔ – – ✔ – – ✔ High
Correlation High
Miraldi et al.
(2013)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Mueller-Mang
et al. (2011)
Diagnostic ✔ – ✔ – – – – – High
Nair et al.
(2010)
Diagnostic ✔ – ✔ – ✔ ✔ ✔ – ✔ High
Correlation Moderately
high
Naismith et al.
(2013)
Diagnostic ✔ – – – ✔ – ✔ – ✔ High
Correlation High
Oh et al.
(2013a)
Correlation ✔ ✔ ✔ – ✔ ✔ ✔ – Moderately
high
Oh et al. Diagnostic ✔ ✔ ✔ – ✔ ✔ ✔ – ✔ Moderately
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consecutive
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factors
(2013b) high
Correlation Moderately
low
Oh et al.
(2015)
Diagnostic ✔ ✔ ✔ – ✔ ✔ ✔ – ✔ Moderately
high
Correlation Moderately
low
Ohgiya et al.
(2007)
Diagnostic ✔ ✔ ✔ – ✔ – – – High
Pessoa et al.
(2012)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Petersen et al.
(2012)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – ✔ High
Correlation Moderately
high
Rajasekaran
et al. (2014)
Diagnostic ✔ – ✔ – ✔ – ✔ – ✔ High
Correlation High
Raz et al.
(2013)
Diagnostic ✔ ✔ ✔ ✔ ✔ – ✔ – ✔ Moderately
high
Correlation Moderately
low
Renoux et al.
(2006)
Diagnostic ✔ – – – ✔ – – – High
Rocca et al.
(2001)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – ✔ High
Correlation Moderately
high
Rocca et al.
(2006)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – ✔ High
Correlation Moderately
high
Rocca et al.
(2012)
Diagnostic ✔ ✔ ✔ – ✔/–
DTI/fMRI
– ✔ – ✔ High
Correlation Moderately
high
(DTI)/high
(fMRI)
Rovaris et al.
(2000)
Correlation ✔ ✔ ✔ – ✔ – ✔ – High
Rovaris et al.
(2001a)
Diagnostic ✔ ✔ ✔ ✔ ✔ – – – High
Rovaris et al.
(2001b)
Diagnostic ✔ ✔ ✔ ✔ ✔ – ✔ – ✔ Moderately
high
Correlation Moderately
low
Rovaris et al.
(2004)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – High
Rovaris et al.
(2008)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – High
Salamon et al.
(2013)
Diagnostic ✔ – ✔ – – ✔ ✔ – ✔ High
Correlation High
Shanmuganat-
Shanmugan-
athan et al.
Diagnostic – – – – – – – – High
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(2008)
Silver et al.
(1997)
Diagnostic ✔ ✔ ✔ – – ✔ ✔ – – High
Correlation High
Song et al.
(2011)
Diagnostic ✔ ✔ ✔ ✔ – – – – High
Stroman et al.
(2004)
Diagnostic ✔ – ✔ – – – – – High
Taha Ali and
Badawy
(2013)
Diagnostic ✔ – ✔ – – – – – High
Toosy et al.
(2014)
Diagnostic ✔ ✔ ✔ – – ✔ ✔ – ✔ High
Correlation Moderately
high
Uda et al.
(2013)
Diagnostic ✔ – – ✔ ✔ – – ✔ High
Ukmar et al.
(2012)
Diagnostic ✔ – ✔ – – – – – – High
Correlation High
Valsasina et al.
(2005)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Valsasina et al.
(2007)
Diagnostic ✔ ✔ ✔ ✔ – – ✔ – ✔ High
Correlation Moderately
high
Valsasina et al.
(2010)
Diagnostic ✔ ✔ ✔ – – – ✔ – – High
Correlation High
Valsasina et al.
(2012)
Diagnostic ✔ ✔ ✔ – – – – – ✔ High
Correlation High
van Hecke
et al. (2009)
Diagnostic ✔ ✔ ✔ – ✔ ✔ – – High
Vedantam
et al. (2015)
Diagnostic – ✔ ✔ – – – ✔ – ✔ High
Correlation High
von
Meyenburg
et al. (2013)
Diagnostic ✔ – ✔ – ✔ – ✔ – ✔ High
Correlation High
Wang et al.
(2012)
Diagnostic ✔ – ✔ – – – ✔ – ✔ High
Correlation High
Wang et al.
(2014)
Diagnostic ✔ ✔ ✔ – – – ✔ – ✔ High
Correlation High
Wen et al.
(2014a)
Diagnostic ✔ – ✔ – ✔ – – – High
Wen et al.
(2014b)
Diagnostic ✔ – ✔ – ✔ – ✔ – ✔ ✔ ✔ ✔ – High
Correlation High
Prognostic High
Xiangshui
et al. (2010)
Diagnostic ✔ ✔ ✔ – – – – – High
Yan et al.
(2015)
Diagnostic ✔ ✔ ✔ – – – – – High
Zackowski
et al. (2009)
Diagnostic ✔ – ✔ – ✔ – ✔ – ✔ High
Correlation High
Zhou et al.
(2014)
Diagnostic ✔ ✔ ✔ – ✔ – ✔ – High
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